<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 A Systematic Analysis for the Global Burden of Disease Study</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-12-03">December 3, 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>MD, MPH</roleName><forename type="first">Christina</forename><surname>Fitzmaurice</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jama</forename><surname>Oncology</surname></persName>
						</author>
						<author>
							<persName><forename type="first">69</forename><surname>Ahern</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Hematology</orgName>
								<orgName type="department" key="dep2">Department of Medicine</orgName>
								<orgName type="department" key="dep3">Institute for Health Metrics and Evaluation</orgName>
								<orgName type="institution">University of Washington</orgName>
								<address>
									<addrLine>Ste 600</addrLine>
									<postCode>2301 5th, 98121</postCode>
									<settlement>Ave, Seattle</settlement>
									<region>WA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department">Institute for Prevention Research and Epidemiology</orgName>
								<address>
									<settlement>Research, Hessen, Bremen</settlement>
									<country>Germany (Westerman); Leibniz, Germany (Zeeb</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">Cairo University</orgName>
								<address>
									<settlement>Cairo, Egypt (Abd-Allah)</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution" key="instit1">College of Health Sciences</orgName>
								<orgName type="institution" key="instit2">Jimma University</orgName>
								<address>
									<settlement>Jimma</settlement>
									<country>Ethiopia (Ahmed</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution" key="instit1">College of Health Sciences</orgName>
								<orgName type="institution" key="instit2">University of Sheffield</orgName>
								<address>
									<settlement>Sheffield</settlement>
									<country>England (Alabed</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="department">Department of Otolaryngology-Head and Neck Surgery</orgName>
								<orgName type="institution">Queensland Health Herston</orgName>
								<address>
									<settlement>Brisbane</settlement>
									<region>Queensland</region>
									<country>Australia (Alam</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="department">Saudi Arabia (Aldhahri)</orgName>
								<orgName type="institution">King Saud University</orgName>
								<address>
									<settlement>Riyadh</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<orgName type="institution">Debre Markos University</orgName>
								<address>
									<addrLine>Debre Markos</addrLine>
									<country>Ethiopia (Alem, Boneya</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff8">
								<orgName type="department">School of Public Health</orgName>
								<orgName type="laboratory">Cancer Epidemiology Unit</orgName>
								<orgName type="institution">Mekelle University</orgName>
								<address>
									<settlement>Mekelle</settlement>
									<country>Ethiopia (Alemayohu</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff9">
								<orgName type="institution">University of Oxford</orgName>
								<address>
									<addrLine>England (Ali)</addrLine>
									<settlement>Oxford</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff10">
								<orgName type="department">Department of Preventive Medicine</orgName>
								<orgName type="institution" key="instit1">Public Health Directorate</orgName>
								<orgName type="institution" key="instit2">Ministry of Health</orgName>
								<address>
									<addrLine>Saudi Arabia (Al-Raddadi)</addrLine>
									<settlement>Jeddah, Makkah</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff11">
								<orgName type="department">School of Medicine</orgName>
								<orgName type="institution">University of Adelaide</orgName>
								<address>
									<settlement>Adelaide</settlement>
									<country>Australia (Amare</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff12">
								<orgName type="department" key="dep1">College of Medicine and Health Sciences</orgName>
								<orgName type="department" key="dep2">Department of Medicine</orgName>
								<orgName type="institution">Bahir Dar University</orgName>
								<address>
									<addrLine>Bahir Dar</addrLine>
									<country>Ethiopia (Amare</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff13">
								<orgName type="department">Department of Community Health Science</orgName>
								<orgName type="institution">Komfo Anokye Teaching Hospital Ghana</orgName>
								<address>
									<settlement>Kumasi</settlement>
									<country>Ghana (Amoako</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff14">
								<orgName type="department" key="dep1">Department of Medical Emergency</orgName>
								<orgName type="department" key="dep2">School of Paramedic</orgName>
								<orgName type="institution">University of Manitoba</orgName>
								<address>
									<settlement>Winnipeg</settlement>
									<region>Manitoba</region>
									<country>Canada (Artaman</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff15">
								<orgName type="department" key="dep1">College of Medicine and Health Sciences</orgName>
								<orgName type="department" key="dep2">Department of Nursing</orgName>
								<orgName type="institution">Qom University of Medical Sciences</orgName>
								<address>
									<settlement>Qom</settlement>
									<country>Iran (Asayesh</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff16">
								<orgName type="institution">Mizan Tepi University</orgName>
								<address>
									<addrLine>Mizan Teferi</addrLine>
									<country>Ethiopia (Atnafu</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff17">
								<orgName type="department">Department of Biostatistics</orgName>
								<orgName type="institution">Nayati Multi Super Speciality Hospital</orgName>
								<address>
									<region>Mathura</region>
									<country>India (Awasthi</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff18">
								<orgName type="department" key="dep1">Department of Community Medicine</orgName>
								<orgName type="department" key="dep2">Aden Cancer Registry, and Research Center Faculty of Medicine and Health Sciences</orgName>
								<orgName type="institution">Aden University</orgName>
								<address>
									<settlement>Aden</settlement>
									<country>Yemen (Saleem</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff19">
								<orgName type="department">Clinic for Infectious and Tropical Diseases</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff20">
								<orgName type="department" key="dep1">Clinical Center of Serbia</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution">University of Belgrade</orgName>
								<address>
									<settlement>Belgrade</settlement>
									<country>Serbia (Barac</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff21">
								<orgName type="department" key="dep1">Department of Epidemiology</orgName>
								<orgName type="department" key="dep2">Tropical Disease Unit</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff22">
								<orgName type="department">College of Public Health and Tropical Medicine</orgName>
								<address>
									<addrLine>Saudi Arabia (Bedi)</addrLine>
									<settlement>Jazan</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff23">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution">University of São Paul</orgName>
								<address>
									<settlement>São Paul</settlement>
									<country>Brazil (Bensenor</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff24">
								<orgName type="department">Division of Population and Patient Health</orgName>
								<orgName type="institution" key="instit1">College of Health Sciences</orgName>
								<orgName type="institution" key="instit2">Debre Berhan University</orgName>
								<address>
									<settlement>Debre Berhan</settlement>
									<country>Ethiopia) (Berhane</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff25">
								<orgName type="department">England (Bernabé, Marcenes)</orgName>
								<orgName type="institution">King&apos;s College London Dental Institute</orgName>
								<address>
									<settlement>London</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff26">
								<orgName type="institution">Mekelle University</orgName>
								<address>
									<settlement>Tigray</settlement>
									<country>Ethiopia (Betsu</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff27">
								<orgName type="institution">University of Global Health Equit</orgName>
								<address>
									<settlement>Kigali</settlement>
									<country>Rwanda (Binagwaho</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff28">
								<orgName type="department">Department of Global Health and Social Medicine</orgName>
								<orgName type="institution" key="instit1">Harvard Medical School</orgName>
								<orgName type="institution" key="instit2">Harvard University</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<region>Massachusetts (Binagwaho)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff29">
								<orgName type="institution">National Institute of Public Health</orgName>
								<address>
									<addrLine>Campos-Nonato)</addrLine>
									<settlement>Morelos</settlement>
									<country key="MX">Mexico</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff30">
								<orgName type="institution">Instituto Nacional de Salud Bogota</orgName>
								<address>
									<settlement>Bogota</settlement>
									<country>Colombia (Castañeda-Orjuela</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff31">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">University of Valencia/ INCLIVA Health Research Institute and CIBERSAM</orgName>
								<address>
									<settlement>Valencia</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff32">
								<orgName type="department">Clinical Epidemiology Program</orgName>
								<orgName type="institution" key="instit1">(Catalá-López</orgName>
								<orgName type="institution" key="instit2">Tabarés-Seisdedos)</orgName>
								<orgName type="institution" key="instit3">Ottawa Hospital Research Institute</orgName>
								<address>
									<settlement>Ottawa</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff33">
								<orgName type="institution">Coast Health</orgName>
								<address>
									<settlement>Southport</settlement>
									<region>Queensland, Chiang)</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff34">
								<orgName type="institution">National Center for Child Health and Development</orgName>
								<address>
									<settlement>Tokyo</settlement>
									<country>Japan (Chibueze</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff35">
								<orgName type="institution">Ministry of Health</orgName>
								<address>
									<settlement>Baghdad</settlement>
									<country>Iraq (Chitheer</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff36">
								<orgName type="institution">Seoul National University Hospital</orgName>
								<address>
									<settlement>Seoul</settlement>
									<country>South Korea (Choi</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff37">
								<orgName type="institution">WHO Collaborating Centre for Viral Hepatitis</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff38">
								<orgName type="institution">Doherty Institute</orgName>
								<address>
									<settlement>Melbourne</settlement>
									<country>Australia (Cowie</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff39">
								<orgName type="department">School of Public Health</orgName>
								<orgName type="institution" key="instit1">College of Health Sciences and Medicine</orgName>
								<orgName type="institution" key="instit2">Wolaita Sodo University</orgName>
								<address>
									<settlement>Wolaita Sodo</settlement>
									<country>Ethiopia) (Damtew</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff40">
								<orgName type="department">Instituto de Investigação e Inovação em Saúde</orgName>
								<orgName type="institution">University of Porto</orgName>
								<address>
									<settlement>Porto</settlement>
									<country>Portugal (das Neves</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff41">
								<orgName type="department" key="dep1">Department of Community Medicine</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution" key="instit1">Indian Institute of Public Health-Delhi</orgName>
								<orgName type="institution" key="instit2">Public Health Foundation of India</orgName>
								<address>
									<settlement>Gurgaon</settlement>
									<country>India (Dey</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff42">
								<orgName type="institution">University of Peradeniya</orgName>
								<address>
									<settlement>Peradeniya</settlement>
									<country key="LK">Sri Lanka</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff43">
								<orgName type="department" key="dep1">Injuries</orgName>
								<orgName type="department" key="dep2">Department of Nutrition</orgName>
								<orgName type="institution">Public Health Foundation of India</orgName>
								<address>
									<settlement>Gurgaon</settlement>
									<country>India (Dhillon</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff44">
								<orgName type="department">Massachusetts (Ding)</orgName>
								<orgName type="institution">Harvard University</orgName>
								<address>
									<settlement>Boston</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff45">
								<orgName type="department">Sydney School of Public Health</orgName>
								<orgName type="institution">University of Sydney</orgName>
								<address>
									<settlement>Sydney</settlement>
									<region>New South Wales, Driscoll)</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff46">
								<orgName type="department" key="dep1">Division of Cancer Prevention and Control</orgName>
								<orgName type="department" key="dep2">National Center for Chronic Disease</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff47">
								<address>
									<addrLine>September 9</addrLine>
									<postCode>2016</postCode>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 A Systematic Analysis for the Global Burden of Disease Study</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-12-03">December 3, 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">9EFB29E5FBED09DB707053BCC5AA4973</idno>
					<idno type="DOI">10.1001/jamaoncol.2016.5688</idno>
					<note type="submission">Accepted for Publication: October 10, 2016.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:19+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>JAMA Oncology | Special Communication Flaxman AD</term>
					<term>Vahdatpour A</term>
					<term>James SL</term>
					<term>Birnbaum JK</term>
					<term>Murray CJ; Population Health Metrics Research Consortium (PHMRC). Direct estimation of cause-specific mortality fractions from verbal autopsies: multisite validation study using clinical diagnostic gold standards</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Global Burden of Disease Cancer Collaboration</head><p><s>IMPORTANCE Cancer is the second leading cause of death worldwide.</s><s>Current estimates on the burden of cancer are needed for cancer control planning.</s><s>OBJECTIVE To estimate mortality, incidence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 32 cancers in 195 countries and territories from 1990 to 2015.</s></p><p><s>EVIDENCE REVIEW Cancer mortality was estimated using vital registration system data, cancer registry incidence data (transformed to mortality estimates using separately estimated mortality to incidence [MI] ratios), and verbal autopsy data.</s><s>Cancer incidence was calculated by dividing mortality estimates through the modeled MI ratios.</s><s>To calculate cancer prevalence, MI ratios were used to model survival.</s><s>To calculate YLDs, prevalence estimates were multiplied by disability weights.</s><s>The YLLs were estimated by multiplying age-specific cancer deaths by the reference life expectancy.</s><s>DALYs were estimated as the sum of YLDs and YLLs.</s><s>A sociodemographic index (SDI) was created for each location based on income per capita, educational attainment, and fertility.</s><s>Countries were categorized by SDI quintiles to summarize results.</s><s>FINDINGS In 2015, there were 17.5 million cancer cases worldwide and 8.7 million deaths.</s><s>Between 2005 and 2015, cancer cases increased by 33%, with population aging contributing 16%, population growth 13%, and changes in age-specific rates contributing 4%.</s><s>For men, the most common cancer globally was prostate cancer (1.6 million cases).</s><s>Tracheal, bronchus, and lung cancer was the leading cause of cancer deaths and DALYs in men (1.2 million deaths and 25.9 million DALYs).</s><s>For women, the most common cancer was breast cancer (2.4 million cases).</s><s>Breast cancer was also the leading cause of cancer deaths and DALYs for women (523 000 deaths and 15.1 million DALYs).</s><s>Overall, cancer caused 208.3 million DALYs worldwide in 2015 for both sexes combined.</s><s>Between 2005 and 2015, age-standardized incidence rates for all cancers combined increased in 174 of 195 countries or territories.</s><s>Age-standardized death rates (ASDRs) for all cancers combined decreased within that timeframe in 140 of 195 countries or territories.</s><s>Countries with an increase in the ASDR due to all cancers were largely located on the African continent.</s><s>Of all cancers, deaths between 2005 and 2015 decreased significantly for Hodgkin lymphoma (−6.1% [95% uncertainty interval (UI), −10.6% to −1.3%]).</s><s>The number of deaths also decreased for esophageal cancer, stomach cancer, and chronic myeloid leukemia, although these results were not statistically significant.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONCLUSION AND RELEVANCE</head><p><s>As part of the epidemiological transition, cancer incidence is expected to increase in the future, further straining limited health care resources.</s><s>Appropriate allocation of resources for cancer prevention, early diagnosis, and curative and palliative care requires detailed knowledge of the local burden of cancer.</s><s>The GBD 2015 study results demonstrate that progress is possible in the war against cancer.</s><s>However, the major findings also highlight an unmet need for cancer prevention efforts, including tobacco control, vaccination, and the promotion of physical activity and a healthy diet.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>I</head><p><s>n 2015, cancer caused over 8.7 million deaths globally and was the second leading cause of death behind cardiovascular diseases. 1</s><s>Even though these impressive numbers are testimony that the "war on cancer" has not been won, recent developments in personalized medicine and novel treatment approaches like immunotherapy have raised hope of significantly improving cancer survival. 2-4</s><s>These expectations for patients with cancer in highincome countries contrast with the challenge of making basic diagnostic and treatment options widely available in low-resource settings. 5</s><s>Both the equity and affordability of cancer care from individual and societal perspectives are increasingly being questioned. 6</s><s> Survival rates between and within high-income countries differ for reasons such as variation in education, access to specialized care, effective treatment, and insurance status. 7-9</s><s>The full potential of cancer prevention for reducing incidence and mortality is far from being realized, and efforts are especially lagging in low-income countries. 10</s><s> Awareness of this "cancer divide," with substantially worse outcomes and a high burden in socioeconomically disadvantaged populations, has led to a focus on global oncology by the international health community. 4,5,10</s><s>This is reflected in the third Sustainable Development Goal (SDG) to "by 2030, reduce by one-third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being." 11</s><s> Estimates of the burden of cancer are produced annually as part of the Global Burden of Disease (GBD) study providing a unique means of tracking progress in closing this divide.</s><s>Here, we present results of the GBD 2015 study for 32 cancer groups covering cancer incidence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life years (DALYs) for 195 countries or territories from 1990 to 2015 for both sexes across age groups.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Differences Between GBD 2015 and GBD 2013</head><p><s>General methods for GBD 2015 and prior GBD studies have been described previously. 1,12</s><s>Here, we present methods and results specific to the GBD 2015 cancer estimation.</s><s>The general framework for the cancer estimation in GBD 2015 has remained similar to GBD 2013, exceptions are detailed below. 13</s><s>The GBD 2015 study is compliant with the newly developed Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER). 14</s><s>A chart detailing fulfillment of GATHER requirements is provided in eTable 1 in the Supplement; flowcharts and a detailed description for each estimation step are also available in the eAppendix and in the numerous eTables and eFigures in the Supplement.</s><s>Box 1 includes a list of the figures and tables in this article.</s><s>Further details about methods and data sources are provided in the eAppendix, eFigures, and eTables in the Supplement.</s><s>Box 2 contains a list of the supplementary figures and tables.</s><s>Additional information is available from the authors in web tables 1 through 3; the web addresses for these items are listed in Box 3. Hereinafter, citations to web tables are for those given in Box 3. Data sources for GBD 2015 are listed in eTable 2 in the Supplement, including which new sources were added compared with GBD 2013.</s></p><p><s>Relevant changes in the estimation strategy since GBD 2013 include the addition of 7 territories (American Samoa, Bermuda, Greenland, Guam, Northern Mariana Islands, Puerto Rico, and the US Virgin Islands), which previously were only included in the GBD regional totals.</s><s>Results for the United Kingdom are reported for Northern <ref type="bibr">Ireland, Scotland, Wales, and England)</ref>.</s><s>Changes to the GBD causes include dividing "leukemia" into acute lymphoid leukemia, chronic lymphoid leukemia, acute myeloid leukemia, and chronic myeloid leukemia.</s><s>Methodological updates were made to the mortality to incidence (MI) ratio estimation, which are described in detail in the eAppendix in the Supplement.</s><s>Major updates for the MI ratio predictions were out-of-sample validation of multiple model types and selection of 1 model per cancer based on the out-of-sample rootmean-squared error.</s></p><p><s>For GBD 2015, a sociodemographic index (SDI) was developed, which is a summary indicator derived from measures of income per capita, educational attainment, and fertility.</s><s>Detailed methods describing computation of the SDI are reported elsewhere. 1</s><s>In brief, the SDI weighs each component, which is rescaled between 0 and 1, equally.</s><s>The composite SDI index is the mean of the 3 rescaled components.</s><s>An SDI of 1.0 can be interpreted as a location that has the highest observed educational attainment, the highest log income per capita, and the lowest fertility rate.</s><s>For GBD 2015, SDI quintiles were used to group countries that are similar based on their development status.</s><s>Locations were grouped into quintiles based on their SDI value in 2015.</s><s>Quintile cutoffs were based on the distribution of geography-years from 1980 to 2015 with the exception of populations smaller than 1 million.</s><s>eFigure 4 and eTable 8 in the Supplement show the SDI quintile for each country.</s><s>As for every GBD study, the full time series estimated for each GBD cycle supersedes prior GBD studies.</s><s>For GBD 2015, the full time series from 1990 to 2015 was estimated.</s><s>We focus here on changes over the last decade.</s><s>Estimates before 2005 as well as additional results can be found online (https://vizhub.healthdata.org/gbd-compare/).</s></p><p><s>To maximize data availability and take advantage of cancer registry data in countries with scarce mortality data, incidence data from cancer registries were transformed to mortality estimates through the use of separately estimated MI ratios.</s><s>Modeling of the MI ratios is described in detail in the eAppendix in the Supplement.</s><s>In brief, the estimation followed a 3-step approach, the creation of logit random effect models, spatiotemporal smoothing, and Gaussian process regression.</s><s>A final model was selected based on out-of-sample validation.</s><s>Updated cancer registry data for GBD 2015 was obtained from the GBD collaborator network or downloaded from publically available sources.</s><s>All data sources used for MI ratio estimation, as well as those used for incidence data transformed to mortality estimates, are listed in the eAppendix and eTable 2 in the Supplement.</s></p><p><s>For cancer estimation, 333 513 site-years were used from vital registration systems, 785 site-years from verbal autopsy, 619 site years from surveillance data, and 69 013 site years from cancer registry data.</s><s>The number of site-years used by source type and by cancer can be found in eTable 3 in the Supplement.</s><s>All data sources were extracted at the most detailed cause-and age-specific level and mapped to the GBD cause list.</s><s>Codes from the International Classification of <ref type="bibr">Diseases,</ref>, and International Statistical Classification of <ref type="bibr">Diseases and Related Health Problems,</ref>, for each GBD cancer group as well as a description of data processing steps can be found in the eAppendix in the Supplement.</s><s>The 32 cancer groups, together referred to as the "all cancer" group, encompass all malignant neoplasms as defined in the ICD-10 except for nonmelanoma skin cancer (NMSC, ICD-10 code C44) and Kaposi sarcoma (ICD-10 code C46).</s><s>Although NMSC is the most common cancer in many populations, most cancer registries do not include NMSC, which necessitates different estimation methods from the cancers presented here.</s><s>16 Deaths due to Kaposi sarcoma are not separately included because these were attributed to human immunodeficiency virus/AIDS in the GBD study.</s></p><p><s>The combined data on individual causes of death were used as input for the Cause of Death Ensemble model (CODEm). 17</s><s>Covariates used for each cancer are listed in the eAppendix in the Supplement.</s><s>Individual cause mortality estimates from CODEm were constrained to fit independently modeled, all-cause mortality estimates using the tool CodCorrect. 1 We calculated YLLs by multiplying each death with the life expectancy for that age taken from a normative life table; life expectancy at birth was 86.5 years, which is based on the lowest observed death rate in each 5-year age group in populations over 5 million. 1</s><s> Final mortality estimates were transformed into incidence estimates using modeled MI ratios.</s><s>Uncertainty from the mortality estimation and from the MI ratio estimation was propagated to the incidence estimates.</s><s>Ten-year cancer prevalence was modeled by estimating cancer survival using an MI ratio-based scaling factor, which takes into account location, year, and sex (see the eAppendix in the Supplement for details).</s><s>This factor was used to scale the incidence cohort between a theoretical best-case and a theoretical worst-case survival.</s><s>The absolute survival estimates allowed calculation of 10-year prevalence for each incidence cohort.</s></p><p><s>Total prevalence was divided into 4 sequelae reflecting varying degrees of disability during the cancer continuum: (1) diagnosis/ treatment, (2) remission, (3) metastatic/disseminated, and (4) terminal phase.</s><s>Duration of the 4 prevalence phases by cancer can be found in eTable 13 in the Supplement.</s><s>Since data sources including stage distribution and treatment approaches are not available for most countries, the simplifying assumption of a constant duration of the diagnosis and treatment, metastatic/disseminated, and terminal phase for all ages, over time, and all countries was made.</s><s>After dividing total prevalence into these 3 sequelae, we attributed the remaining prevalence to the remission phase.</s></p><p><s>To calculate YLDs, the prevalence for each sequela was multiplied with a disability weight.</s><s>Additional disability was estimated for procedures and procedure-related morbidities associated with the treatment of breast, larynx, colorectal, bladder, and prostate cancer (mastectomy, laryngectomy, stoma, urinary incontinence, and impotence) under the assumption that these are major disabling sequelae after cancer treatment.</s><s>Disability weights used for the different sequelae as well as methods to determine disability prevalence for these cancer-related outcomes can be found in the  We calculated 2 scenarios to analyze the contribution of population aging, population growth, and changes in the age-specific incidence rates on the absolute change of cancer incidence.</s><s>In the first scenario, the age structure, sex structure, and the age-specific rates from 2005 were applied to the total population of the year 2015.</s><s>The difference between the total number of cases in 2005 and the hypothetical scenario were attributed to population growth.</s><s>In the second hypothetical scenario, the age-specific rates from 2005 were applied to the age structure, sex structure, and population size of 2015.</s><s>Differences between the second hypothetical scenario and the first hypothetical scenario were attributed to population aging.</s><s>Differences between the total number of cases in 2015 and the second hypothetical scenario were attributed to changes in the agespecific rates.</s></p><p><s>In this publication, all rates are reported per 100 000 personyears.</s><s>The GBD world population standard was used for the calculation of age-standardized weights. 18</s><s>We report 95% uncertainty intervals (UIs) for all estimates (listed in parentheses after point estimates).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Global Incidence, Mortality, and DALYs</head><p><s>In 2015, there were 17.5 million incident cancer cases worldwide and 8.7 million cancer deaths, as detailed in Table <ref type="table" target="#tab_0">1</ref>.</s><s>Cancer caused 208.3 million DALYs in 2015, of which 96% came from YLLs and 4% came from YLDs (Web Table <ref type="table">3</ref>).</s><s>At the global level, the odds of developing cancer during a lifetime (age 0-79 years) differed between the sexes: they were 1 in 3 for men and 1 in 4 for women (eTable 16 in the Supplement).</s><s>These odds differ substantially among SDI categories.</s><s>In the lowest SDI quintile, the odds of developing cancer for men aged between 0 and 79 years were 1 in 6, whereas in the highest SDI quintile, 1 in 2 men developed cancer.</s><s>For women, the odds of developing cancer was 1 in 5 in the lowest SDI quintile and 1 in 3 in the highest quintile.</s></p><p><s>In 2015, prostate cancer, TBL (tracheal, bronchus, and lung) cancer, and colorectal cancer were the most common incident (95% UI) cancers in men-accounting for 42% of all cancer cases among menwith 1.6 million (1. <ref type="bibr">3-2.2 million), 1.4 million (1.3-1.5 million)</ref>, and 920 000 (878 000-965 000) cases, respectively (Table <ref type="table" target="#tab_0">1</ref>).</s><s>The most common causes of cancer deaths for men were TBL, liver, and stomach cancer with 1. <ref type="bibr">21 (1.16-1.25</ref>)</s><s>million, 577 000 (524 000-622 000),and535 000(516 000-556 000)deaths,respectively.The leading causes for cancer DALYs in 2015 for men were TBL, liver, and stomach cancer, with 25.9 million (25.0-27.0 million), <ref type="bibr">15.4 million (14.0-16.7 million), and 11.7 million (11.2-12.2 million)</ref>, respectively.</s><s>For women in 2015, the most common incident cancers were breast, colorectal, and TBL cancer, with 2.4 million (2.2-2.5 million), 733 000 (702 000-767 000), and 640 000 (602 000-690 000), respectively.</s><s>These cancers were responsible for 46% of all incident cases among women.</s><s>The leading causes of cancer deaths were breast, TBL, and colorectal cancer, 523 000 (492 000-543 000), 517 000 (497 000-538 000), and 376 000 (363 000-391 000) deaths, respectively.</s><s>Breast, TBL, and colorectal cancer were also the leading causes for female cancer DALYs in 2015, with 15.1 million <ref type="bibr">(14.2-15.9 million), 10.5 million (10.1-11.0 million), and 7.2 million (7.0-7.5 million)</ref>, respectively.</s></p><p><s>Figure <ref type="figure" target="#fig_1">1</ref> shows the pattern of cancer incidence and mortality by age group.</s><s>For childhood cancers (age 0-14 years), the most common were leukemia, other neoplasms (see eTables 4 and 5 in the Supplement for ICD codes included under "other neoplasms"), non-Hodgkin lymphoma (NHL), and brain and nervous system cancers (Figure <ref type="figure" target="#fig_1">1A</ref>).</s><s>Leukemia, other neoplasms, and brain and nervous system cancers were also the leading contributors to childhood cancer deaths (Figure <ref type="figure" target="#fig_1">1B</ref>).</s><s>For adolescents and young adults (age 15-39 years) the most common cancers at the global level were breast cancer, cervical cancer, and other neoplasms.</s><s>The main causes of cancer deaths for this age group were leukemia, other neoplasms, and liver cancer.</s><s>For the population older than 39 years, the cancers contributing the most incident cases were TBL, breast, prostate, and colorectal cancer, while the main contributors to cancer deaths in this age group were TBL, stomach, and colorectal cancer.</s></p><p><s>Between 2005 and 2015, age-standardized incidence rates (ASIRs) for all cancers combined increased in 174 of 195 countries or territories (Figure <ref type="figure" target="#fig_2">2</ref>).</s><s>China was a notable exception, with a 12% decrease in cancer incidence.</s><s>In contrast, age-standardized death rates (ASDR) for all cancers combined decreased within that timeframe in 140 of 195 countries or territories, as shown in Figure <ref type="figure" target="#fig_3">3</ref>, which also shows that countries with an increase in ASDR were largely located on the African continent.</s></p><p><s>The number (95% UI) of incident cases increased in all SDI quintiles between 2005 and 2015 for nearly all cancers; exceptions were esophageal cancer in middle and high-middle SDI countries, where incidence fell by 9% (−24.3% to 8.3%) and 4% (−17.7% to 14.0%), respectively, and cervical cancer in middle, high-middle, and high SDI countries, with a 5% (−19.6% to 12.3%), 5% (−14.3 to 6.2), and 2% (−7.4% to 2.9%) decrease, respectively (Web Table <ref type="table" target="#tab_0">1</ref>).</s><s>However, these decreases were not statistically significant.</s><s>The largest increase in cancer incident cases between 2005 and 2015 occurred in low SDI countries, with a 50% increase, of which population growth contributed 33%, changing age-specific incidence rates 13%, and changing age structure 4% (eTable 15 in the Supplement).</s><s>The second largest increase occurred in the low-middle SDI quintile, with a 40% increase, followed by high SDI countries, with a 36% increase, highmiddle SDI countries, with a 28% increase, and middle SDI countries, with a 27% increase (eTable 15 in the Supplement).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Global Top 10 Cancers in 2015</head><p><s>The top 10 cancers were ranked highest (top) number of incident cases (Figure <ref type="figure">4</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Breast Cancer</head><p><s>Breast cancer was the most common cancer overall, with an estimated 2.4 million (95% UI, 2.3-2.5 million) incident cases in 2015.</s><s>The vast majority occurred in women, with 2.4 million (95% UI, 2.2-2.5 million) cases vs 44 000 (95% UI, 40 000-49 000) cases in men (Table <ref type="table" target="#tab_0">1</ref>).</s><s>Breast cancer was the leading cause of cancer in all SDI quintiles except for the high and high-middle SDI quintiles where it was the second most common cancer (Figure <ref type="figure">4</ref>).</s><s>It was the cause of death for 523 000 (95% UI, 492 000-543 000) women and 10 000 (95% UI, 9000-11 000) men, making it the fifth leading cause of cancer deaths for both sexes in 2015 at the global and the low SDI countries, the fourth leading cause in high SDI countries, the sixth leading cause in high-middle and middle SDI countries, and the third leading cause in the low-middle SDI quintile (Figure <ref type="figure">5</ref>).</s><s>For women, breast cancer was the leading cause of death in 2015 (Table <ref type="table" target="#tab_0">1</ref>).</s><s>Breast cancer caused 15.4 million (95% UI, 14.4-16.2</s><s>million) DALYs for both sexes, of which 88% came from YLLs, and 12% from YLDs (eFigure 13 in the Supplement).</s><s>One in 14 women and 1 in 603 men developed breast cancer between birth and age 79 years (eTable 16 in the Supplement) at the global level.</s><s>For women, the odds of developing breast cancer were the highest in high SDI countries, with 1 in 9 women developing breast cancer, compared with the lowest odds of 1 in 20 women in middle SDI countries developing breast cancer between age 0 and 79 years.</s></p><p><s>For women (per 100 000 person-years) in 2015, ASIRs (95% UIs) and ASDRs (95% UIs) were the lowest in East Asia: , ; South Asia: , ; and Andean Latin America: ASIR 47.2 <ref type="bibr">(39.6-54.6)</ref>,</s><s>(Web Tables <ref type="table" target="#tab_7">1 and 2</ref>).</s><s>They were the highest in high-income North America: ASIR 124. ; Western Europe: ASIR 124.</s><s><ref type="bibr">7 (116.3-138.3)</ref>, .</s><s><ref type="bibr">5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69</ref>  Breast cancer was the most common cancer for women in 183 countries or territories and the most common cause of cancer deaths in women in 115 countries or territories (eFigures 10 and 12 in the Supplement).</s></p><p><s>Between 2005 and 2015, breast cancer remained the fifth leading cause of global cancer YLLs, as shown in Figure <ref type="figure" target="#fig_5">6</ref>.</s><s>If global population size and age structure had remained stable between 2005 and 2015, the change in age-specific incidence rates between 2005 and 2015 would have resulted in a 15% increase in incident cases (Table <ref type="table" target="#tab_1">2</ref>).</s><s>Overall incident cases increased by 43% because of population growth (contributing an additional 13%) and aging (contributing 15%).</s><s>The ASIR (95% UI) for women (per 100 000 person-years) between 2005 and 2015 increased by 12% (95% UI, 4.3%-19.5%)</s><s>at the global level from 58.5 <ref type="bibr">(55.7-61.9)</ref> to <ref type="bibr">65.5 (61.7-68.8)</ref>.</s><s>The largest increase occurred in low SDI countries, with a 26% increase, from <ref type="bibr">52.8 (43.8-70.2)</ref> to <ref type="bibr">66.4 (51.3-88.2)</ref>.</s><s>ASIR at the global level and for all SDI quintiles increased since 1990 (Figure <ref type="figure" target="#fig_6">7</ref>).</s><s>Age-standardized DALY rates (95% UI) for women between 2005 and 2015 decreased by 6% (−12.1% to −1.0%) at the global level, with the largest decrease of 10% (−17.9% to −3.3%) in high-middle SDI countries and the largest increase in low SDI countries of 10% (−12.5% to 38.5%), which was not statistically significant (Web Table <ref type="table">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Tracheal, Bronchus, and Lung Cancer</head><p><s>In 2015, there were 2 million (95% UI, 1.9-2.1 million) incident cases of TBL cancer and 1.7 million (95% UI, 1.67-1.77</s><s>million) deaths.</s><s>Tra-cheal, bronchus, and lung cancer caused 36.4 million (95% UI, 35.4-37.6 million) DALYs in 2015, of which 99% came from YLLs and 1% from YLDs (eFigure 13 in the Supplement).</s><s>Men were more likely to develop TBL cancer than women, with 1 in 18 men and 1 in 45 women developing TBL cancer between birth and age 79 years (eTable 16 in the Supplement).</s><s>The odds were the highest in high SDI countries, with 1 in 13 men and 1 in 27 women developing TBL cancer.</s><s>In low SDI countries the odds were substantially lower, with 1 in 70 men and 1 in 199 women developing TBL cancer between birth and age 79 years.</s><s>Overall, TBL cancer had the second highest absolute incidence globally as well as in middle and low-middle SDI countries; TBL was the leading cause of cancer in high-middle SDI countries and ranked fourth in high SDI countries and tenth in low SDI countries (Figure <ref type="figure">4</ref>).</s><s>It was the most common cause of cancer deaths by absolute cases globally as well as in all SDI quintiles except for countries in the low SDI group, where TBL cancer ranked seventh (Figure <ref type="figure">5</ref>).</s></p><p><s>ASIRs and ASDRs (95% UI) (per 100 000 person-years) for men were the lowest in Eastern Sub-Saharan Africa: ASIR 8.6 (6.9-10.7),</s><s>; Central Sub-Saharan Africa: ; and Western Sub-Saharan Africa: ASIR 12.8 <ref type="bibr">(10.7-16.5)</ref>, .</s><s>They were the highest in men in high-income North America: ASIR 70.9 <ref type="bibr">(66.3-75.7)</ref>,</s><s>; Central Europe: ASIR 70.5 <ref type="bibr">(66.5-75.0)</ref>,</s><s>ASDR 61 <ref type="bibr">(58.6-63.1)</ref>;</s><s>and high-income Asia Pacific: ASIR 67.5 <ref type="bibr">(62.8-72.4)</ref>, .</s><s>For women in 2015, incidence rates were the lowest in Eastern Sub-Saharan Africa: ASIR 2.7 (2.0-3.6),</s><s>ASDR 3.2 <ref type="bibr">(2.3-4.2)</ref>;</s><s>Western Sub-Saharan Africa: ASIR 5.2 (3.9-7.5), ; and South Asia: ASIR 5.3 (4.5-6.3),</s><s>ASDR 5.5 <ref type="bibr">(5.1-5.9)</ref>.</s><s>Incidence rates were the highest in high-income North America: ASIR 51.7 ; Australasia: ASIR 28. ; and high-income Asia Pacific: ASIR 25.4 .</s><s>(Web Tables <ref type="table" target="#tab_7">1 and 2</ref>).</s><s>Tracheal, bronchus, and lung cancer was the cause of the most incident cases for men in 38 countries and the most common cause for cancer deaths in 113 countries or territories (eFigures 9 and 11 in the Supplement).</s></p><p><s>For women, TBL cancer was the most common cause of cancer deaths in 20 countries and territories (eFigure 12 in the Supplement).</s></p><p><s>Between 2005 and 2015, TBL cancer cases increased by 29% (95% UI, 21.5%-37.0%)</s><s>(Web Table <ref type="table" target="#tab_0">1</ref>).</s><s>Population growth alone contributed 13%.</s><s>Aging of the population contributed 18% of the total increase.</s><s>This increase was partially offset by a decrease in agespecific rates, which would have led to a 2% decrease in incidence if the age structure and population size had remained constant between 2005 and 2015.</s><s>Figure <ref type="figure" target="#fig_7">8</ref> shows slightly decreasing ASIR at the global level for men and increasing trends for women between 1990 and 2015.</s><s>This trend was much more pronounced for the high SDI quintile.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Colon and Rectum Cancer</head><p><s>In 2015, there were 1.7 million (95% UI, 1.6-1.7 million) incident cases of colon and rectum cancer, and it caused 832 000 (95% UI, 812 000-855 000) deaths (Table <ref type="table" target="#tab_0">1</ref>).</s><s>Colon and rectum cancer caused 17 million (95% UI, 16.6-17.5</s><s>million) DALYs in 2015 of which 96% came from YLLs and 4% came from YLDs (eFigure 13 in the Supplement).</s><s>The odds of developing colon and rectum cancer before age 79 years at the global level was higher for men than for women (1 in 28 men, 1 in 43 women, eTable 16 in the Supplement).</s><s>The highest odds were in the high SDI quintile, with 1 in 14 men and 1 in 23 women developing colorectal cancer compared with 1 in 94 men and 1 in 112 women in the low SDI quintile.</s><s>Globally, and for high SDI countries, colon and rectum cancer ranked third for cancer incidence and second for cancer deaths in 2015 as shown in Figures <ref type="figure">4 and 5</ref>. Colon and rectum cancer incidence ranked lowest in low SDI countries as the eighth most common cancer and was the sixth leading cause for cancer mortality.</s></p><p><s>As can be seen in Web Tables <ref type="table" target="#tab_7">1 and 2</ref>, in 2015 ASIRs and ASDRs (95% UI) per 100 000 person-years for men were the lowest in South Asia: ASIR 8.2 (6.9-9.5), ; Central Sub-Saharan Africa: ASIR 8.7 (5.9-12.9),</s><s>ASDR 9.5 <ref type="bibr">(6.4-14.1)</ref>;</s><s>and Western Sub-Saharan Africa: ASIR 9.0 <ref type="bibr">(7.4-12.2)</ref>, .</s><s>Rates were highest in Australasia: ASIR 86. <ref type="bibr">4 (76.1-98.5)</ref>,</s><s>; high-income Asia Pacific: ASIR 78.</s><s><ref type="bibr">7 (74.3-83.4)</ref>,</s><s>; and Western Europe: ASIR 60.0 <ref type="bibr">(56.7-63.3)</ref>, .</s><s>For women, rates in 2015 were the lowest in Western Sub-Saharan Africa: ASIR 7.1 <ref type="bibr">(5.6-9.8)</ref>, ; South Asia: ASIR 7.1 (6.0-8.4), ; and Central Sub-Saharan Africa: , .</s><s>They were the highest in Australasia: ASIR 64.9 <ref type="bibr">(56.6-74.5)</ref>,</s><s>; high-income Asia  Pacific: ; and highincome North America: , .</s><s>Colon and rectum cancer was the cancer with the highest incidence in 2015 for men in 6 countries (eFigure 9 in the Supplement).</s><s>For women, colon and rectum cancer was the most common cause of cancer deaths in 5 countries (eFigure 12 in the Supplement).</s></p><p><s>Colon and rectum cancer has remained the fourth leading cause for cancer YLLs between 2005 and 2015 (Figure <ref type="figure" target="#fig_5">6</ref>).</s><s>As summarized Figure <ref type="figure" target="#fig_8">9</ref> shows similar trends in ASIRs between men and women for all levels of SDI except for the high-middle SDI quintile, where trends are decreasing in women but increasing in men.</s><s>As can be seen in Web Table <ref type="table" target="#tab_0">1</ref>, ASIRs (95% UIs) have increased by 7% (1.8%-11.6%)</s><s>between 2005 and 2015 for men but have remained stable for women at the global level: −0.2% (−4.3% to 4.4%).</s><s>The largest in-crease occurred in low-middle SDI countries at 25% (10.3%-40.2%)</s><s>for men and 13% (0.7%-27.4%) for women.</s></p><p><s>Between 2005 and 2015, age-standardized DALY rates for both sexes decreased by 8% (−10.2% to −6.2%) at the global level, with the largest decrease in high-SDI countries of 11% (−13.6% to −9.1%) and the largest (nonsignificant) increase in the low SDI quintile of 9% (−6.0% to 27.8%) (Web Table <ref type="table">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Prostate Cancer</head><p><s>In 2015, there were 1.6 million (95% UI, 1.3-2.2 million) incident cases of prostate cancer and 366 000 (95% UI, 303 000-460 000) deaths.</s><s>Prostate cancer caused 6.3 million (95% UI, 5.2-7.9 million) DALYs globally in 2015, with 82% coming from YLLs and 18% from  YLDs (eFigure 13 in the Supplement).</s><s>The odds of developing prostate cancer between ages 0 to 79 years was 1 in 14 at the global level and ranged from 1 in 47 men for low-middle SDI countries to 1 in 6 men in high SDI countries (eTable 16 in the Supplement).</s><s>The y-axes differ in scale between male and female graphs to reflect differing incidence rates between sexes.</s><s>The colored section of the higher-scale y-axis represents the entirety of the lower-scale y-axis.</s><s>The y-axes differ in scale between male and female graphs to reflect differing incidence rates between sexes.</s><s>The colored section of the higher-scale y-axis represents the entirety of the lower-scale y-axis.</s><s>The y-axes differ in scale between male and female graphs to reflect differing incidence rates between sexes.</s><s>The colored section of the higher-scale y-axis represents the entirety of the lower-scale y-axis.</s></p><p><s>ASIRs and ASDRs (95% UIs) for prostate cancer in 2015 were the lowest in South Asia: , ; East Asia: ASIR 12.1 <ref type="bibr">(8.6-16.9)</ref>,</s><s>; and Central Sub-Saharan Africa: .</s><s>They were the highest in Australasia: ASIR 243. <ref type="bibr">9 (162.6-336.6)</ref>,</s><s>; high-income North America: ASIR 158.</s><s>, ) (Web Tables <ref type="table" target="#tab_7">1 and 2</ref>).</s></p><p><s>In 2015, prostate cancer was the cancer with the highest incidence for men in 103 countries or territories, and the leading cause of cancer deaths for men in 29 countries (eFigures 9 and 11 in the Supplement).</s></p><p><s>Prostate cancer ranked 14th in 2005 and 12th in 2015 for cancer YLLs (Figure <ref type="figure" target="#fig_5">6</ref>) with an increase of 26% (95% UI, 22.0%-29.9%) in absolute YLLs between 2005 and 2015.</s><s>As summarized in Table <ref type="table" target="#tab_1">2</ref>, the increasing incidence rates, together with an aging and growing population, have led to a 66% increase in prostate cancer cases since 2005 (974 000 in 2005, 1.6 million in 2015).</s><s>Thirty-four percent of this increase can be attributed to a change in the age-specific rates.</s></p><p><s>Prostate cancer ASIRs (95% UIs) for men were the lowest in lowmiddle SDI countries <ref type="bibr">(17.6; 12.9-22.5</ref>)</s><s>and the highest in high SDI countries <ref type="bibr">(123.6; 92.6-181.7)</ref>.</s><s>ASIRs have been increasing in all SDI quintiles between 1990 and 2015, with the largest increase in the high-SDI countries (Figure <ref type="figure" target="#fig_9">10</ref>).</s><s>Age-standardized DALY rates (95% UIs) in men were the highest in low SDI countries (368.2;</s><s>249.</s><s><ref type="bibr">3-476.1)</ref></s><s>and the second highest in high SDI countries (302.4;</s><s>231.0-432.0)</s><s>(Web Table <ref type="table">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.">Stomach Cancer</head><p><s>In 2015, there were 1.3 million (1.2-1.4 million) incident cases of stomach cancer and 819 000 (95% UI, 795 000-844 000) deaths worldwide.</s><s>Stomach cancer caused 17.4 million (95% UI, 16.9-18 million) DALYs in 2015 with 98% coming from YLLs and 2% coming from YLDs (eFigure 13 in the Supplement).</s><s>One in 27 men and 1 in 68 women develop stomach cancer before age 79 years.</s><s>The highest odds for men occurred in middle SDI countries (1 in 25), whereas the lowest occurred in low-middle SDI countries (1 in 48).</s><s>For women, the highest odds were in low SDI countries (1 in 58) and the lowest in low-middle SDI countries (1 in 83) (eTable 16 in the Supplement).</s><s>Globally and for high SDI countries, stomach cancer ranked fifth for cancer incidence and third for cancer deaths in 2015 (Figures <ref type="figure">4 and   5</ref>).</s><s>In high-middle, middle, low-middle, and low SDI countries, stomach cancer ranked third for incidence.</s><s>For cancer mortality in highmiddle, middle, and low SDI countries, stomach cancer ranked third.</s><s>For low-middle SDI countries it ranked second for cancer mortality.</s></p><p><s>ASIRs and ASDRs (95% UIs) for men in 2015 were lowest in highincome North America: ; South Asia: ASIR 12.8 (10.9-14.9),</s><s>; and Australasia: ASIR 15.1 (12.9-18.1),</s><s>, as summarized in Web Tables <ref type="table" target="#tab_7">1 and 2</ref>. They were the highest in high-income Asia Pacific: ASIR 90.1 (83.5-96.9),</s><s>ASDR 28. <ref type="bibr">5 (27.5-29.5)</ref>;</s><s>East Asia: ASIR <ref type="bibr">46.2 (38.8-56.5)</ref>,</s><s>, .</s><s>For women, rates were the lowest in high-income North America: ASIR 6.1 <ref type="bibr">(5.4-6.8)</ref>,</s><s>ASDR 2.9 (2.8-3.0);</s><s>South Asia: ASIR 6.2 <ref type="bibr">(5.1-7.4)</ref>, ; and Southern Sub-Saharan Africa: ASIR 7.5 <ref type="bibr">(6.2-8.8)</ref>, .</s><s>They were the highest in high-income Asia Pacific: ASIR 31.5 (28.9-34.2),</s><s>; Andean Latin America: , ; and East Asia ASIR 18.0 <ref type="bibr">(15.0-21.3)</ref>, .</s></p><p><s>Stomach cancer was highest in absolute incidence in 2015 for men in 26 countries and territories and was the leading cause of cancer deaths in 11 countries (eFigures 9 and 11 in the Supplement).</s><s>For women it was the leading cause of cancer deaths in 4 countries (eFigure 12 in the Supplement).</s></p><p><s>Stomach cancer has remained the third highest cause for crude cancer YLLs between 2005 and 2015, with a 7% decrease in absolute YLLs due to stomach cancer (Figure <ref type="figure" target="#fig_5">6</ref>).</s><s>If the population age structure and size had remained the same in 2015 as it was in 2005, incidence would have dropped by 21% due to decreasing rates (Table <ref type="table" target="#tab_1">2</ref>).</s><s>ASIRs have dropped substantially since 1990 at the global level and for all SDI quintiles except the low SDI quintile (Figure <ref type="figure" target="#fig_10">11</ref>).</s></p><p><s>Between 2005 and 2015, age-standardized DALYs for both sexes decreased by 27% (95% UI, −29.4% to −24.5%) globally, with the largest decrease in high-middle SDI countries of 32% (95% UI, −35.8% to −27.5%) (Web Table <ref type="table">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6.">Liver Cancer</head><p><s>In 2015, there were 854 000 (95% UI, 768 000-961 000) incident cases for liver cancer globally and 810 000 (750 000-863 000) deaths.</s><s>Liver cancer caused <ref type="bibr">20.6 million (19-22 million)</ref> DALYs in 2015 with 99% coming from YLLs and 1% coming from YLDs (eFigure 13 in the Supplement).</s><s>Liver cancer was more common in men, with 1 in 45 men developing liver cancer before age 79 years compared with 1 in 113 women at the global level.</s><s>The highest odds of developing liver cancer was in middle SDI countries, with 1 in 38 men and 1 in 96 women developing liver cancer, whereas the lowest odds were seen in low-middle SDI countries, with 1 in 98 men and 1 in 144 women developing liver cancer during their lifetime (eTable 16 in the Supplement).</s><s>Globally, liver cancer ranked sixth for cancer incidence and fourth for cancer deaths in 2015, as shown in Figures <ref type="figure">4 and 5</ref>.</s><s>In low SDI countries, it ranked fourth for cancer incidence and first for cancer mortality, whereas in middle and highmiddle SDI countries it ranked fourth and sixth, respectively, for cancer incidence but second for cancer mortality.</s></p><p><s>ASIRs (95% UIs) (per 100 000 person-years) were the highest in middle SDI countries in 2015 <ref type="bibr">(15.6; 13.2-18.8)</ref>,</s><s>followed by low SDI countries <ref type="bibr">(14.5; 11.5-17.1)</ref>,</s><s>high-middle <ref type="bibr">(13.7; 11.6-16.3)</ref>,</s><s>high <ref type="bibr">(11.7; 10.8-12.7)</ref>,</s><s>and low-middle SDI countries <ref type="bibr">(7.1; 6.2-8.3)</ref>.</s><s>ASDRs in 2015 for both sexes were the highest in the low SDI quintile <ref type="bibr">(16.6; 13.2-19.7)</ref>,</s><s>followed by middle SDI countries <ref type="bibr">(15.8; 14.5-17.5)</ref>,</s><s>high-middle SDI countries <ref type="bibr">(14.5; 12.9-15.8)</ref>,</s><s>high SDI countries <ref type="bibr">(7.9; 7.6-8.2)</ref>,</s><s>and lowmiddle SDI countries <ref type="bibr">(7.5; 6.7-8.7</ref>)</s><s>(Web Tables <ref type="table" target="#tab_7">1 and 2</ref>).</s></p><p><s>In 2015, ASIRs and ASDRs (95% UIs) for men were the lowest in South Asia: , ; Southern Latin America: ASIR 6.1 <ref type="bibr">(5.4-7.3)</ref>, ; and Tropical Latin America: ASIR 6.5 <ref type="bibr">(5.5-8.2)</ref>, .</s><s>They were the highest in high-income Asia Pacific: ASIR 40.1 <ref type="bibr">(34.4-48.3)</ref>,</s><s>; East Asia: , ; and Central Sub-Saharan Africa: .</s><s>For women, rates were the lowest in South Asia: ASIR 3.2 ; Australasia: ASIR 3.6 ; and Southern Latin America: ASIR 4.0 <ref type="bibr">(3.3-5.</ref>2),</s><s>ASDR 3.9 <ref type="bibr">(3.5-4.3)</ref> and the highest in high-income Asia Pacific: ASIR 14.2 <ref type="bibr">(10.9-19.6)</ref>, ; East Asia: ASIR 12.5 (9.0-18.2),</s><s>ASDR 12.1 <ref type="bibr">(10.3-14.1)</ref>;</s><s>and Western Sub-Saharan Africa: ASIR 10.9 <ref type="bibr">(7.0-15.8)</ref>,</s><s>(Web Tables <ref type="table" target="#tab_7">1 and 2</ref>).</s></p><p><s>Liver cancer was the most commonly diagnosed cancer in 2015 for men in 11 countries (eFigure 9 in the Supplement) and the most common cause of cancer deaths in 40 countries (eFigure 11 in the Supplement).</s><s>Liver cancer was the most commonly diagnosed cancer for women in Mongolia (eFigure 10 in the Supplement) in 2015 and the leading cause of cancer deaths for women in 5 countries in 2015 (eFigure 12 in the Supplement).</s></p><p><s>Liver cancer remained the second leading cause of cancer YLLs between 2005 and 2015 (Figure <ref type="figure" target="#fig_5">6</ref>).</s><s>Aging and population growth were the drivers of the increase from 709 000 (616 000-782 000) cases in 2005 to 854 000 (768 000-961 000) cases in 2015, as summarized in Table <ref type="table" target="#tab_1">2</ref>.</s><s>If the population age structure and size had remained the same in 2015 as they were in 2005, 8% fewer cases of liver cancer would have been diagnosed in 2015 than in 2005.</s><s>Globally, ASIRs slowly decreased since the late 1990s (Figure <ref type="figure" target="#fig_11">12</ref>).</s><s>This global trend, however, masks an increase in low and high SDI countries since 1990.</s><s>ASIRs have been increasing for low SDI countries since 1990; in high SDI countries, rates decreased until the early 2000s for men and the late 2000s for women and then increased.</s><s>Between 2005 and 2015, age-standardized DALY rates for liver cancer decreased for both sexes by 17% (95% UI, −21.4% to −8.7%) at The y-axes differ in scale between male and female graphs to reflect differing incidence rates between sexes.</s><s>The colored section of the higher-scale y-axis represents the entirety of the lower-scale y-axis.</s><s>Male cases</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>B</head><p><s>The y-axes differ in scale between male and female graphs to reflect differing incidence rates between sexes.</s><s>The colored section of the higher-scale y-axis represents the entirety of the lower-scale y-axis.</s></p><p><s>the global level, with the largest decrease in high-middle SDI countries of 24% (95% UI, −30.6% to −11.3%) (Web Table <ref type="table">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="7.">Non-Hodgkin Lymphoma</head><p><s>In 2015, there were 666 000 (95% UI, 584 000-710 000) incident cases of NHL and 231 000 (95% UI, 196 000-244 000) deaths.</s><s>Non-Hodgkin lymphoma caused 6.3 million (95% UI, 5.4-6.6 million) DALYs in 2015, with 95% coming from YLLs and 5% from YLDs (eFigure 13 in the Supplement).</s><s>One in 78 men and 1 in 110 women at the global level developed NHL between birth and age 79 years.</s><s>The highest odds for developing NHL were in high SDI countries with 1 in 44 men and 1 in 63 women developing NHL.</s><s>The lowest odds occurred in low SDI countries, with 1 in 148 men and 1 in 190 women developing NHL.</s><s>Globally, for both sexes combined in 2015, NHL ranked seventh for cancer incidence and 11th for cancer deaths (Figures <ref type="figure">4 and  5</ref>).</s><s>The highest rank for the incidence of NHL was in low SDI countries, where it was fifth.</s><s>However, NHL cancer in low SDI countries ranked only 11th for death.</s></p><p><s>Web Tables <ref type="table" target="#tab_7">1 and 2</ref> illustrate that incidence and death rates in 2015 for men were the lowest in Central Sub-Saharan Africa: ASIR 5.5 <ref type="bibr">(3.4-8.9)</ref>, ; Oceania: ASIR 5.8 (4.1-9.7),</s><s>ASDR 3.0 (2.1-4.7); and South Asia: ASIR 6.0 (4.7-7.4),</s><s>ASDR 2.9 <ref type="bibr">(2.4-3.2)</ref>.</s><s>They were the highest in high-income North America: ASIR 28.5 <ref type="bibr">(24.2-35.0</ref>),</s><s>; Australasia: ASIR 25.3 <ref type="bibr">(20.4-31.4</ref>),</s><s>ASDR 6.9 <ref type="bibr">(5.4-8.1)</ref>; and Western Europe: ASIR 20.0 (15.9-23.0), .</s><s>For women, incidence rates in 2015 were the lowest in Central Asia: ASIR 4.1 <ref type="bibr">(3.4-4.6)</ref>,</s><s>ASDR 1. <ref type="bibr">5 (1.3-1.6)</ref>;</s><s>North Africa and Middle East: , ASDR 2.0 (1.8-2.6); and South Asia: , .</s><s>They were the highest in highincome North America: , ASDR 5.0 (4.6-6.1);</s><s>Australasia: ASIR 18.8 ; and Western Europe: , .</s></p><p><s>Non-Hodgkin lymphoma ranked 11th for cancer YLLs in 2005 and in 2015 (Figure <ref type="figure" target="#fig_5">6</ref>).</s><s>Cases of NHL increased by 56% between 2005 and 2015 (Table <ref type="table" target="#tab_1">2</ref>).</s><s>Population growth and population aging would have increased incidence by 13% each.</s><s>Rising age-specific incidence rates with stable population size and structure between 2005 and 2015 would have increased cases by 29%. Figure <ref type="figure" target="#fig_12">13</ref> shows the slight increase in ASIRs between 1990 and 2015 graphically with very similar trends for men and women and all SDI quintiles.</s><s>On the global level, ASIRs per 100 000 person-years (95% UI) for both sexes for NHL have increased by 23% (13.1%-29.4%)</s><s>between 2005 and 2015, from 8.0 (7.2-8.5) to 9.8 <ref type="bibr">(8.5-10.4)</ref>,</s><s>with the largest increase in middle SDI countries: 33% (11.3%-52.1%)</s><s>(Web Table <ref type="table" target="#tab_0">1</ref>).</s><s>During this timeframe, age-standardized DALY rates (95% UIs) for both sexes increased at the global level (1.3% increase; −8.5% to 7.0%), although this increase was not statistically significant.</s><s>Large, but not significant decreases of 6% (−10.2% to 0.1%) occurred in high SDI countries, and the largest, but also nonsignificant, increase occurred in lowmiddle SDI countries (7%; −9.4% to 17.9%) (Web Table <ref type="table">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="8.">Leukemia</head><p><s>In 2015 there were 606 000 (95% UI, 573 000-643 000) new cases of leukemia worldwide and 353 000 (95% UI, 345 000-363 000) deaths.</s><s>In 2015, leukemia caused 12.0 million (95% UI, 11.6-12.5 million) DALYs globally, with 97% coming from YLLs and 3% from YLDs (eFigure 13 in the Supplement).</s><s>One in 87 men compared with 1 in 137 women developed leukemia between ages 0 and 79 years at the global level.</s><s>The highest odds were seen in the high SDI quintile, with 1 in 64 men and 1 in 116 women developing leukemia.</s><s>The lowest odds occurred in low SDI countries, with 1 in 124 men and 1 in 164 women developing leukemia (eTable 16 in the Supplement).</s></p><p><s>Leukemia ranked eighth for cancer incidence and ninth for cancer deaths at the global level in 2015 (Figures <ref type="figure">4 and 5</ref>).</s><s>Leukemia incidence was ranked highest for low-SDI and low-middle SDI countries at sixth place (leukemia was ninth and eighth for cancer deaths in low-SDI and low-middle SDI countries, respectively).</s><s>Leukemia was ranked lowest in high-SDI countries at 13th place (eighth for cancer deaths).</s></p><p><s>In 2015, ASIRs and ASDRs (95% UIs) for men were the lowest in Eastern Sub-Saharan Africa: ASIR 6.5 <ref type="bibr">(5.0-8.3)</ref>, ; South Asia: ASIR 7.0 <ref type="bibr">(5.8-8.4)</ref>, ; and Central Sub-Saharan Africa: ASIR 7.2 <ref type="bibr">(4.5-10.8)</ref>, .</s><s>They were the highest for men in high-income North America: ASIR 17.1 <ref type="bibr">(15.6-18.9)</ref>,</s><s>ASDR 8.9 <ref type="bibr">(8.5-9.4)</ref>;</s><s>Australasia: ASIR 16.1 (12.6-21.0),</s><s>; and Western Europe: ASIR 14.9 <ref type="bibr">(13.7-16.5)</ref>, .</s><s>For women, they were the lowest in Eastern Sub-Saharan Africa: ASIR The y-axes differ in scale between male and female graphs to reflect differing incidence rates between sexes.</s><s>The colored section of the higher-scale y-axis represents the entirety of the lower-scale y-axis.</s><s><ref type="bibr">3.2 (2.5-4.3)</ref>.</s><s>Rates were the highest in high-income North America: ASIR 10.0 (8.9-11.2),</s><s>ASDR 4.9 (4.7-5.2);</s><s>Southeast Asia: , ; and North Africa and Middle East: ASIR 8.9 (7.9-10.1), ) (Web Tables <ref type="table" target="#tab_7">1 and 2</ref>).</s><s>Leukemia led incident cases in 2015 for men in 5 countries (eFigure 9 in the Supplement).</s><s>It remained the sixth leading cause of cancer YLLs between 2005 and 2015, with a 6% (95% UI, 2.5%-9.9%)</s><s>increase in absolute YLLs and an 8% (95% UI, −11.1% to −4.9%) decrease in age-standardized YLLs (Figure <ref type="figure" target="#fig_5">6</ref>).</s></p><p><s>Between 2005 and 2015, incident cases at the global level increased from 481 000 (95% UI, 456 000-512 000) to 606 000 (95% UI, 573 000-643 000) (total increase of 26% (95% UI, 19.6%-33.2%);</s><s>population growth and aging were the drivers behind this increase.</s><s>Had the population growth and age-specific rates remained the same as in 2005, there would be only 3% more cases of leukemia in 2015 (Table <ref type="table" target="#tab_1">2</ref>).</s><s>Increasing trends in ASIRs are similar for all SDI quintiles except for countries in the high-middle SDI group, where rates have decreased since the 2000s (Figure <ref type="figure" target="#fig_13">14</ref>).</s></p><p><s>Between 2005 and 2015, age-standardized DALY rates (95% UIs) for both sexes decreased by 8% (−10.8% to −4.6%) at the global level, with the largest decrease in high-middle SDI countries at 12% (−16.6% to −8.6%), and the largest increase in low SDI countries at 9% (−3.9 to 22.8), although this increase was not significant (Web Table <ref type="table">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="9.">Bladder Cancer</head><p><s>In 2015, there were 541 000 (95% UI, 517 000-567 000) incident cases for bladder cancer globally and 188 000 (95% UI, 183 000-193 000) deaths.</s><s>Bladder cancer caused 3.4 million (95% UI, 3.3-3.5 million) DALYs in 2015, with 92% coming from YLLs and 8% from YLDs (eFigure 13 in the Supplement).</s><s>Bladder cancer was more common in men, with 1 in 59 men being diagnosed before age 79 years compared with 1 in 239 women.</s><s>The odds of developing bladder cancer during a lifetime were the highest in high-SDI countries (1 in 36 men and 1 in 165 women) and the lowest in low-SDI countries (1 in 122 men and 1 in 310 women) (eTable 16 in the Supplement).</s><s>Globally, bladder cancer ranked ninth for cancer incidence and 13th for cancer deaths in 2015, as shown in Figures <ref type="figure">4 and 5</ref>.</s><s>It ranked the highest in high-SDI countries at position 8 (11th for mortality).</s></p><p><s>In 2015, ASIRs and ASDRs (95% UIs) for men were the lowest in Oceania: ASIR 4.5 <ref type="bibr">(3.6-5.8)</ref>,</s><s>ASDR 2.3 (1.9-2.9);</s><s>Andean Latin America: , ASDR 2.1 (1.9-2.4); and Central Latin America: ASIR 5.9 <ref type="bibr">(5.0-6.8)</ref>, .</s><s>They were the highest in high-income North America: ASIR 31.</s><s><ref type="bibr">6 (28.5-35.1)</ref>,</s><s>ASDR 6.1 <ref type="bibr">(5.8-6.4)</ref>;</s><s>Western Europe: ASIR 26.0 <ref type="bibr">(24.1-27.9)</ref>,</s><s>; and Central Europe: , .</s><s>For women, incidence rates in 2015 were the lowest in Oceania: ASIR 2.1 (1.</s><s><ref type="bibr">6-2.8)</ref>,</s><s>ASDR 1.2 (0.9-1.5); Southeast Asia: ASIR 2.2 (1.8-2.7),</s><s>ASDR 1.2 (1.0-1.4); and Andean Latin America: ASIR 2. <ref type="bibr">3 (1.8-2.8)</ref>,</s><s>ASDR 1.1 (0.9-1.2).</s><s>They were the highest in high-income North America: , ASDR 1.8 (1.7-1.9);</s><s>Western Europe: ASIR 5.7 <ref type="bibr">(5.2-6.3)</ref>,</s><s>ASDR 2.0 (1.9-2.2); and Southern Sub-Saharan Africa: ASIR 5.1 (4.0-6.6),</s><s>ASDR 2.4 (2.0-2.9)</s><s>(Web Tables <ref type="table" target="#tab_7">1 and 2</ref>).</s></p><p><s>Bladder cancer was the most commonly diagnosed cancer in 2015 for men in Egypt (eFigure 9 in the Supplement).</s><s>Globally, it dropped from the 17th to the 18th leading cause of cancer YLLs between 2005 and 2015 (Figure <ref type="figure" target="#fig_5">6</ref>).</s><s>Aging and population growth were the drivers of the increase: from 413 000 (95% UI, 403 000-424 000) cases in 2005 to 541 000 (95% UI, 517 000-567 000) cases in 2015 (Table <ref type="table" target="#tab_1">2</ref>).</s><s>If population age structure and size had remained the same in 2015 as they were in 2005, bladder cancer incidence would have been stable.</s><s>However, population growth and aging led to a 31% increase in incident cases.</s><s>Worldwide, as well as in high and high-middle SDI countries, ASIRs peaked in the late 1990s in both sexes followed by a slow decrease (Figure <ref type="figure" target="#fig_14">15</ref>).</s><s>Rates increased in the low and low-middle quintiles.</s><s>Between 2005 and 2015, age-standardized DALY rates (95% UIs) for both sexes for bladder cancer decreased by 9% (−11.5% to −6.2%) at the global level, with the largest decrease in high-middle SDI countries by 13% (−17.0% to −9.7%), and the largest (although nonsignificant) increase in low SDI countries of 3% (−8.8% to 18.2%) (Web Table <ref type="table">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="10.">Cervical Cancer</head><p><s>In 2015, 526 000 (95% UI, 483 000-571 000) women developed cervical cancer worldwide, and it caused 239 000 (95% UI, The y-axes differ in scale between male and female graphs to reflect differing incidence rates between sexes.</s><s>The colored section of the higher-scale y-axis represents the entirety of the lower-scale y-axis.</s></p><p><s>225 000-252 000) deaths (Table <ref type="table" target="#tab_0">1</ref>).</s><s>Cervical cancer caused 7 million (95% UI, 6.5-7.4 million) DALYs, with 96% coming from YLLs and 4% from YLDs (eFigure 13 in the Supplement).</s></p><p><s>One in 68 women developed cervical cancer between birth and age 79 years at the global level (eTable 16 in the Supplement).</s><s>The odds were the highest in low SDI countries, with 1 in 24 women developing cervical cancer, and the lowest in high SDI countries, where 1 in 115 women developed cervical cancer during a lifetime.</s></p><p><s>In 2015, ASIRs and ASDRs per 100 000 person-years (95% UIs) for women were the lowest in Australasia: , ; North Africa and Middle East: ASIR 7.5 ; and high-income North America: , ASDR 2.9 <ref type="bibr">(2.8-3.1)</ref>; and the highest in Central Sub-Saharan Africa: , ; Southern Sub-Saharan Africa: , ASDR 27.0 <ref type="bibr">(21.7-34.0)</ref>;</s><s>and Oceania: ASIR <ref type="bibr">42.3 (22.7-70.2)</ref>, 1) (Web Tables <ref type="table" target="#tab_7">1 and 2</ref>).</s></p><p><s>In 2015, cervical cancer was the most commonly diagnosed cancer for women in 11 countries (eFigure 10 in the Supplement) and the most common cause of cancer deaths for women in 50 countries (eFigure 12 in the Supplement).</s></p><p><s>Cervical cancer dropped from the ninth to the tenth leading cause for cancer YLLs between 2005 and 2015, with a 19% (95% UI, −25.8% to −12.0%) decrease in age-standardized YLLs (Figure <ref type="figure" target="#fig_5">6</ref>).</s><s>Total incidence would have decreased by 26% if the population size and age structure had remained the same as in 2005 due to decreasing incidence rates (Table <ref type="table" target="#tab_1">2</ref>).</s><s>ASIRs decreased globally for all SDI quintiles (Figure <ref type="figure" target="#fig_15">16</ref>).</s><s>Between 2005 and 2015, age-standardized DALYs decreased globally in women by 19% (95% UI, −23.9% to −12.2%) with rates decreasing by 17% to 23% in low-middle, middle, high-middle, and high SDI countries, but only by 13% (95% UI, −32.6% to 10.0%) in low SDI countries (Web Table <ref type="table">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Trends in Incidence for Less Common Cancers</head><p><s>Incidence (95% UI) for both sexes increased substantially between 2005 and 2015 for certain cancers, as summarized in Table <ref type="table" target="#tab_1">2</ref>. Thyroid cancer cases almost doubled between 2005 and 2015, from 168 000 (160 000-178 000) to 334 000 (310 000-353 000) cases.</s><s>Seventyone percent of this change can be explained by an increase in age-specific incidence rates (Table <ref type="table" target="#tab_1">2</ref>).</s><s>At the same time, the agestandardized YLL rate for thyroid cancer decreased significantly by 7% (95% UI, −15.0% to −2.3%) (Figure <ref type="figure" target="#fig_5">6</ref>).</s><s>Melanoma cases increased from 225 000 (187 000-289 000) in 2005 to 352 000 (282 000-445 000) in 2015, a 56% (95% UI, 48.0%-63.9%)</s><s>increase.</s><s>Twentyeight percent of the change can be explained by an increase in the agespecific incidence rates (Table <ref type="table" target="#tab_1">2</ref>).</s><s>Kidney cancer cases increased by 53% (95% UI, 45.7%-59.7%)</s><s>between 2005 and 2015 (from 279 000 (271 000-288 000) to 425 000 (405 000-447 000), with agespecific rates contributing 23% to this total increase.</s><s>Mesothelioma has increased from 26 000 (25 000-27 000) to 37 000 (35 000-29 000) cases between 2005 and 2015, a 40% (33.4%-47.0%)</s><s>increase, of which 9% can be attributed to a rise in age-specific rates.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>Between 2005 and 2015, the proportion of deaths from noncommunicable diseases (NCDs) increased from 65% in 2005 to 71% in 2015 at the global level. 1 Fourteen percent of all deaths in 2005 were due to cancer, which increased to 16% in 2015. 1 Seven percent of all DALYs The y-axes differ in scale between male and female graphs to reflect differing incidence rates between sexes.</s><s>The colored section of the higher-scale y-axis represents the entirety of the lower-scale y-axis. in 2005 were due to cancer, which increased to 9% in 2015. 19</s><s>Deaths due to communicable, maternal, neonatal, and nutritional diseases decreased from 26% in 2005 to 20% in 2015. 1 These numbers are evidence that NCDs may be a barrier to future development. 20</s><s>The international health community has responded to this threat, with major milestones being the 2011 United Nations political declaration on NCD prevention and control, 21 the World Health Organization Global Action Plan for the Prevention and Control of NCDs 2013-2020, 22 and the integration of NCDs in the Sustainable Development Goals. 11</s><s> The GBD 2015 study identifies some progress in meeting the targets of the Sustainable Development Goals. 23</s><s>Between 2005 and 2015, many countries experienced a decrease in cancer mortality despite increasing incidence rates.</s><s>Countries with increasing cancer mortality rates were dominantly in Sub-Saharan Africa where, with few exceptions, the complex health care infrastructure required to treat cancer is generally lacking. 24</s><s>Efforts are ongoing to expand the existing resources in the region to allow for improved cancer care. 25-28</s><s>Cancer prevention efforts may, however, be as important as delivery of care, given the profile of cancer in low SDI countries where the top 3 leading causes of cancer mortality (liver cancer, cervical cancer, and stomach cancer) are largely preventable.</s></p><p><s>Prevention and treatment of chronic hepatitis B and C, which account for the majority of liver cancer deaths, would reduce the incidence and mortality of liver cancer. 29</s><s>The World Health Organization has adopted a global health sector strategy on viral hepatitis that features a 2030 target of a 65% reduction in mortality related to hepatitis B and C.</s><s>This is to be achieved by reducing the occurrence of new chronic hepatitis B and C infections by 90% through increased newborn hepatitis B immunization coverage, blood and injection safety, harm reduction, and by an 80% treatment rate for chronic hepatitis B and C. 30 Our results show that trends for liver cancer incidence differ among the SDI quintiles.</s><s>ASIRs have been decreasing at the global level and for most SDI quintiles since at least 2000.</s><s>However, rates for high SDI countries have increased since 1990, and rates for low SDI countries increased in the most recent observations (from 2010 to 2015).</s><s>These findings are consistent with observations in some highincome countries, where obesity, diabetes, and hepatitis C are thought to be major contributors to rising incidence rates. 31,32</s><s> Human papillomavirus vaccination is universally recommended by health authorities and is expected to reduce cervical cancer incidence over the next decades if vaccination uptake is successful.</s><s>In the meantime, screen and treat approaches that have been shown to reduce cervical cancer mortality in high-income countries should be implemented in regions with a high burden of cervical cancer. 33-35</s><s>The stark inequity between high SDI countries where cervical cancer is the 18th leading cause of cancer deaths compared with low SDI countries where it ranks second (Figure <ref type="figure">5</ref>) is widely recognized by the international community; an emerging political commitment to reducing this gap will hopefully translate into a decreased burden of cervical cancer in the most affected countries. 36</s><s> Our results show that progress in reducing cervical cancer burden was the slowest in low SDI countries where the decrease in ASIRs and ASDRs was the lowest; a 12% decrease in ASIR occurred for countries at low SDI compared to a greater than 14% decrease in all other SDI quintiles, and a 14% decrease in ASDR in low SDI compared to the other SDI quintiles, with decreases in ASDR of greater than 16%.</s></p><p><s>Stomach cancer rates have been declining globally for decades. 37</s><s>However, our results demonstrate that this trend has not been uni-form among the SDI quintiles.</s><s>ASIRs in the lowest SDI quintile increased throughout the GBD study timeframe <ref type="bibr">(1990 to 2015)</ref>.</s><s>In the highest SDI quintile, rates declined until 2010 but have since increased.</s><s>One possible explanation is the increasing trend of gastric cancer of the cardia in high-income countries owing to risk factors such as obesity, although the mechanism explaining this association is not fully understood. 37-39</s><s>Treatment for Helicobacter pylori infection, which causes about 78% of all stomach cancers, reduces gastric cancer incidence, and the International Agency for Research on Cancer (IARC) recommends that countries investigate whether populationbasedscreeningandtreatmentprogramsfor Hpyloriareindicated. 40,41  Despite this recommendation, few countries with high incidence of stomach cancer have implemented populationwide screening programs.</s><s>Although studies have shown reductions in stomach cancer mortality in screened populations, the target group, onset, and modality of screening programs remain controversial. 37,42-46</s><s> Prevention and treatment of carcinogenic infections that lead to these observed cancer patterns in low SDI countries have the potential to decrease future cancer burden as well as reducing associated diseases like cirrhosis in endemic areas. 47</s><s>In addition, limiting transmission can lead to prevention efforts that are sustained beyond 1 generation. 10</s><s> The dominance of infection-related cancers in low SDI countries is an exceptional pattern compared with the leading causes of cancer deaths for countries in higher SDI quintiles, where TBL, colorectal, stomach, liver, and breast cancer lead the rankings.</s><s>The importance of tobacco control as a crucial cancer control strategy should therefore not be underestimated, especially since tobacco control has health benefits reaching far beyond cancer prevention. 48</s><s>Effective primary and secondary prevention strategies are available for colorectal cancer with many risk factors being attributed to "Western lifestyles." 49</s><s>Increased physical exercise, avoidance of processed meat, alcohol, and tobacco, as well as aspirin use have all been associated with reduced colorectal cancer incidence. 49-52</s><s>Multiple modalities for colorectal screening are known to reduce colorectal mortality in high-income countries. 53,54</s><s>Means of implementation in other health care settings is currently being investigated. 55</s><s>Primary prevention of breast cancer, which is the leading cause of cancer incidence, death, and DALYs in women, should be emphasized.</s><s>However, even in the setting of populationwide primary prevention efforts, it is estimated that only between 20% and 50% of breast cancer can be prevented. 48,56</s><s>Therefore, breast cancer control strategies must also focus on early detection in addition to effective treatment.</s><s>Early detection strategies can range from improving breast cancer awareness and clinical breast examination in basic resource settings to mammography screening. 57</s><s>Clearly, cancer control strategies focused on early detection should also target access to the full spectrum of care including surgical, medical, and radiation oncology; affordable chemotherapeutics and supportive drugs; and survivorship support and palliative and hospice care. 58</s><s>This is imperative not only for breast cancer but for comprehensive cancer care in general.</s></p><p><s>The variation in the leading causes of cancer incidence and mortality between countries documented in the GBD study are remarkable.</s><s>The largest ranges in rankings for cancer mortality were found in cervical cancer, acute lymphoid leukemia, and nasopharynx cancer followed by esophageal, lip and oral cavity, gallbladder and biliary tract cancer, and melanoma (eFigure 8 in the Supplement).</s><s>For cancer incidence, the largest divergence was seen in esophageal cancer, cervical cancer, melanoma, acute lymphoid leukemia, kidney, larynx, and gallbladder and biliary tract cancer (eFigure 7 in the Supplement).</s><s>For most of these cancers, the observed pattern can be explained by known risk factors or by access to care.</s><s>In acute lymphoid leukemia, for example, it is well known that the survival rate for children differs substantially between countries from around 15% to over 90%, suggestive of disparities in treatment. 59</s><s>For nasopharynx cancer it is also well known that incidence differs drastically between populations; this can in part be explained by early infection with Epstein-Barr virus as well as by a high intake of salt-preserved food. 60</s><s> Melanoma is a much more common in populations with lighter skin types. 61</s><s>Esophageal cancer is a similar example of widely differing incidence rates attributable to risk factor profiles.</s><s>Risk factors for esophageal cancer vary depending on the histologic characteristics of squamous cell carcinoma vs adenocarcinoma.</s><s>For example, it is postulated that the diverse incidence of esophageal squamous cell carcinoma, the dominant histologic type in high-endemic areas, is driven by chronic cell damage from risk factors like smoking, alcohol consumption, heat damage, and nutritional deficiency. 62,63</s><s>Risk factors for esophageal adenocarcinoma, which is increasing in traditionally lowendemic areas, include a high body mass index, smoking, reflux disease, and a diet low in fruits and vegetables. 64,65</s><s> A detailed analysis of the reasons behind the observed variation in cancer burden goes beyond the scope of this analysis.</s><s>However, the cited examples show that the descriptive epidemiology approach of the GBD study can identify patterns of cancer burden that can be hypothesis generating.</s><s>This is especially true when cancer burden is analyzed in conjunction with nonmalignant diseases that might share similar risk factors-a potential provided by the comprehensive nature of the GBD approach.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Limitations</head><p><s>As in prior GBD studies, our estimates depend on the quality and quantity of the data sources available to inform the estimates.</s><s>Because of the lag time for data reporting, estimates for 2015 are mainly based on data and trends from recent years.</s><s>For many countries, data sources for informing cancer burden estimation are still sparse, and the GBD estimates rely heavily on covariate selection in the models and regional patterns.</s><s>Only an estimated 38% of deaths worldwide were registered in 2012. 66</s><s>Alternative data sources for cancer mortality, such as verbal autopsy, are substantially less reliable. 67</s><s> To overcome the limitation from lack of data sources, the GBD study includes cancer incidence data from registries in the mortality estimation.</s><s>Cancer registration has a long tradition in many countries.</s><s>However, in regions where the burden of cancer is expected to grow significantly due to anticipated population growth and aging, cancer registries often only cover a small fraction of the population, are of low quality, or do not exist. 68</s><s>Compared with almost complete coverage of the population with high-quality cancer registration in Nordic countries or North America, less than 10% of the population in South America, Asia, and Africa are covered by high-quality cancer registries. 68</s><s>With technological innovation, including an improved ability to identify and link different types of data sources, cancer surveillance will hopefully become a routine component of ev-ery health care system.</s><s>Endeavors like the Global Initiative for Cancer Registry Development (http://gicr.iarc.fr)</s><s>play a major role in this task.</s></p><p><s>Cancer mortality estimates are predominantly based on vital registration data, cancer registry data, and to a much lesser extent other data sources.</s><s>If a large proportion of deaths are miscoded, the redistribution of these so-called garbage codes can substantially affect mortality estimates.</s><s>Since GBD cancer incidence estimates are based on mortality estimates, garbage code redistribution directly affects cancer incidence.</s><s>Misclassification of metastatic sites as primary cancer sites (eg, liver, lung, brain) is another source of potential bias, especially in locations with limited diagnostic resources.</s><s>Changes in coding practices or coding systems may also have an effect, even though mapping to the GBD causes list includes adjustments to account for different coding systems. 69</s><s> Cervical and uterine cancer incidence rates are potentially overestimated in the GBD in locations where hysterectomies are common, since rates are calculated without adjustments for the population at risk.</s></p><p><s>For GBD 2015, we have updated the MI (mortality to incidence) ratios and used out-of-sample validation of a set of potential models to choose the most appropriate MI model.</s><s>However, in young age groups with sparse data, and in areas where no matching mortality and incidence data exist (which is the case for most countries in Sub-Saharan Africa), the MI model is based on the combination of trends for older age groups as well as covariate selection.</s></p><p><s>The addition of the leukemia subtypes for the GBD 2015 study is a necessary step; aggregating "leukemia" into a single entity is appropriate from neither a public health nor a clinical perspective.</s><s>However, when interpreting the results, it is important to recognize that those data sources for the MI ratios that determine incidence for leukemia subtypes are mostly from high-income countries.</s><s>Another caveat is that leukemia subtypes are scaled to sum to the leukemia "parent" cause, which can lead to incidence estimates for leukemia subtypes that are different than what would be expected based on the MI ratio alone.</s><s>Changes in classification of leukemia subtypes over time can also have an effect on the GBD estimates.</s><s>With the wider availability of cancer registry data, including childhood cancer registries, it is expected that estimates will continue to be adjusted in future iterations of the GBD.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p><s>Despite significant reductions in cancer mortality in many countries, cancer poses a barrier to future development.</s><s>Incidence is expected to increase, straining resources even in countries with advanced health care systems.</s><s>An expanding arsenal of cancer prevention and treatment interventions, together with a political commitment to address NCDs, offers hope that this threat can be controlled.</s><s>The GBD study enables timely tracking of progress toward defined targets. 23</s><s>Since most cancer prevention efforts have a much broader impact than just reducing cancer incidence, the ability of the GBD to put single diseases into the perspective of population health is unique and of the utmost importance.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Box 1 .Figure 2 .Figure 3 .Figure 4 .Figure 5 .Figure 6 .Figure 7 .Figure 8 .Figure 9 .Figure 10 .Figure 11 .Figure 13 .Figure 14 .Figure 15 .Figure 16 .</head><label>123456789101113141516</label><figDesc><div><p><s>Figure 1.</s><s>Age-Specific Global Contributions of Cancer Types to Total Cancer Incidence and Mortality for Both Sexes, 2015 Figure 2. Relative Changes in Age-Standardized Cancer Incidence Rates in Both Sexes for All Cancers in 195 Countries or Territories From 2005 to 2015 Figure 3. Relative Changes in Age-Standardized Cancer Mortality Rates in Both Sexes for All Cancers in 195 Countries or Territories From 2005 to 2015Figure 4. Cancers Ranked by Number of Incident Cases in Both Sexes, Global, by Region, by Sociodemographic Index, and in the 50 Most Populous Countries, 2015 Figure 5. Cancers Ranked by Number of Deaths in Both Sexes, Global, by Region, by Sociodemographic Index, and in the 50 Most Populous Countries, 2015 Figure 6.</s><s>Cancers Ranked Globally and for Both Sexes by Absolute Years of Life Lost Figure 7. Trends in Age-Standardized Incidence Rates for Breast Cancer, 1990-2015 Figure 8. Trends in Age-Standardized Incidence Rates for Tracheal, Bronchus, and Lung Cancer, 1990-2015 Figure 9. Trends in Age-Standardized Incidence Rates for Colon and Rectum Cancer, 1990-2015 Figure 10.</s><s>Trends in Age-Standardized Incidence Rates for Prostate Cancer, 1990-2015 Figure 11.</s><s>Trends in Age-Standardized Incidence Rates for Stomach Cancer, 1990-2015 Figure 12.</s><s>Trends in Age-Standardized Incidence Rates for Liver Cancer, 1990-2015 Figure 13.</s><s>Trends in Age-Standardized Incidence Rates for Non-Hodgkin Lymphoma, 1990-2015 Figure 14.</s><s>Trends in Age-Standardized Incidence Rates for Leukemia, 1990-2015 Figure 15.</s><s>Trends in Age-Standardized Incidence Rates for Bladder Cancer, 1990-2015 Figure 16.</s><s>Trends in Age-Standardized Incidence Rates for CervicalCancer, 1990Cancer,  -2015</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Age-Specific Global Contributions of Cancer Types to Total Cancer Incidence and Mortality For Both Sexes, 2015</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. Relative Changes in Age-Standardized Cancer Incidence Rates in Both Sexes for All Cancers in 195 Countries or Territories From 2005 to 2015</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 3 .</head><label>3</label><figDesc><div><p><s>Figure 3. Relative Changes in Age-Standardized Cancer Mortality Rates in Both Sexes for All Cancers in 195 Countries or Territories From 2005 to 2015</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure</head><label></label><figDesc><div><p><s>Figure 4. Cancers Ranked by Number of Incident Cases in Both Sexes, Global, by Region, by Sociodemographic Index (SDI), and in the 50 Most Populous Countries, 2015</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 6 .</head><label>6</label><figDesc><div><p><s>Figure 6.</s><s>Cancers Ranked Globally and for Both Sexes by Absolute Years of Life Lost (YLLs)</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 7 .</head><label>7</label><figDesc><div><p><s>Figure 7. Trends in Age-Standardized Incidence Rates for Breast Cancer, 1990<ref type="bibr" target="#b81">-2015</ref></s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Figure 8 .</head><label>8</label><figDesc><div><p><s>Figure 8. Trends in Age-Standardized Incidence Rates for Tracheal, Bronchus, and Lung Cancer, 1990-2015</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>Figure 9 .</head><label>9</label><figDesc><div><p><s>Figure 9. Trends in Age-Standardized Incidence Rates for Colon and Rectum Cancer, 1990-2015</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>Figure 10 .</head><label>10</label><figDesc><div><p><s>Figure 10.</s><s>Trends in Age-Standardized Incidence Rates for ProstateCancer, 1990Cancer,  -2015</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_10"><head>Figure 11 .</head><label>11</label><figDesc><div><p><s>Figure 11.</s><s>Trends in Age-Standardized Incidence Rates for Stomach Cancer, 1990<ref type="bibr" target="#b81">-2015</ref></s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_11"><head>Figure 12 .</head><label>12</label><figDesc><div><p><s>Figure 12.</s><s>Trends in Age-Standardized Incidence Rates for Liver Cancer, 1990-2015</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_12"><head>Figure 13 .</head><label>13</label><figDesc><div><p><s>Figure 13.</s><s>Trends in Age-Standardized Incidence Rates for Non-Hodgkin Lymphoma, 1990<ref type="bibr" target="#b81">-2015</ref></s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_13"><head>Figure 14 .</head><label>14</label><figDesc><div><p><s>Figure 14.</s><s>Trends in Age-Standardized Incidence Rates forLeukemia, 1990Leukemia,  -2015</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_14"><head>Figure 15 .</head><label>15</label><figDesc><div><p><s>Figure 15.</s><s>Trends in Age-Standardized Incidence Rates for Bladder Cancer, 1990<ref type="bibr" target="#b81">-2015</ref></s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_15"><head>Figure 16 .</head><label>16</label><figDesc><div><p><s>Figure 16.</s><s>Trends in Age-Standardized Incidence Rates for CervicalCancer, 1990Cancer,  -2015</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>2015 Global Incidence and Deaths for All Cancers and 32 Cancer Groups</s></p></div></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Decomposition Analysis of Cancer Trends in Global Incidence, Both Sexes, 2005 to 2015</s></p></div></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head></head><label></label><figDesc><div><p><s>4. Cancers Ranked by Number of Incident Cases in Both Sexes, Global, by Region, by Sociodemographic Index (SDI), and in the 50 Most Populous Countries, 2015</s></p></div></figDesc><table><row><cell cols="9">Clinical Review &amp; Education Special Communication</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="9">Global Burden of Cancer</cell><cell></cell></row><row><cell>Country</cell><cell>Breast cancer</cell><cell>Tracheal, bronchus,</cell><cell>and lung cancer</cell><cell>Colon and rectum</cell><cell>cancer</cell><cell>Prostate cancer</cell><cell>Stomach cancer</cell><cell>Liver cancer</cell><cell>Non-Hodgkin</cell><cell>lymphoma</cell><cell>Leukemia</cell><cell>Bladder cancer</cell><cell>Cervical cancer</cell><cell>Esophageal cancer</cell><cell>Uterine cancer</cell><cell>Pancreatic cancer</cell><cell>Kidney cancer</cell><cell>Lip and oral cavity</cell><cell>cancer</cell><cell>Malignant skin</cell><cell>melanoma</cell><cell>Thyroid cancer</cell><cell>Brain and nervous</cell><cell>system cancer</cell><cell>Ovarian cancer</cell><cell>Larynx cancer</cell><cell>Chronic lymphoid</cell><cell>leukemia</cell><cell>Acute myeloid</cell><cell>leukemia</cell><cell>Gallbladder and</cell><cell>biliary tract cancer</cell><cell>Other pharynx</cell><cell>cancer</cell><cell>Acute lymphoid</cell><cell>leukemia</cell><cell>Multiple myeloma</cell><cell>Nasopharynx</cell><cell>cancer</cell><cell>Hodgkin lymphoma</cell><cell>Testicular cancer</cell><cell>Chronic myeloid</cell><cell>leukemia</cell><cell>Mesothelioma</cell></row><row><cell>Global</cell><cell>1</cell><cell cols="2">2</cell><cell cols="2">3</cell><cell>4</cell><cell>5</cell><cell>6</cell><cell cols="2">7</cell><cell>8</cell><cell cols="33">9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 31</cell></row><row><cell>High SDI</cell><cell>2</cell><cell cols="2">4</cell><cell cols="2">3</cell><cell>1</cell><cell cols="38">5 10 6 13 8 22 15 11 12 7 18 9 14 17 16 24 21 23 20 25 30 19 31 27 26 29</cell></row><row><cell>High-middle SDI</cell><cell>2</cell><cell cols="2">1</cell><cell cols="2">4</cell><cell>5</cell><cell>3</cell><cell>6</cell><cell cols="2">9</cell><cell cols="34">7 10 11 8 12 13 16 15 20 18 14 19 17 23 24 21 26 22 27 25 28 29 31</cell></row><row><cell>Middle SDI</cell><cell>1</cell><cell cols="2">2</cell><cell cols="2">5</cell><cell>9</cell><cell>3</cell><cell cols="6">4 10 8 12 7</cell><cell cols="31">6 13 15 23 11 26 17 14 20 16 21 22 25 24 18 27 19 28 30 31</cell></row><row><cell>Low-middle SDI</cell><cell>1</cell><cell cols="2">2</cell><cell cols="4">7 10 3</cell><cell>9</cell><cell cols="2">8</cell><cell cols="34">6 12 4 11 18 17 23 5 26 21 14 20 13 25 19 24 15 16 28 22 27 30 31</cell></row><row><cell>Low SDI</cell><cell cols="5">1 10 8</cell><cell>7</cell><cell>3</cell><cell>4</cell><cell cols="2">5</cell><cell cols="3">6 13 2</cell><cell cols="31">9 20 15 23 11 21 19 16 18 17 27 14 24 22 12 25 26 29 30 31</cell></row><row><cell>South Asia</cell><cell>1</cell><cell cols="2">3</cell><cell cols="7">5 10 4 14 8</cell><cell cols="3">6 12 7</cell><cell cols="31">9 19 16 28 2 27 22 15 18 11 23 17 24 13 20 25 21 26 30 31</cell></row><row><cell>India</cell><cell>1</cell><cell cols="2">4</cell><cell cols="7">6 10 3 14 8</cell><cell cols="3">7 13 5</cell><cell cols="31">9 20 15 28 2 25 22 16 18 11 23 17 24 12 19 26 21 27 30 31</cell></row><row><cell>Pakistan</cell><cell>1</cell><cell cols="2">3</cell><cell cols="7">5 16 9 13 4</cell><cell>6</cell><cell cols="33">8 17 7 11 20 22 2 29 21 12 14 10 27 19 25 15 18 23 24 28 26 31</cell></row><row><cell>Bangladesh</cell><cell>1</cell><cell cols="2">2</cell><cell cols="7">4 12 7 11 8</cell><cell cols="34">6 14 5 10 22 18 29 3 26 21 17 20 9 23 16 25 13 15 28 19 24 30 31</cell></row><row><cell>Nepal</cell><cell>1</cell><cell cols="2">5</cell><cell cols="7">9 15 3 11 8</cell><cell cols="34">4 16 2 12 22 17 29 6 27 19 18 20 7 23 14 25 10 13 28 21 24 30 31</cell></row><row><cell>East Asia</cell><cell>4</cell><cell cols="2">1</cell><cell cols="4">5 12 2</cell><cell>3</cell><cell cols="2">8</cell><cell>7</cell><cell cols="33">9 11 6 10 14 19 15 24 20 13 22 17 18 25 23 27 21 26 16 28 31 30</cell></row><row><cell>China</cell><cell>4</cell><cell cols="2">1</cell><cell cols="4">5 12 2</cell><cell>3</cell><cell cols="2">8</cell><cell>7</cell><cell cols="33">9 11 6 10 14 20 15 24 19 13 23 17 18 25 22 27 21 26 16 28 31 30</cell></row><row><cell>Southeast Asia</cell><cell>1</cell><cell cols="2">2</cell><cell cols="2">3</cell><cell>9</cell><cell>7</cell><cell>4</cell><cell cols="2">8</cell><cell cols="34">6 15 5 20 13 16 19 10 26 12 17 14 21 25 23 24 22 11 29 18 27 30 31</cell></row><row><cell>Indonesia</cell><cell>1</cell><cell cols="2">9</cell><cell cols="2">7</cell><cell>5</cell><cell>4</cell><cell>8</cell><cell cols="2">6</cell><cell cols="34">3 13 2 20 10 16 21 15 26 14 17 12 19 24 22 25 23 11 29 18 27 31 30</cell></row><row><cell>Philippines</cell><cell>1</cell><cell cols="2">2</cell><cell cols="2">3</cell><cell cols="39">6 11 7 10 4 21 5 25 12 19 20 9 22 8 16 15 18 24 14 27 26 13 28 17 29 30 31</cell></row><row><cell>Vietnam</cell><cell>2</cell><cell cols="2">1</cell><cell cols="4">3 10 4</cell><cell>5</cell><cell cols="2">6</cell><cell cols="34">8 17 11 12 16 14 22 7 27 15 20 13 21 29 23 24 9 19 28 18 26 25 31</cell></row><row><cell>Thailand</cell><cell>2</cell><cell cols="2">1</cell><cell cols="2">4</cell><cell>8</cell><cell>9</cell><cell cols="37">3 11 5 14 7 18 21 17 13 10 28 15 16 20 19 25 23 12 22 6 29 24 27 30 31</cell></row><row><cell>Myanmar</cell><cell>1</cell><cell cols="2">3</cell><cell cols="4">5 14 4</cell><cell>8</cell><cell cols="2">9</cell><cell cols="34">6 16 2 25 12 15 24 7 26 11 17 13 21 23 20 22 19 10 29 18 27 30 31</cell></row><row><cell>Malaysia</cell><cell>1</cell><cell cols="2">2</cell><cell cols="2">3</cell><cell>6</cell><cell>7</cell><cell>9</cell><cell cols="2">5</cell><cell cols="34">4 15 8 20 16 17 19 13 24 12 21 14 18 23 22 28 25 11 26 10 29 30 31</cell></row><row><cell>North Africa and Middle East</cell><cell>1</cell><cell cols="2">2</cell><cell cols="2">5</cell><cell>6</cell><cell cols="4">3 10 8</cell><cell>4</cell><cell cols="33">7 11 22 18 14 20 19 24 16 9 21 17 13 12 23 29 15 27 28 26 30 31</cell></row><row><cell>Egypt</cell><cell>1</cell><cell cols="2">5</cell><cell cols="2">7</cell><cell>9</cell><cell>8</cell><cell cols="4">4 13 2</cell><cell cols="33">3 18 23 17 16 20 14 26 15 6 21 19 10 12 24 25 11 27 30 29 31 28</cell></row><row><cell>Iran</cell><cell>2</cell><cell cols="2">5</cell><cell cols="2">6</cell><cell>3</cell><cell cols="5">1 14 12 4</cell><cell cols="33">7 17 9 25 19 21 23 16 20 8 24 10 13 11 22 30 15 27 28 26 29 31</cell></row><row><cell>Turkey</cell><cell>2</cell><cell cols="2">1</cell><cell cols="2">4</cell><cell>5</cell><cell cols="4">3 14 7</cell><cell>6</cell><cell cols="33">8 21 26 13 10 17 22 19 15 9 18 16 12 11 24 31 20 23 28 27 25 30</cell></row><row><cell>Sudan</cell><cell>1</cell><cell cols="2">4</cell><cell cols="4">6 12 2</cell><cell>7</cell><cell cols="2">5</cell><cell cols="34">3 14 8 19 23 15 25 16 27 13 9 24 18 17 11 22 26 10 29 28 21 30 31</cell></row><row><cell>Algeria</cell><cell>1</cell><cell cols="2">2</cell><cell cols="2">4</cell><cell>8</cell><cell cols="4">5 15 7</cell><cell>3</cell><cell>9</cell><cell cols="32">6 28 20 14 25 23 26 18 10 22 19 17 13 11 29 16 24 12 21 31 30</cell></row><row><cell>Iraq</cell><cell>1</cell><cell cols="2">3</cell><cell cols="8">8 18 6 11 10 2</cell><cell cols="33">7 14 25 17 15 19 16 24 13 4 20 22 12 5 26 23 9 27 28 29 30 31</cell></row><row><cell>Morocco</cell><cell>1</cell><cell cols="2">2</cell><cell cols="2">7</cell><cell>5</cell><cell cols="4">3 10 9</cell><cell>4</cell><cell>8</cell><cell cols="32">6 27 12 14 25 15 24 17 11 21 18 16 13 19 23 20 26 22 29 31 30</cell></row><row><cell>Afghanistan</cell><cell>1</cell><cell cols="2">5</cell><cell cols="4">8 17 2</cell><cell>6</cell><cell cols="2">7</cell><cell cols="34">4 12 3 15 19 23 28 20 27 10 9 25 21 18 14 16 24 11 29 26 13 31 30</cell></row><row><cell>Saudi Arabia</cell><cell>1</cell><cell cols="2">4</cell><cell cols="2">2</cell><cell>6</cell><cell>8</cell><cell>7</cell><cell cols="2">5</cell><cell cols="34">3 10 20 23 15 12 11 17 28 13 9 19 16 18 14 25 29 21 24 26 27 30 31</cell></row><row><cell>Yemen</cell><cell>1</cell><cell cols="2">4</cell><cell cols="4">7 14 2</cell><cell>8</cell><cell cols="2">6</cell><cell cols="34">3 13 5 20 23 17 28 16 26 12 9 24 21 15 11 22 25 10 29 27 18 31 30</cell></row><row><cell>Western Europe</cell><cell>2</cell><cell cols="2">4</cell><cell cols="2">3</cell><cell>1</cell><cell cols="38">9 12 6 10 5 22 18 13 11 7 17 8 14 15 16 25 19 24 21 23 31 20 30 29 26 27</cell></row><row><cell>Germany</cell><cell>1</cell><cell cols="2">4</cell><cell cols="2">3</cell><cell>2</cell><cell cols="38">7 13 6 11 9 23 20 12 10 8 18 5 15 16 14 25 21 24 19 22 30 17 31 29 26 27</cell></row><row><cell>France</cell><cell>2</cell><cell cols="2">4</cell><cell cols="2">3</cell><cell cols="5">1 10 12 5</cell><cell>8</cell><cell cols="33">9 24 15 16 13 6 14 7 11 18 20 22 17 23 25 19 31 21 28 29 26 30</cell></row><row><cell>United Kingdom</cell><cell>1</cell><cell cols="2">3</cell><cell cols="2">2</cell><cell>4</cell><cell cols="4">9 15 7</cell><cell cols="34">8 11 23 12 13 10 5 19 6 22 17 14 26 16 20 24 25 31 18 30 28 27 21</cell></row><row><cell>Italy</cell><cell>2</cell><cell cols="2">4</cell><cell cols="2">3</cell><cell>1</cell><cell>6</cell><cell>8</cell><cell cols="36">7 12 5 22 24 13 11 10 20 14 9 15 18 21 17 23 19 25 31 16 30 29 27 28</cell></row><row><cell>England</cell><cell>1</cell><cell cols="2">4</cell><cell cols="2">2</cell><cell>3</cell><cell cols="4">9 15 7</cell><cell cols="34">8 11 23 12 13 10 5 19 6 22 17 14 27 16 20 24 25 31 18 30 29 26 21</cell></row><row><cell>Spain</cell><cell>3</cell><cell cols="2">4</cell><cell cols="2">2</cell><cell>1</cell><cell>7</cell><cell>9</cell><cell cols="36">8 10 5 20 24 12 13 6 15 11 16 14 17 19 18 25 22 23 30 21 29 28 27 31</cell></row><row><cell>Western Sub-Saharan Africa</cell><cell>1</cell><cell cols="2">8</cell><cell cols="2">9</cell><cell>6</cell><cell>3</cell><cell>4</cell><cell cols="2">5</cell><cell cols="34">7 10 2 17 20 11 15 16 21 23 14 22 18 27 12 19 24 13 25 29 26 30 31</cell></row><row><cell>Nigeria</cell><cell>1</cell><cell cols="2">8</cell><cell cols="2">9</cell><cell>6</cell><cell>3</cell><cell>5</cell><cell cols="2">2</cell><cell cols="34">7 12 4 17 22 11 10 16 21 24 15 20 18 26 13 19 23 14 25 29 27 30 31</cell></row><row><cell>Ghana</cell><cell cols="5">1 12 8</cell><cell>4</cell><cell>6</cell><cell>5</cell><cell cols="2">2</cell><cell cols="34">7 10 3 19 16 9 17 14 24 25 11 20 18 26 15 23 21 13 22 29 28 30 31</cell></row><row><cell>Eastern Sub-Saharan Africa</cell><cell cols="5">1 11 9</cell><cell>7</cell><cell>4</cell><cell>5</cell><cell cols="2">3</cell><cell cols="3">8 13 2</cell><cell cols="31">6 19 16 25 10 21 20 15 14 18 27 17 26 24 12 23 22 30 29 31</cell></row><row><cell>Ethiopia</cell><cell cols="5">1 11 6</cell><cell>8</cell><cell>4</cell><cell>3</cell><cell cols="2">5</cell><cell cols="3">7 15 2</cell><cell cols="31">9 19 14 26 10 21 18 17 13 20 27 16 25 23 12 24 22 30 29 31</cell></row><row><cell>Tanzania</cell><cell cols="5">1 10 8</cell><cell>6</cell><cell>7</cell><cell>4</cell><cell cols="2">3</cell><cell cols="3">5 14 2</cell><cell cols="31">9 21 17 23 12 20 19 13 15 18 27 16 26 25 11 22 24 29 31 30</cell></row><row><cell>Kenya</cell><cell cols="5">2 17 8</cell><cell>4</cell><cell>3</cell><cell>7</cell><cell cols="2">6</cell><cell cols="34">5 19 1 10 20 14 26 9 24 22 13 12 11 27 16 23 25 15 21 18 30 29 31</cell></row><row><cell>Uganda</cell><cell cols="5">1 10 6</cell><cell>4</cell><cell>9</cell><cell>7</cell><cell cols="2">3</cell><cell cols="3">8 17 2</cell><cell cols="31">5 18 15 22 13 21 20 14 11 23 27 16 26 25 12 24 19 30 29 31</cell></row><row><cell>Mozambique</cell><cell>1</cell><cell cols="2">9</cell><cell cols="4">7 12 4</cell><cell>3</cell><cell cols="2">8</cell><cell cols="3">5 15 2</cell><cell cols="31">6 20 17 24 10 22 19 14 16 18 26 13 25 21 11 23 28 29 31 30</cell></row><row><cell>High-income North America</cell><cell>2</cell><cell cols="2">3</cell><cell cols="2">4</cell><cell cols="16">1 13 14 5 11 7 22 21 10 12 9 15 6</cell><cell cols="23">8 17 19 23 18 20 26 24 29 16 31 27 25 28</cell></row><row><cell>United States</cell><cell>2</cell><cell cols="2">3</cell><cell cols="2">4</cell><cell cols="16">1 14 13 5 11 7 23 21 9 12 10 15 6</cell><cell cols="23">8 17 19 22 18 20 26 24 30 16 31 27 25 28</cell></row><row><cell>Canada</cell><cell>2</cell><cell cols="2">4</cell><cell cols="2">3</cell><cell>1</cell><cell cols="38">7 17 5 10 9 23 21 11 12 6 20 8 13 14 18 24 16 19 22 25 29 15 31 27 26 28</cell></row><row><cell>Central Latin America</cell><cell>1</cell><cell cols="2">6</cell><cell cols="2">5</cell><cell>2</cell><cell>3</cell><cell>9</cell><cell cols="2">8</cell><cell cols="34">7 16 4 25 15 12 10 19 18 13 17 14 22 23 21 20 29 11 26 30 27 24 31</cell></row><row><cell>Mexico</cell><cell>1</cell><cell cols="2">7</cell><cell cols="2">4</cell><cell>2</cell><cell>5</cell><cell>9</cell><cell cols="2">8</cell><cell cols="34">6 16 3 27 15 14 10 21 18 11 17 12 24 23 22 19 29 13 26 30 25 20 31</cell></row><row><cell>Colombia</cell><cell>1</cell><cell cols="2">4</cell><cell cols="2">5</cell><cell>3</cell><cell>2</cell><cell>9</cell><cell cols="2">6</cell><cell cols="34">8 17 7 24 18 10 20 16 13 11 12 14 21 22 23 19 29 15 25 30 27 28 31</cell></row><row><cell>Venezuela</cell><cell>1</cell><cell cols="2">4</cell><cell cols="2">5</cell><cell>2</cell><cell cols="4">6 14 7</cell><cell cols="34">8 11 3 26 9 12 10 16 20 17 18 13 15 23 21 22 29 19 25 30 24 28 31</cell></row><row><cell>Eastern Europe</cell><cell>2</cell><cell cols="2">3</cell><cell cols="2">1</cell><cell>5</cell><cell cols="9">4 15 12 10 9 14 19 6</cell><cell>8</cell><cell cols="28">7 17 13 24 16 11 18 20 26 22 21 29 23 30 25 27 31</cell></row><row><cell>Russia</cell><cell>2</cell><cell cols="2">3</cell><cell cols="2">1</cell><cell>6</cell><cell cols="9">5 14 9 10 11 15 19 4</cell><cell>8</cell><cell cols="28">7 17 12 24 16 13 20 18 26 25 23 28 22 30 21 27 31</cell></row><row><cell>Ukraine</cell><cell>3</cell><cell cols="2">2</cell><cell cols="2">1</cell><cell>5</cell><cell cols="9">4 17 18 12 8 11 19 6</cell><cell cols="29">7 10 14 13 23 16 9 15 30 22 20 21 28 24 31 27 29 25</cell></row><row><cell>Tropical Latin America</cell><cell>1</cell><cell cols="2">4</cell><cell cols="2">3</cell><cell>2</cell><cell cols="4">5 16 7</cell><cell cols="34">8 10 6 11 18 13 19 9 14 17 12 21 15 25 22 23 20 26 24 30 27 29 31</cell></row><row><cell>Brazil</cell><cell>1</cell><cell cols="2">4</cell><cell cols="2">3</cell><cell>2</cell><cell cols="4">5 16 7</cell><cell cols="34">9 10 6 11 18 13 19 8 14 17 12 21 15 25 22 23 20 26 24 30 27 29 31</cell></row><row><cell>High-income Asia Pacific</cell><cell>5</cell><cell cols="2">3</cell><cell cols="2">1</cell><cell>4</cell><cell>2</cell><cell>6</cell><cell cols="8">9 14 13 16 12 15 7</cell><cell cols="28">8 18 28 10 20 17 23 25 19 11 22 24 21 30 31 27 29</cell></row><row><cell>Japan</cell><cell>5</cell><cell cols="2">3</cell><cell cols="2">1</cell><cell>4</cell><cell>2</cell><cell>6</cell><cell cols="8">9 14 12 18 11 15 7</cell><cell cols="28">8 16 29 13 20 17 23 27 19 10 22 24 21 30 31 25 26</cell></row><row><cell>South Korea</cell><cell>5</cell><cell cols="2">3</cell><cell cols="2">2</cell><cell>7</cell><cell>1</cell><cell cols="37">4 10 12 13 14 15 16 8 11 19 27 6 18 17 22 25 20 9 24 23 21 28 29 30 31</cell></row><row><cell>Central Europe</cell><cell>3</cell><cell cols="2">1</cell><cell cols="2">2</cell><cell>4</cell><cell cols="9">6 15 11 10 5 14 23 8</cell><cell>9</cell><cell cols="28">7 17 12 25 13 16 18 19 26 21 20 29 24 30 27 22 31</cell></row><row><cell>Poland</cell><cell>2</cell><cell cols="2">1</cell><cell cols="2">3</cell><cell>4</cell><cell cols="9">8 20 13 11 5 14 21 7</cell><cell>9</cell><cell cols="28">6 17 15 24 12 10 16 18 26 19 22 29 23 31 27 25 30</cell></row><row><cell>Central Sub-Saharan Africa</cell><cell>1</cell><cell cols="2">6</cell><cell cols="2">7</cell><cell>9</cell><cell>4</cell><cell>3</cell><cell cols="2">8</cell><cell cols="34">5 15 2 10 21 14 22 11 20 19 17 18 12 25 16 24 23 13 26 27 28 30 31</cell></row><row><cell>Democratic Republic of the Congo</cell><cell>1</cell><cell cols="2">6</cell><cell cols="4">8 10 3</cell><cell>4</cell><cell cols="2">7</cell><cell cols="3">5 16 2</cell><cell cols="31">9 20 14 25 11 21 18 17 19 12 24 15 23 22 13 26 27 28 30 31</cell></row><row><cell>Central Asia</cell><cell>1</cell><cell cols="2">3</cell><cell cols="2">4</cell><cell>7</cell><cell>2</cell><cell cols="37">9 13 6 11 5 10 8 16 17 14 19 23 12 18 15 22 20 24 25 21 29 30 26 27 31</cell></row><row><cell>Uzbekistan</cell><cell>1</cell><cell cols="2">3</cell><cell cols="7">6 11 2 13 8</cell><cell cols="3">4 14 5</cell><cell cols="31">7 15 20 18 12 19 26 9 22 10 21 16 24 25 17 30 27 23 29 31</cell></row><row><cell>Southern Sub-Saharan Africa</cell><cell>1</cell><cell cols="2">4</cell><cell cols="2">5</cell><cell>2</cell><cell>7</cell><cell cols="6">9 12 8 11 3</cell><cell cols="31">6 16 13 22 10 14 20 21 17 15 23 19 25 26 18 24 28 27 31 29</cell></row><row><cell>South Africa</cell><cell>1</cell><cell cols="2">4</cell><cell cols="2">5</cell><cell>2</cell><cell cols="7">7 14 13 8 10 3</cell><cell cols="31">6 16 12 21 9 11 18 22 17 15 24 19 25 26 20 23 28 27 31 29</cell></row><row><cell>Southern Latin America</cell><cell>1</cell><cell cols="2">4</cell><cell cols="2">3</cell><cell>2</cell><cell cols="10">5 17 13 11 10 6 15 14 8</cell><cell cols="28">9 19 16 12 20 18 22 23 21 7 29 26 25 31 28 24 30</cell></row><row><cell>Argentina</cell><cell>1</cell><cell cols="2">4</cell><cell cols="2">3</cell><cell>2</cell><cell cols="6">5 18 12 11 8</cell><cell cols="4">6 15 13 7</cell><cell cols="28">9 17 16 10 21 19 20 23 22 14 29 26 25 31 28 24 30</cell></row><row><cell>Andean Latin America</cell><cell>1</cell><cell cols="2">7</cell><cell cols="2">5</cell><cell>3</cell><cell cols="4">2 10 6</cell><cell cols="34">8 15 4 24 9 13 16 21 20 12 14 19 22 25 18 11 26 17 23 30 29 28 31</cell></row><row><cell>Peru</cell><cell>1</cell><cell cols="2">6</cell><cell cols="2">5</cell><cell>2</cell><cell>3</cell><cell>9</cell><cell cols="2">7</cell><cell cols="34">8 16 4 25 10 11 15 21 19 12 14 17 22 23 20 13 26 18 24 30 29 27 31</cell></row><row><cell>Caribbean</cell><cell>2</cell><cell cols="2">4</cell><cell cols="2">3</cell><cell>1</cell><cell cols="4">6 11 8</cell><cell cols="34">9 10 5 16 7 14 15 12 22 18 17 19 13 21 23 25 24 26 20 29 27 30 31</cell></row><row><cell>Australasia</cell><cell>3</cell><cell cols="2">5</cell><cell cols="2">2</cell><cell>1</cell><cell cols="38">8 15 6 10 12 25 17 9 11 7 23 4 13 14 18 26 19 20 22 21 28 16 31 30 27 24</cell></row><row><cell>Oceania</cell><cell>1</cell><cell cols="2">4</cell><cell cols="4">7 10 3</cell><cell>6</cell><cell cols="2">9</cell><cell cols="34">5 18 2 24 8 16 28 11 22 13 23 20 15 29 12 25 14 21 27 19 26 30 31</cell></row></table><note><p><s>E10JAMA Oncology Published online December 3, 2016 (Reprinted) jamaoncology.com</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head></head><label></label><figDesc><div><p><s>Figure 5. Cancers Ranked by Number of Deaths in Both Sexes, Global, by Region, by Sociodemographic Index (SDI), and in the 50 Most Populous Countries, 2015</s></p></div></figDesc><table><row><cell>Global Burden of Cancer 2015</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="19">Special Communication Clinical Review &amp; Education</cell></row><row><cell>Country</cell><cell>Tracheal, bronchus,</cell><cell>and lung cancer</cell><cell>Colon and rectum</cell><cell>cancer</cell><cell>Stomach cancer</cell><cell>Liver cancer</cell><cell>Breast cancer</cell><cell>Esophageal cancer</cell><cell>Pancreatic cancer</cell><cell>Prostate cancer</cell><cell>Leukemia</cell><cell>Cervical cancer</cell><cell>Non-Hodgkin</cell><cell>lymphoma</cell><cell>Brain and nervous</cell><cell>system cancer</cell><cell>Bladder cancer</cell><cell>Ovarian cancer</cell><cell>Acute myeloid</cell><cell>leukemia</cell><cell>Lip and oral cavity</cell><cell>cancer</cell><cell>Gallbladder and</cell><cell>biliary tract cancer</cell><cell>Kidney cancer</cell><cell>Acute lymphoid</cell><cell>leukemia</cell><cell>Larynx cancer</cell><cell>Multiple myeloma</cell><cell>Uterine cancer</cell><cell>Other pharynx</cell><cell>cancer</cell><cell>Nasopharynx</cell><cell>cancer</cell><cell>Chronic lymphoid</cell><cell>leukemia</cell><cell>Malignant skin</cell><cell>melanoma</cell><cell>Chronic myeloid</cell><cell>leukemia</cell><cell>Mesothelioma</cell><cell>Thyroid cancer</cell><cell>Hodgkin lymphoma</cell><cell>Testicular cancer</cell></row><row><cell>Global</cell><cell cols="2">1</cell><cell cols="2">2</cell><cell>3</cell><cell>4</cell><cell>5</cell><cell>6</cell><cell>7</cell><cell>8</cell><cell cols="34">9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31</cell></row><row><cell>High SDI</cell><cell cols="2">1</cell><cell cols="2">2</cell><cell>3</cell><cell>6</cell><cell cols="3">4 10 5</cell><cell>7</cell><cell cols="34">8 18 9 14 11 13 15 20 16 12 26 23 17 21 24 29 22 19 27 25 28 30 31</cell></row><row><cell>High-middle SDI</cell><cell cols="2">1</cell><cell cols="2">4</cell><cell>3</cell><cell>2</cell><cell>6</cell><cell>5</cell><cell>7</cell><cell>8</cell><cell cols="34">9 11 12 10 13 15 16 18 14 19 17 20 21 22 24 23 25 26 27 29 28 30 31</cell></row><row><cell>Middle SDI</cell><cell cols="2">1</cell><cell cols="2">4</cell><cell>3</cell><cell>2</cell><cell>6</cell><cell>5</cell><cell cols="3">8 10 7</cell><cell cols="33">9 12 11 15 17 16 14 19 22 13 20 23 21 24 18 25 28 27 30 26 29 31</cell></row><row><cell>Low-middle SDI</cell><cell cols="2">1</cell><cell cols="2">5</cell><cell>2</cell><cell>4</cell><cell>3</cell><cell cols="4">6 11 10 8</cell><cell cols="33">7 12 13 15 16 18 9 20 23 17 14 22 19 21 24 26 29 25 31 28 27 30</cell></row><row><cell>Low SDI</cell><cell cols="2">7</cell><cell cols="2">6</cell><cell>3</cell><cell>1</cell><cell>5</cell><cell cols="3">4 10 8</cell><cell>9</cell><cell cols="33">2 11 12 13 14 17 18 19 21 16 22 20 15 23 25 26 27 24 31 29 28 30</cell></row><row><cell>South Asia</cell><cell cols="2">1</cell><cell cols="2">3</cell><cell>5</cell><cell>8</cell><cell>2</cell><cell cols="4">4 10 13 7</cell><cell cols="33">9 11 14 15 16 17 6 20 24 19 12 21 22 18 23 27 29 25 31 28 26 30</cell></row><row><cell>India</cell><cell cols="2">1</cell><cell cols="2">4</cell><cell>2</cell><cell>8</cell><cell>5</cell><cell cols="4">3 10 11 7</cell><cell cols="33">6 13 14 16 15 17 9 20 24 19 12 21 23 18 22 27 29 25 31 28 26 30</cell></row><row><cell>Pakistan</cell><cell cols="2">2</cell><cell cols="2">4</cell><cell>9</cell><cell>6</cell><cell>1</cell><cell cols="37">3 14 15 8 19 7 10 12 16 20 5 23 22 18 11 17 13 21 24 28 30 25 31 29 27 26</cell></row><row><cell>Bangladesh</cell><cell cols="2">1</cell><cell cols="2">2</cell><cell>5</cell><cell>9</cell><cell>4</cell><cell cols="4">7 10 12 6</cell><cell cols="33">8 13 11 17 18 15 3 21 26 16 14 23 22 19 20 27 30 24 31 28 25 29</cell></row><row><cell>Nepal</cell><cell cols="2">1</cell><cell cols="2">6</cell><cell>2</cell><cell>7</cell><cell>3</cell><cell>8</cell><cell cols="3">9 13 5</cell><cell cols="33">4 12 11 18 16 15 14 20 27 17 10 23 21 19 22 26 29 24 31 28 25 30</cell></row><row><cell>East Asia</cell><cell cols="2">1</cell><cell cols="2">5</cell><cell>3</cell><cell>2</cell><cell>7</cell><cell>4</cell><cell cols="36">6 10 8 12 11 9 15 20 18 17 16 21 13 19 23 22 27 14 24 26 30 28 25 29 31</cell></row><row><cell>China</cell><cell cols="2">1</cell><cell cols="2">5</cell><cell>3</cell><cell>2</cell><cell>7</cell><cell>4</cell><cell cols="36">6 10 8 12 11 9 15 20 18 17 16 21 13 19 23 22 28 14 24 26 30 27 25 29 31</cell></row><row><cell>Southeast Asia</cell><cell cols="2">1</cell><cell cols="2">3</cell><cell>5</cell><cell>2</cell><cell cols="5">4 11 8 10 6</cell><cell cols="33">7 12 14 18 13 17 15 16 20 9 22 25 21 23 19 30 29 26 28 24 27 31</cell></row><row><cell>Indonesia</cell><cell cols="2">5</cell><cell cols="2">6</cell><cell>3</cell><cell>2</cell><cell cols="3">1 12 8</cell><cell>9</cell><cell>4</cell><cell cols="33">7 11 14 16 13 15 22 18 20 10 21 24 19 23 17 30 28 26 29 25 27 31</cell></row><row><cell>Philippines</cell><cell cols="2">1</cell><cell cols="2">3</cell><cell>8</cell><cell>4</cell><cell cols="4">2 20 10 6</cell><cell>5</cell><cell cols="33">7 13 12 22 14 11 15 24 19 9 21 25 17 26 16 29 27 23 28 18 30 31</cell></row><row><cell>Vietnam</cell><cell cols="2">1</cell><cell cols="2">3</cell><cell>4</cell><cell>2</cell><cell>5</cell><cell>6</cell><cell cols="36">7 12 8 11 9 16 17 13 20 10 19 22 15 21 24 23 14 18 31 29 27 28 25 26 30</cell></row><row><cell>Thailand</cell><cell cols="2">2</cell><cell cols="2">3</cell><cell>7</cell><cell>1</cell><cell cols="5">5 13 10 12 4</cell><cell cols="33">9 18 14 16 17 21 11 8 15 6 19 25 24 22 20 30 29 28 26 23 27 31</cell></row><row><cell>Myanmar</cell><cell cols="2">1</cell><cell cols="2">3</cell><cell>4</cell><cell>6</cell><cell cols="5">2 16 8 13 7</cell><cell cols="33">5 12 14 18 10 19 11 17 22 9 21 25 15 23 20 28 29 26 30 24 27 31</cell></row><row><cell>Malaysia</cell><cell cols="2">1</cell><cell cols="2">2</cell><cell>6</cell><cell>4</cell><cell cols="38">3 14 9 11 5 12 8 16 17 13 18 15 23 19 7 21 20 24 25 10 29 27 26 30 22 28 31</cell></row><row><cell>North Africa and Middle East</cell><cell cols="2">1</cell><cell cols="2">4</cell><cell>2</cell><cell>6</cell><cell cols="3">3 13 9</cell><cell>8</cell><cell cols="34">5 15 12 7 11 17 10 24 16 19 14 18 21 20 30 25 22 29 23 28 27 26 31</cell></row><row><cell>Egypt</cell><cell cols="2">2</cell><cell cols="2">6</cell><cell>8</cell><cell>1</cell><cell cols="10">4 15 10 12 3 19 13 5</cell><cell cols="28">7 16 11 22 21 18 9 17 24 20 27 29 14 28 23 25 26 30 31</cell></row><row><cell>Iran</cell><cell cols="2">2</cell><cell cols="2">5</cell><cell>1</cell><cell>9</cell><cell>7</cell><cell cols="3">4 11 8</cell><cell cols="34">3 20 16 6 14 19 10 22 15 18 13 12 23 26 29 27 21 24 17 30 28 25 31</cell></row><row><cell>Turkey</cell><cell cols="2">1</cell><cell cols="2">2</cell><cell>3</cell><cell>9</cell><cell cols="3">6 18 5</cell><cell>7</cell><cell cols="34">4 22 11 8 12 13 10 25 19 16 17 15 14 20 31 26 21 24 27 23 28 29 30</cell></row><row><cell>Sudan</cell><cell cols="2">2</cell><cell cols="2">6</cell><cell>1</cell><cell>4</cell><cell cols="4">3 13 10 8</cell><cell cols="4">5 14 9</cell><cell cols="30">7 15 17 11 22 16 21 12 19 23 18 28 27 24 30 20 29 26 25 31</cell></row><row><cell>Algeria</cell><cell cols="2">1</cell><cell cols="2">2</cell><cell>5</cell><cell>9</cell><cell cols="3">3 20 6</cell><cell>8</cell><cell cols="34">4 10 12 7 14 18 13 25 11 21 15 19 17 22 28 16 23 30 24 29 27 26 31</cell></row><row><cell>Iraq</cell><cell cols="2">1</cell><cell cols="2">7</cell><cell>8</cell><cell>5</cell><cell cols="38">2 17 9 13 3 18 12 4 11 15 6 20 23 14 10 22 24 16 26 27 21 28 19 29 25 30 31</cell></row><row><cell>Morocco</cell><cell cols="2">1</cell><cell cols="2">4</cell><cell>3</cell><cell>7</cell><cell cols="3">2 17 9</cell><cell>5</cell><cell cols="34">6 10 12 8 11 16 14 23 15 22 18 19 20 13 26 24 21 30 25 27 29 28 31</cell></row><row><cell>Afghanistan</cell><cell cols="2">3</cell><cell cols="2">5</cell><cell>1</cell><cell>4</cell><cell>2</cell><cell cols="4">9 15 11 6</cell><cell cols="33">7 10 8 14 20 17 24 12 23 16 18 25 13 28 27 22 30 21 29 26 19 31</cell></row><row><cell>Saudi Arabia</cell><cell cols="2">2</cell><cell cols="2">1</cell><cell>7</cell><cell>3</cell><cell cols="8">4 12 8 10 5 21 9</cell><cell cols="30">6 15 16 11 22 18 13 14 20 17 24 27 23 25 29 19 30 26 28 31</cell></row><row><cell>Yemen</cell><cell cols="2">1</cell><cell cols="2">6</cell><cell>2</cell><cell>4</cell><cell cols="8">3 13 9 11 5 10 8</cell><cell cols="30">7 15 18 14 24 16 22 12 19 25 17 27 28 23 30 20 29 26 21 31</cell></row><row><cell>Western Europe</cell><cell cols="2">1</cell><cell cols="2">2</cell><cell>6</cell><cell>8</cell><cell cols="3">3 11 5</cell><cell>4</cell><cell cols="34">7 21 10 13 9 12 15 20 17 14 27 24 16 23 25 29 18 19 26 22 28 30 31</cell></row><row><cell>Germany</cell><cell cols="2">1</cell><cell cols="2">2</cell><cell>6</cell><cell>8</cell><cell cols="3">3 14 4</cell><cell>5</cell><cell cols="34">7 22 10 13 9 12 15 20 16 11 28 25 17 23 21 29 18 19 26 24 27 30 31</cell></row><row><cell>France</cell><cell cols="2">1</cell><cell cols="2">2</cell><cell>8</cell><cell>6</cell><cell cols="3">3 10 4</cell><cell>5</cell><cell cols="34">7 22 11 15 9 12 16 19 18 14 27 23 13 24 20 28 17 21 26 25 29 30 31</cell></row><row><cell>United Kingdom</cell><cell cols="2">1</cell><cell cols="2">2</cell><cell cols="3">8 12 3</cell><cell>6</cell><cell>5</cell><cell>4</cell><cell cols="34">7 23 10 13 9 11 14 22 20 15 28 26 16 21 25 27 19 18 24 17 29 30 31</cell></row><row><cell>Italy</cell><cell cols="2">1</cell><cell cols="2">2</cell><cell>4</cell><cell>6</cell><cell cols="3">3 18 5</cell><cell>7</cell><cell cols="34">8 23 10 12 9 14 15 19 13 11 27 21 16 24 26 29 17 20 25 22 28 30 31</cell></row><row><cell>England</cell><cell cols="2">1</cell><cell cols="2">2</cell><cell cols="3">8 12 3</cell><cell>6</cell><cell>5</cell><cell>4</cell><cell cols="34">7 23 10 13 9 11 14 22 20 15 28 25 17 21 26 27 19 18 24 16 29 30 31</cell></row><row><cell>Spain</cell><cell cols="2">1</cell><cell cols="2">2</cell><cell>5</cell><cell>8</cell><cell cols="3">3 15 6</cell><cell>4</cell><cell cols="34">9 23 10 11 7 12 13 19 17 14 27 20 16 21 24 28 18 22 25 26 29 30 31</cell></row><row><cell>Western Sub-Saharan Africa</cell><cell cols="2">4</cell><cell cols="2">7</cell><cell>2</cell><cell>1</cell><cell cols="3">6 11 9</cell><cell>5</cell><cell>8</cell><cell cols="33">3 10 12 13 18 14 21 17 15 16 22 20 19 23 30 27 26 24 31 29 25 28</cell></row><row><cell>Nigeria</cell><cell cols="2">3</cell><cell cols="2">6</cell><cell>2</cell><cell>1</cell><cell cols="3">7 11 9</cell><cell>5</cell><cell>8</cell><cell cols="33">4 10 12 16 19 14 21 17 13 15 22 18 20 23 28 27 25 24 31 29 26 30</cell></row><row><cell>Ghana</cell><cell cols="5">8 10 4</cell><cell>1</cell><cell cols="3">2 13 6</cell><cell>3</cell><cell>9</cell><cell>5</cell><cell cols="32">7 11 14 18 15 20 19 21 12 22 17 16 23 29 25 26 24 30 28 27 31</cell></row><row><cell>Eastern Sub-Saharan Africa</cell><cell cols="2">8</cell><cell cols="2">4</cell><cell>6</cell><cell>2</cell><cell>5</cell><cell cols="3">3 11 7</cell><cell>9</cell><cell cols="33">1 10 13 14 12 18 17 22 21 16 20 19 15 24 23 28 25 27 30 26 31 29</cell></row><row><cell>Ethiopia</cell><cell cols="2">8</cell><cell cols="2">3</cell><cell>6</cell><cell>2</cell><cell>5</cell><cell cols="3">4 11 7</cell><cell>9</cell><cell cols="33">1 10 13 16 12 18 14 20 22 17 21 19 15 24 23 27 26 28 30 25 31 29</cell></row><row><cell>Tanzania</cell><cell cols="2">8</cell><cell cols="2">3</cell><cell>7</cell><cell>2</cell><cell>5</cell><cell cols="3">4 11 6</cell><cell>9</cell><cell cols="33">1 10 13 14 12 16 19 22 20 15 21 18 17 24 23 28 25 27 29 26 31 30</cell></row><row><cell>Kenya</cell><cell cols="4">11 4</cell><cell>2</cell><cell>3</cell><cell>5</cell><cell>7</cell><cell>9</cell><cell>6</cell><cell>8</cell><cell cols="33">1 13 12 20 10 16 18 21 23 17 14 15 19 24 22 25 28 26 30 27 31 29</cell></row><row><cell>Uganda</cell><cell cols="2">6</cell><cell cols="2">2</cell><cell>8</cell><cell>4</cell><cell>9</cell><cell cols="5">1 12 3 10 5</cell><cell cols="32">7 13 17 11 9 20 23 18 16 22 15 14 24 21 28 25 27 30 26 31 29</cell></row><row><cell>Mozambique</cell><cell cols="2">7</cell><cell cols="2">5</cell><cell>4</cell><cell>1</cell><cell>6</cell><cell cols="3">3 12 9</cell><cell>8</cell><cell cols="33">2 10 11 15 14 16 17 22 21 13 20 19 18 23 28 25 26 24 29 27 30 31</cell></row><row><cell>High-income North America</cell><cell cols="2">1</cell><cell cols="2">2</cell><cell>9</cell><cell>8</cell><cell cols="3">3 10 4</cell><cell>5</cell><cell cols="34">6 20 7 13 11 14 12 21 22 15 26 23 16 19 25 30 18 17 27 24 28 29 31</cell></row><row><cell>United States</cell><cell cols="2">1</cell><cell cols="4">2 14 8</cell><cell>3</cell><cell>9</cell><cell>4</cell><cell>5</cell><cell cols="34">6 20 7 12 11 13 10 21 23 15 26 22 16 19 25 30 18 17 27 24 28 29 31</cell></row><row><cell>Canada</cell><cell cols="2">1</cell><cell cols="2">2</cell><cell cols="5">6 12 3 10 5</cell><cell>4</cell><cell cols="34">8 20 7 11 9 13 15 21 17 14 27 24 16 23 25 29 18 19 26 22 28 30 31</cell></row><row><cell>Central Latin America</cell><cell cols="2">1</cell><cell cols="2">3</cell><cell>2</cell><cell>6</cell><cell cols="3">5 17 9</cell><cell>4</cell><cell>7</cell><cell cols="33">8 10 12 18 13 16 22 14 15 11 20 19 21 28 30 26 23 25 31 24 27 29</cell></row><row><cell>Mexico</cell><cell cols="2">1</cell><cell cols="2">4</cell><cell>2</cell><cell>6</cell><cell cols="3">5 18 9</cell><cell>3</cell><cell>7</cell><cell cols="33">8 10 13 17 14 16 21 15 12 11 20 19 22 30 31 27 24 26 29 23 25 28</cell></row><row><cell>Colombia</cell><cell cols="2">2</cell><cell cols="2">3</cell><cell>1</cell><cell>7</cell><cell cols="3">4 15 9</cell><cell>5</cell><cell>6</cell><cell cols="33">8 10 11 17 14 16 21 13 19 12 20 18 22 28 29 26 23 24 30 25 27 31</cell></row><row><cell>Venezuela</cell><cell cols="2">1</cell><cell cols="2">4</cell><cell>3</cell><cell>9</cell><cell cols="3">5 17 8</cell><cell>2</cell><cell>7</cell><cell cols="33">6 10 11 18 12 16 22 19 13 14 15 20 21 27 29 26 24 23 31 28 25 30</cell></row><row><cell>Eastern Europe</cell><cell cols="2">1</cell><cell cols="2">2</cell><cell>3</cell><cell>8</cell><cell cols="3">4 13 5</cell><cell>6</cell><cell cols="34">9 14 18 12 11 7 20 15 22 10 25 17 23 16 21 30 24 19 26 28 27 29 31</cell></row><row><cell>Russia</cell><cell cols="2">1</cell><cell cols="2">2</cell><cell>3</cell><cell>7</cell><cell cols="3">4 12 5</cell><cell cols="35">6 10 14 18 11 13 9 21 16 22 8 25 17 23 15 20 30 24 19 28 29 26 27 31</cell></row><row><cell>Ukraine</cell><cell cols="2">1</cell><cell cols="2">2</cell><cell cols="5">3 14 4 16 5</cell><cell>6</cell><cell cols="7">8 10 19 11 9</cell><cell cols="27">7 17 15 21 12 26 13 24 22 20 27 31 18 25 23 28 29 30</cell></row><row><cell>Tropical Latin America</cell><cell cols="2">1</cell><cell cols="2">2</cell><cell>3</cell><cell>8</cell><cell>5</cell><cell>7</cell><cell>6</cell><cell cols="35">4 10 9 12 11 15 18 17 13 14 19 23 16 21 22 20 30 25 24 26 29 27 28 31</cell></row><row><cell>Brazil</cell><cell cols="2">1</cell><cell cols="2">3</cell><cell>2</cell><cell>8</cell><cell>5</cell><cell>7</cell><cell>6</cell><cell cols="35">4 10 9 12 11 15 18 17 13 14 19 23 16 21 22 20 30 25 24 26 29 27 28 31</cell></row><row><cell>High-income Asia Pacific</cell><cell cols="2">1</cell><cell cols="2">3</cell><cell>2</cell><cell>4</cell><cell>7</cell><cell>8</cell><cell cols="36">5 10 11 17 9 19 12 15 13 18 6 14 22 25 16 20 21 26 29 27 28 24 23 30 31</cell></row><row><cell>Japan</cell><cell cols="2">1</cell><cell cols="2">3</cell><cell>2</cell><cell>4</cell><cell>7</cell><cell>8</cell><cell cols="36">5 10 11 18 9 20 12 15 13 17 6 14 23 25 16 19 21 26 29 27 28 24 22 30 31</cell></row><row><cell cols="45">South Korea Central Europe in Table 2, between 2005 and 2015, incidence (95% UI) increased 1 4 3 2 7 10 5 11 8 15 9 13 12 16 17 20 6 14 19 21 18 24 23 26 28 25 27 29 22 30 31 1 2 4 7 3 16 5 6 8 13 15 9 10 12 19 17 14 11 25 18 23 22 20 29 24 21 26 30 27 28 31</cell></row><row><cell cols="45">Poland Central Sub-Saharan Africa by 37% (32.1%-41.0%) from 1.2 million (1.19-1.24 million) to 1.7 mil-1 2 4 14 3 15 5 6 8 13 16 9 5 7 3 1 4 6 9 10 8 2 11 12 14 13 16 18 19 21 15 22 20 17 23 26 24 27 25 30 29 28 31 7 11 19 18 12 10 25 17 21 23 24 30 22 20 26 29 27 28 31</cell></row><row><cell cols="45">Democratic Republic of the Congo Central Asia Uzbekistan lion (1.6-1.7 million) cases. Most of this increase can be explained by 5 7 3 1 4 6 10 9 8 2 11 12 15 13 16 18 19 21 14 22 20 17 23 26 24 28 25 30 29 27 31 1 5 2 3 4 6 8 11 7 10 16 9 14 12 13 18 20 17 19 15 24 21 22 28 25 23 26 30 29 27 31 2 5 1 7 4 3 10 14 6 9 13 8 18 20 11 16 17 19 15 12 22 21 23 28 27 24 25 31 30 26 29 an aging and growing population, however, even with the same popu-</cell></row><row><cell cols="45">Southern Sub-Saharan Africa South Africa lation size and age structure, colon and rectum cancer cases would 1 5 9 7 4 3 8 6 10 2 13 15 11 12 16 14 22 21 17 19 18 20 26 27 24 23 28 25 29 30 31 1 6 9 7 4 3 8 5 10 2 13 18 14 11 15 12 22 21 17 19 16 20 26 27 25 23 28 24 29 30 31</cell></row><row><cell cols="45">Southern Latin America have increased by 5% between 2005 and 2015 reflecting a change 1 2 3 11 4 9 6 5 10 8 13 16 14 15 17 21 7 12 23 20 18 19 27 31 24 22 25 29 26 30 28</cell></row><row><cell cols="3">Argentina Andean Latin America in age-specific incidence rates. 1 2</cell><cell cols="2">2 4</cell><cell cols="5">4 12 3 10 6 1 6 7 18 9</cell><cell>5 3</cell><cell>9 8</cell><cell cols="33">7 13 16 14 15 17 21 8 11 23 18 20 19 28 31 24 22 25 27 26 29 30 5 11 12 20 15 13 21 10 17 14 23 19 16 24 31 27 25 26 29 22 28 30</cell></row><row><cell>Peru</cell><cell cols="2">2</cell><cell cols="2">4</cell><cell>1</cell><cell>5</cell><cell cols="3">7 19 9</cell><cell>3</cell><cell>8</cell><cell cols="33">6 10 12 20 15 13 21 11 16 14 23 18 17 25 31 27 24 26 29 22 28 30</cell></row><row><cell>Caribbean</cell><cell cols="2">1</cell><cell cols="2">3</cell><cell>5</cell><cell>7</cell><cell cols="3">4 11 8</cell><cell>2</cell><cell>9</cell><cell cols="33">6 10 12 14 18 19 16 21 20 22 15 17 13 24 28 23 26 25 30 29 27 31</cell></row><row><cell>Australasia</cell><cell cols="2">1</cell><cell cols="2">2</cell><cell cols="5">8 12 4 10 5</cell><cell>3</cell><cell cols="34">6 22 7 11 13 16 15 21 19 14 25 26 17 23 24 27 20 9 28 18 29 30 31</cell></row><row><cell>Oceania</cell><cell cols="2">1</cell><cell cols="2">6</cell><cell>3</cell><cell>4</cell><cell cols="4">2 14 10 8</cell><cell>7</cell><cell cols="33">5 11 16 22 13 12 15 23 25 19 18 24 9 20 21 31 27 17 29 26 28 30</cell></row><row><cell>jamaoncology.com</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="25">(Reprinted) JAMA Oncology Published online December 3, 2016</cell><cell>E11</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_7"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Decomposition Analysis of Cancer Trends in Global Incidence, Both Sexes, 2005 to 2015</s></p></div></figDesc><table><row><cell>1</cell><cell>Tracheal, bronchus, and lung cancer</cell><cell>Tracheal, bronchus, and lung cancer</cell><cell>1</cell></row><row><cell>2</cell><cell>Liver cancer</cell><cell>Liver cancer</cell><cell>2</cell></row><row><cell>3</cell><cell>Stomach cancer</cell><cell>Stomach cancer</cell><cell>3</cell></row><row><cell>4</cell><cell>Colon and rectum cancer</cell><cell>Colon and rectum cancer</cell><cell>4</cell></row><row><cell>5</cell><cell>Breast cancer</cell><cell>Breast cancer</cell><cell>5</cell></row><row><cell>6</cell><cell>Leukemia</cell><cell>Leukemia</cell><cell>6</cell></row><row><cell>7</cell><cell>Esophageal cancer</cell><cell>Esophageal cancer</cell><cell>7</cell></row><row><cell>8</cell><cell>Brain and nervous system cancer</cell><cell>Pancreatic cancer</cell><cell>8</cell></row><row><cell>9</cell><cell>Cervical cancer</cell><cell>Brain and nervous system cancer</cell><cell>9</cell></row><row><cell>10</cell><cell>Pancreatic cancer</cell><cell>Cervical cancer</cell><cell>10</cell></row><row><cell>11</cell><cell>Non-Hodgkin lymphoma</cell><cell>Non-Hodgkin lymphoma</cell><cell>11</cell></row><row><cell>12</cell><cell>Acute lymphoid leukemia</cell><cell>Prostate cancer</cell><cell>12</cell></row><row><cell>13</cell><cell>Acute myeloid leukemia</cell><cell>Acute lymphoid leukemia</cell><cell>13</cell></row><row><cell>14</cell><cell>Prostate cancer</cell><cell>Acute myeloid leukemia</cell><cell>14</cell></row><row><cell>15</cell><cell>Ovarian cancer</cell><cell>Ovarian cancer</cell><cell>15</cell></row><row><cell>16</cell><cell>Lip and oral cavity cancer</cell><cell>Lip and oral cavity cancer</cell><cell>16</cell></row><row><cell>17</cell><cell>Bladder cancer</cell><cell></cell><cell>17</cell></row><row><cell>18</cell><cell>Kidney cancer</cell><cell>Bladder cancer</cell><cell>18</cell></row><row><cell>19</cell><cell>Gallbladder and biliary tract cancer</cell><cell>Gallbladder and biliary tract cancer</cell><cell>19</cell></row><row><cell>20</cell><cell>Larynx cancer</cell><cell>Larynx cancer</cell><cell>20</cell></row><row><cell>21</cell><cell>Uterine cancer</cell><cell>Multiple myeloma</cell><cell>21</cell></row><row><cell>22</cell><cell>Nasopharynx cancer</cell><cell>Uterine cancer</cell><cell>22</cell></row><row><cell>23</cell><cell>Multiple myeloma</cell><cell>Nasopharynx cancer</cell><cell>23</cell></row><row><cell>24</cell><cell>Other pharynx cancer</cell><cell>Other pharynx cancer</cell><cell>24</cell></row><row><cell>25</cell><cell>Malignant skin melanoma</cell><cell>Malignant skin melanoma</cell><cell>25</cell></row><row><cell>26</cell><cell>Chronic lymphoid leukemia</cell><cell>Chronic lymphoid leukemia</cell><cell>26</cell></row></table><note><p><s>jamaoncology.com</s><s>(Reprinted) JAMA Oncology Published online December 3, 2016 E13</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_8"><head>com/ by a Queensland Univ of Technology User on 12/08/2016</head><label></label><figDesc></figDesc><table><row><cell>Global Burden of Cancer 2015</cell><cell>Special Communication Clinical Review &amp; Education</cell></row><row><cell>4.6 (3.3-6.2), ASDR 2.7 (2.1-3.5); South Asia: ASIR 4.7 (3.8-5.8), ASDR</cell><cell></cell></row><row><cell>2.8 (2.6-3.1); and Western Sub-Saharan Africa: ASIR 5.5 (4.1-7.8), ASDR</cell><cell></cell></row></table><note><p><s>jamaoncology.com(Reprinted)JAMA</s><s>Oncology Published online December 3, 2016 E17Copyright 2016 American Medical Association.All rights reserved.Downloaded From: http://jamanetwork.</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Copyright 2016 American Medical Association. All rights reserved. Downloaded From: http://jamanetwork.com/ by a Queensland Univ of Technology User on 12/08/2016</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Copyright 2016 American Medical Association. All rights reserved. Downloaded From: http://jamanetwork.com/ by a Queensland Univ of Technology User on 12/08/2016 Copyright 2016 American Medical Association. All rights reserved.</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">JAMA Oncology Published online December 3, 2016 (Reprinted) jamaoncology.com Copyright 2016 American Medical Association. All rights reserved. Downloaded From: http://jamanetwork.com/ by a Queensland Univ of Technology User on 12/08/2016</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Downloaded From: http://jamanetwork.com/ by a Queensland Univ of Technology User on 12/08/2016</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0" />
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Affiliations of The Global Burden of Disease</head><p><s>Cancer Collaboration: Division of Hematology, Department of Medicine, University of Washington, Seattle <ref type="bibr">(Fitzmaurice)</ref>; Institute for Health Metrics and Evaluation, University of Washington, Seattle <ref type="bibr">(Fitzmaurice, Allen, Barber, Dicker, L. Dandona, Fleming, Forouzanfar, Hancock, Hunter-Merrill, Huynh, Johnson, Kutz, Lim, MacIntyre, Marczak, Marquez, Mokdad, Pinho, Sandar, Shackelford, Stanaway, Steiner, Vos, Wagner, Wang, Zoeckler, Murray, Naghavi)</ref>; University of Gothenburg, Gothenburg, Sweden <ref type="bibr">(Barregard)</ref> Author Contributions Drs Naghavi and Fitzmaurice had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.</s><s>Concept and design: Fitzmaurice, Dicker, Forouzanfar, Jonas, Liang, Mokdad, Stanaway, Vos, Alem, Barac, Ding, James, Jee, Leigh, Marcenes, Meles, Mohammad, Satpathy, Sawhney, Soneji, Tessema, Younis, Zaidi, Murray, Naghavi.</s><s>Acquisition, analysis, or interpretation of data: Fitzmaurice, Allen, Barber, <ref type="bibr">Barregard, Bhutta, Brenner, Dicker, Fleming, Hancock, Hay, Hunter-Merrill, Huynh, Hosgood, III, Johnson, Jonas, Khubchandani, Kutz, Lan, Larson, Lim, Marczak, Marquez, Mokdad, Pourmalek, Salomon, Sanabria, Sartorius, Schwartz, Shackelford, Stanaway, Sun, Takahashi, Vollset, Vos, Wagner,</ref> Westerman, Zeeb, Abd-Allah, Ahmed, Alabed, Aldhahri, Alem, Alemayohu, Ali, Al-Raddadi, Amare, Amoako, Artaman, Asayesh, Atnafu, Awasthi, Ba Saleem, Bedi, Bensenor, Berhane, Bernabé, Betsu, Binagwaho, Boneya, Campos-Nonato, Castañeda-Orjuela, Catalá-López, Chibueze, Chitheer, Choi, Cowie, Damtew, das Neves, Dey, Dharmaratne, Dhillon, Driscoll, Ekwueme, Endries, Farvid, Farzadfar, Fernandes, Fischer, G/hiwot, Gebru, Gopalani, Hailu, Horino, Horita, Husseini, Huybrechts, Inoue, Islami, Jakovljevic, Javanbakht, Jee, <ref type="bibr">Kasaeian, Khader, Khang, Kim, Leigh, Linn, Lunevicius, Magdy</ref>  Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</s></p><p><s>Additional Information: With 3 exceptions, author names are listed in 2 alphabetical series: the first series lists the core authors, who contributed most substantially to the work; the second series lists all of the other authors.</s><s>Dr Fitzmaurice, as the corresponding author, is listed first; senior author Dr Naghavi is listed last; and Dr Murray is listed second to last owing to his critical involvement in the Global Burden of Disease enterprise.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<author>
			<persName><forename type="first">A-Ylls</forename></persName>
		</author>
		<title level="m">% (95% CI) Change in AS-YLL Rate, % (95% CI)</title>
				<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title level="m" type="main">The &quot;other cancers&quot; group is not included in these data because it contains multiple different types of cancers. Solid lines connecting the 2005 and 2015 charts indicate increased or unchanged rank for the connected cancers</title>
		<imprint>
			<date type="published" when="2005">2005. 2015</date>
		</imprint>
	</monogr>
	<note>Illustrated data include the percentage change in absolute YLLs (A-YLLs) and the percentage change in the age-standardized YLL (AS-YLL) rate between. dotted lines indicate decreased rank</note>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Phd</forename><surname>Barregard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Md; Zulfiqar</surname></persName>
		</author>
		<author>
			<persName><surname>Bhutta</surname></persName>
		</author>
		<imprint>
			<publisher>PhD</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Hermann</forename><surname>Brenner</surname></persName>
		</author>
		<imprint>
			<pubPlace>MD, PhD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Daniel</forename><forename type="middle">J</forename><surname>Dicker</surname></persName>
		</author>
		<author>
			<persName><surname>Bs;</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Odgerel Chimed-Orchir</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Rakhi</forename><surname>Dandona</surname></persName>
		</author>
		<author>
			<persName><surname>Phd; Lalit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Dandona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph; Tom</forename><surname>Fleming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Bs; Mohammad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Jamie</forename><surname>Forouzanfar</surname></persName>
		</author>
		<author>
			<persName><surname>Hancock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mls; Roderick</surname></persName>
		</author>
		<author>
			<persName><surname>Hay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ma; Chantal</forename><surname>Hunter-Merrill</surname></persName>
		</author>
		<author>
			<persName><surname>Huynh</surname></persName>
		</author>
		<author>
			<persName><surname>Ba; H. Dean</surname></persName>
		</author>
		<author>
			<persName><surname>Hosgood</surname></persName>
		</author>
		<author>
			<persName><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="middle">O</forename><surname>Mph; Catherine</surname></persName>
		</author>
		<author>
			<persName><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Jost</surname></persName>
		</author>
		<author>
			<persName><surname>Jonas</surname></persName>
		</author>
		<author>
			<persName><surname>Khubchandani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph; G. Anil</forename><surname>Kumar</surname></persName>
		</author>
		<imprint>
			<pubPlace>PhD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Michael</forename><surname>Kutz</surname></persName>
		</author>
		<author>
			<persName><surname>Bs; Qing</surname></persName>
		</author>
		<author>
			<persName><surname>Lan</surname></persName>
		</author>
		<imprint>
			<pubPlace>PhD, MD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">J</forename><surname>Heidi</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Phd; Xiaofeng</forename><surname>Larson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Msc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Stephen</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Phd</forename><surname>Lim</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Alan</forename><forename type="middle">D</forename><surname>Lopez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Michael</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Edm; Laurie</forename><surname>Macintyre</surname></persName>
		</author>
		<author>
			<persName><surname>Marczak</surname></persName>
		</author>
		<imprint>
			<pubPlace>Neal Marquez, BS</pubPlace>
		</imprint>
	</monogr>
	<note type="report_type">PhD</note>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Ali</forename><forename type="middle">H</forename><surname>Mokdad</surname></persName>
		</author>
		<author>
			<persName><surname>Phd; Christine</surname></persName>
		</author>
		<author>
			<persName><surname>Pinho</surname></persName>
		</author>
		<author>
			<persName><surname>Ba; Farshad</surname></persName>
		</author>
		<author>
			<persName><surname>Pourmalek</surname></persName>
		</author>
		<author>
			<persName><surname>Md</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Joshua</forename><forename type="middle">A</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><surname>Salomon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">; Juan Ramon</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Md; Logan</forename><surname>Sanabria</surname></persName>
		</author>
		<author>
			<persName><surname>Sandar</surname></persName>
		</author>
		<imprint>
			<publisher>BS</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Benn Sartorius</title>
		<imprint/>
	</monogr>
	<note type="report_type">PhD</note>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">M</forename><surname>Stephen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd</forename><surname>Schwartz</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Katya</forename><forename type="middle">A</forename><surname>Shackelford</surname></persName>
		</author>
		<author>
			<persName><surname>Ba; Kenji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Md; Jeff</forename><surname>Shibuya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Caitlyn</forename><surname>Stanaway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph; Jiandong</forename><surname>Steiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Ken</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Emil</forename><surname>Md; Stein</surname></persName>
		</author>
		<author>
			<persName><surname>Vollset</surname></persName>
		</author>
		<imprint>
			<pubPlace>DrPH</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Theo</forename><surname>Vos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Joseph</surname></persName>
		</author>
		<author>
			<persName><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><surname>Bs; Haidong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Ronny</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Hajo</forename><surname>Westerman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Leo</forename><surname>Zeeb</surname></persName>
		</author>
		<author>
			<persName><surname>Zoeckler</surname></persName>
		</author>
		<author>
			<persName><surname>Ba; Foad Abd-Allah</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Muktar</forename><surname>Beshir Ahmed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph; Samer</forename><surname>Alabed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Md; Noore</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<monogr>
		<author>
			<persName><forename type="first">Mph</forename><surname>Alam</surname></persName>
		</author>
		<author>
			<persName><surname>Saleh Fahed Aldhahri</surname></persName>
		</author>
		<author>
			<persName><surname>Md; Girma Alem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph; Raghib</forename><surname>Ms; Mulubirhan Assefa Alemayohu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Frcp</forename><surname>Ali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">; Rajaa</forename><surname>Msc</surname></persName>
		</author>
		<author>
			<persName><surname>Al-Raddadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph; Yaw</forename><surname>Phd; Azmeraw Amare</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Amoako</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Fwacp; Al Artaman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Hamid</forename><surname>Asayesh</surname></persName>
		</author>
		<title level="m">PhD; Niguse Atnafu, MS; Ashish Awasthi, PhD; Huda Ba Saleem, PhD; Aleksandra Barac</title>
				<meeting><address><addrLine>Bedi, MD</addrLine></address></meeting>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Isabela</forename><surname>Bensenor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Adugnaw</forename><surname>Md</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Berhane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Eduardo</forename><surname>Bernabé</surname></persName>
		</author>
		<imprint>
			<pubPlace>Balem Betsu, MS</pubPlace>
		</imprint>
	</monogr>
	<note type="report_type">PhD</note>
</biblStruct>

<biblStruct xml:id="b20">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Agnes</forename><surname>Binagwaho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Dube</forename><surname>Md</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph</forename><surname>Boneya</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Ismael</forename><surname>Campos-Nonato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Carlos</forename><surname>Castañeda-Orjuela</surname></persName>
		</author>
		<author>
			<persName><surname>Md; Ferrán Catalá-López</surname></persName>
		</author>
		<imprint>
			<publisher>PhD</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Peggy</forename><surname>Chiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Chioma</forename><surname>Chibueze</surname></persName>
		</author>
		<imprint>
			<pubPlace>MD, PhD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Abdulaal</forename><surname>Chitheer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fetp; Jee-Young</forename><surname>Choi</surname></persName>
		</author>
		<imprint>
			<pubPlace>PhD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Benjamin</forename><surname>Cowie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Solomon</forename><surname>Md</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph</forename><surname>Damtew</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">José</forename><surname>Das Neves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Suhojit</forename><surname>Dey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Samath</forename><surname>Dharmaratne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Md; Preet</forename><surname>Dhillon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Eric</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Scd; Tim</forename><surname>Driscoll</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PhD; Donatus Ekwueme</title>
		<imprint>
			<publisher>PhD</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Mph; Maryam</forename><surname>Aman Yesuf Endries</surname></persName>
		</author>
		<author>
			<persName><surname>Farvid</surname></persName>
		</author>
		<imprint>
			<pubPlace>PhD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Farshad</forename><surname>Farzadfar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Md; Joao</forename><surname>Fernandes</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>PhD</note>
</biblStruct>

<biblStruct xml:id="b28">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Florian</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph; Alemseged</forename><surname>Mph; Tsegaye Tewelde G/Hiwot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph; Sameer</forename><surname>Gebru</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph; Alemayehu</forename><surname>Gopalani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph</forename><surname>Hailu</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Masako</forename><surname>Horino</surname></persName>
		</author>
		<author>
			<persName><surname>Mph; Nobuyuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Horita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Abdullatif</forename><surname>Husseini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Inge</forename><surname>Huybrechts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Manami</forename><surname>Inoue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Farhad</forename><surname>Islami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Mihajlo</forename><surname>Jakovljevic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Spencer</forename><surname>James</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Md; Mehdi</forename><surname>Javanbakht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Sun Ha</forename><surname>Jee</surname></persName>
		</author>
		<imprint>
			<publisher>PhD</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Amir</forename><surname>Kasaeian</surname></persName>
		</author>
		<author>
			<persName><surname>Phd; Muktar Sano Kedir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ms; Yousef</surname></persName>
		</author>
		<author>
			<persName><surname>Khader</surname></persName>
		</author>
		<author>
			<persName><surname>Scd</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Young-Ho</forename><surname>Khang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Daniel</forename><surname>Kim</surname></persName>
		</author>
		<imprint>
			<pubPlace>MD, DrPH</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">James</forename><surname>Leigh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Shai</forename><surname>Md</surname></persName>
		</author>
		<author>
			<persName><surname>Linn</surname></persName>
		</author>
		<imprint>
			<pubPlace>MD, PhD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Raimundas</forename><surname>Lunevicius</surname></persName>
		</author>
		<author>
			<persName><surname>Md</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mbbch; Reza</forename><surname>Phd; Hassan Magdy Abd El Razek</surname></persName>
		</author>
		<author>
			<persName><surname>Malekzadeh</surname></persName>
		</author>
		<imprint>
			<pubPlace>MD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Deborah</forename><surname>Carvalho Malta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Wagner</forename><surname>Marcenes</surname></persName>
		</author>
		<author>
			<persName><surname>Phd; Desalegn Markos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ms; Yohannes</surname></persName>
		</author>
		<author>
			<persName><surname>Melaku</surname></persName>
		</author>
		<author>
			<persName><surname>Mph</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">G</forename><surname>Kidanu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph; Walter</forename><surname>Meles</surname></persName>
		</author>
		<author>
			<persName><surname>Mendoza</surname></persName>
		</author>
		<author>
			<persName><surname>Md; Desalegn Tadese Mengiste</surname></persName>
		</author>
		<imprint>
			<pubPlace>MS</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">J</forename><surname>Tuomo</surname></persName>
		</author>
		<author>
			<persName><surname>Meretoja</surname></persName>
		</author>
		<author>
			<persName><surname>Md</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ted</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd</forename><surname>Miller</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Phd; Alireza</forename><surname>Karzan Abdulmuhsin Mohammad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Shafiu</forename><surname>Mohammadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Maziar</forename><surname>Mohammed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph</forename><surname>Moradi-Lakeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Md; Gabriele</forename><surname>Nagel</surname></persName>
		</author>
		<imprint>
			<pubPlace>MD, PhD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Devina</forename><surname>Nand</surname></persName>
		</author>
		<author>
			<persName><surname>Mph;</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Quyen</forename><forename type="middle">Le</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Md; Sandra</forename><surname>Nolte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Felix</surname></persName>
		</author>
		<author>
			<persName><surname>Ogbo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Md; Kelechi</surname></persName>
		</author>
		<author>
			<persName><surname>Oladimeji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Mahesh</forename><surname>Oren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dnb; Eun-Kee</forename><surname>Pa</surname></persName>
		</author>
		<author>
			<persName><surname>Park</surname></persName>
		</author>
		<imprint>
			<pubPlace>PhD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<monogr>
		<author>
			<persName><forename type="first">M</forename><surname>David</surname></persName>
		</author>
		<author>
			<persName><surname>Pereira</surname></persName>
		</author>
		<title level="m">PhD; Dietrich Plass, DrPH; Mostafa Qorbani, PhD; Amir Radfar</title>
				<meeting><address><addrLine>MD</addrLine></address></meeting>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Anwar</forename><surname>Rafay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ms; Mahfuzar</forename><surname>Rahman</surname></persName>
		</author>
		<imprint>
			<pubPlace>MD, PhD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">M</forename><surname>Saleem</surname></persName>
		</author>
		<author>
			<persName><surname>Rana</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PhD; Kjetil Søreide</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Maheswar Satpathy, PhD; Monika Sawhney</title>
		<imprint/>
	</monogr>
	<note>PhD</note>
</biblStruct>

<biblStruct xml:id="b44">
	<monogr>
		<author>
			<persName><forename type="first">G</forename><surname>Sadaf</surname></persName>
		</author>
		<author>
			<persName><surname>Sepanlou</surname></persName>
		</author>
		<author>
			<persName><surname>Md</surname></persName>
		</author>
		<author>
			<persName><forename type="first">; Masood Ali</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><surname>Shaikh</surname></persName>
		</author>
		<author>
			<persName><surname>Md; Jun</surname></persName>
		</author>
		<author>
			<persName><surname>She</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Ivy</forename><surname>Md</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Hirbo Roba</forename><surname>Shiue</surname></persName>
		</author>
		<author>
			<persName><surname>Shore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mph; Mark</surname></persName>
		</author>
		<author>
			<persName><surname>Shrime</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Samuel</forename><surname>Md</surname></persName>
		</author>
		<author>
			<persName><surname>So</surname></persName>
		</author>
		<author>
			<persName><surname>Mbbs; Samir</surname></persName>
		</author>
		<author>
			<persName><surname>Soneji</surname></persName>
		</author>
		<title level="m">PhD; Vasiliki Stathopoulou, PhD; Konstantinos Stroumpoulis</title>
				<meeting><address><addrLine>MD, PhD</addrLine></address></meeting>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<monogr>
		<title/>
		<author>
			<persName><surname>Muawiyyah Babale Sufiyan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mba; Bryan</surname></persName>
		</author>
		<author>
			<persName><surname>Sykes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Phd; Rafael Tabarés-Seisdedos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph; Bemnet Amare</forename><surname>Phd; Fentaw Tadese</surname></persName>
		</author>
		<author>
			<persName><surname>Tedla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph; J</forename><forename type="middle">S</forename><surname>Bs; Gizachew Assefa Tessema</surname></persName>
		</author>
		<author>
			<persName><surname>Thakur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Kingsley Nnanna</forename><surname>Md; Bach Xuan Tran</surname></persName>
		</author>
		<author>
			<persName><surname>Ukwaja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Md; Benjamin</surname></persName>
		</author>
		<author>
			<persName><surname>Chudi Uzochukwu</surname></persName>
		</author>
		<author>
			<persName><surname>Fwacp; Vasiliy Victorovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Md; Elisabete</forename><surname>Vlassov</surname></persName>
		</author>
		<author>
			<persName><surname>Weiderpass</surname></persName>
		</author>
		<imprint>
			<pubPlace>MD, PhD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<monogr>
		<title/>
		<author>
			<persName><surname>Mamo Wubshet Terefe</surname></persName>
		</author>
		<author>
			<persName><surname>Phd; Henock Gebremedhin Yebyo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph; Naohiro</forename><surname>Ms; Hassen Hamid Yimam</surname></persName>
		</author>
		<author>
			<persName><surname>Yonemoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Mph; Mustafa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Drph</forename><surname>Younis</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Chuanhua</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Zoubida</forename><surname>Zaidi</surname></persName>
		</author>
		<imprint>
			<pubPlace>MD, PhD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Maysaa</forename><surname>El Sayed Zaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Phd; Zerihun Menlkalew Zenebe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Ms; Christopher</surname></persName>
		</author>
		<author>
			<persName><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dphil</forename><surname>Md</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Mohsen</forename><surname>Naghavi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd</forename></persName>
		</author>
		<imprint>
			<pubPlace>Busan, South Korea (Park</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Contech International Health Consultants</title>
		<imprint/>
		<respStmt>
			<orgName>Alborz University of Medical Sciences, Karaj, Iran (Qorbani); College of Graduate Heath Study, A. T. Still University</orgName>
		</respStmt>
	</monogr>
	<note>Epidemiology and Biostatistics. Rafay</note>
</biblStruct>

<biblStruct xml:id="b51">
	<monogr>
		<title level="m" type="main">Contech School of Public Health</title>
		<author>
			<persName><forename type="first">Dhaka</forename><surname>Brac</surname></persName>
		</author>
		<author>
			<persName><forename type="first">(</forename><surname>Bangladesh</surname></persName>
		</author>
		<author>
			<persName><surname>Rahman</surname></persName>
		</author>
		<imprint>
			<pubPlace>Lahore, Pakistan (Rana; Bergen, Norway (Søreide</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway (Søreide); Department of Clinical Medicine, University of Bergen</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<monogr>
		<title level="m" type="main">Department of Public Health, College of Health Professions</title>
		<imprint>
			<pubPlace>New Delhi, India (Satpathy; Huntington, West Virginia</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Jai Prakash Narayan Apex Trauma Centre, All India Institute of Medical Sciences ; Marshall University</orgName>
		</respStmt>
	</monogr>
	<note>Sawhney</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Program in Global Surgery and Social Change</title>
	</analytic>
	<monogr>
		<title level="j">Harvard Medical School</title>
		<imprint/>
		<respStmt>
			<orgName>Northumbria University ; Haramaya University</orgName>
		</respStmt>
	</monogr>
	<note>College of Health and Medical Sciences</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">The Dartmouth Institute for Health Policy and Clinical Practice</title>
	</analytic>
	<monogr>
		<title level="j">Geisel School of Medicine at Dartmouth</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Dartmouth Medical School</title>
		<imprint/>
		<respStmt>
			<orgName>Norris Cotton Cancer Center</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Alexandra General Hospital of Athens</title>
		<imprint/>
		<respStmt>
			<orgName>Department of Community Medicine Faculty of Medicine, Ahmadu Bello University ; Department of Criminology, Law &amp; Society, University of California Irvine ; Department of Public Health, Wollo University</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
	</analytic>
	<monogr>
		<title level="m">Department of Medical Epidemiology and Biostatistics</title>
				<meeting><address><addrLine>Moscow, Russia (Vlassov; Oslo (Weiderpass; Stockholm, Sweden (Weiderpass; Helsinki, Finland (Weiderpass; Tromsø; Norway (Weiderpass</addrLine></address></meeting>
		<imprint>
			<publisher>Folkhälsan Research Center</publisher>
		</imprint>
		<respStmt>
			<orgName>Institute of Public Health, College of Medicine, University of Nigeria Nsukka, Enugu, Nigeria (Uzochukwu); Center for Health Policy, National Research University, Higher School of Economics ; Department of Research, Group of Etiological Cancer Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research ; Department of Community Medicine, University of Tromsø, The Arctic University of Norway</orgName>
		</respStmt>
	</monogr>
	<note>Karolinska Institutet</note>
</biblStruct>

<biblStruct xml:id="b58">
	<monogr>
		<title level="m" type="main">Department of Public Health, St. Paul&apos;s Hospital Millenium Medical College</title>
		<imprint>
			<pubPlace>Addis Ababa, Ethiopia (Wubshet Terefe</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<monogr>
		<title level="m" type="main">Department of Health Policy and Management</title>
		<imprint>
			<pubPlace>Kyoto, Japan (Yonemoto; Jackson, Mississippi (Younis</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Kyoto University ; Jackson State University</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Clinical Pathology Department, Mansoura Faculty of Medicine</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Critical revision of the manuscript for important intellectual content: Fitzmaurice</title>
		<author>
			<persName><surname>Malta</surname></persName>
		</author>
		<author>
			<persName><surname>Shifti</surname></persName>
		</author>
		<author>
			<persName><surname>Melaku</surname></persName>
		</author>
		<author>
			<persName><surname>Mendoza</surname></persName>
		</author>
		<author>
			<persName><surname>Meretoja</surname></persName>
		</author>
		<author>
			<persName><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><surname>Mohammadi</surname></persName>
		</author>
		<author>
			<persName><surname>Mohammed</surname></persName>
		</author>
		<author>
			<persName><surname>Kedir</surname></persName>
		</author>
		<author>
			<persName><surname>Moradi-Lakeh</surname></persName>
		</author>
		<author>
			<persName><surname>Nagel</surname></persName>
		</author>
		<author>
			<persName><surname>Nand</surname></persName>
		</author>
		<author>
			<persName><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><surname>Nolte</surname></persName>
		</author>
		<author>
			<persName><surname>Ogbo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Oren</forename><surname>Oladimeji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><surname>Pereira</surname></persName>
		</author>
		<author>
			<persName><surname>Plass</surname></persName>
		</author>
		<author>
			<persName><surname>Qorbani</surname></persName>
		</author>
		<author>
			<persName><surname>Radfar</surname></persName>
		</author>
		<author>
			<persName><surname>Rafay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rana</forename><surname>Rahman</surname></persName>
		</author>
		<author>
			<persName><surname>Søreide</surname></persName>
		</author>
		<author>
			<persName><surname>Satpathy</surname></persName>
		</author>
		<author>
			<persName><surname>Sawhney</surname></persName>
		</author>
		<author>
			<persName><surname>Sepanlou</surname></persName>
		</author>
		<author>
			<persName><surname>Shaikh</surname></persName>
		</author>
		<author>
			<persName><surname>She</surname></persName>
		</author>
		<author>
			<persName><surname>Shiue</surname></persName>
		</author>
		<author>
			<persName><surname>Shrime</surname></persName>
		</author>
		<author>
			<persName><surname>So</surname></persName>
		</author>
		<author>
			<persName><surname>Stathopoulou</surname></persName>
		</author>
		<author>
			<persName><surname>Stroumpoulis</surname></persName>
		</author>
		<author>
			<persName><surname>Sufiyan</surname></persName>
		</author>
		<author>
			<persName><surname>Sykes</surname></persName>
		</author>
		<author>
			<persName><surname>Tabarés-Seisdedos</surname></persName>
		</author>
		<author>
			<persName><surname>Tadese</surname></persName>
		</author>
		<author>
			<persName><surname>Tedla</surname></persName>
		</author>
		<author>
			<persName><surname>Thakur</surname></persName>
		</author>
		<author>
			<persName><surname>Tran</surname></persName>
		</author>
		<author>
			<persName><surname>Ukwaja</surname></persName>
		</author>
		<author>
			<persName><surname>Uzochukwu</surname></persName>
		</author>
		<author>
			<persName><surname>Vlassov</surname></persName>
		</author>
		<author>
			<persName><surname>Weiderpass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yimam</forename><surname>Yebyo</surname></persName>
		</author>
		<author>
			<persName><surname>Hassen</surname></persName>
		</author>
		<author>
			<persName><surname>Yonemoto</surname></persName>
		</author>
		<author>
			<persName><surname>Younis</surname></persName>
		</author>
		<author>
			<persName><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><surname>Zaidi</surname></persName>
		</author>
		<author>
			<persName><surname>Zaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Naghavi</forename><surname>Zenebe</surname></persName>
		</author>
		<author>
			<persName><surname>Allen</surname></persName>
		</author>
		<author>
			<persName><surname>Fleming</surname></persName>
		</author>
		<author>
			<persName><surname>Hancock</surname></persName>
		</author>
		<author>
			<persName><surname>Hunter-Merrill</surname></persName>
		</author>
		<author>
			<persName><surname>Huynh</surname></persName>
		</author>
		<author>
			<persName><surname>Marczak</surname></persName>
		</author>
		<author>
			<persName><surname>Marquez</surname></persName>
		</author>
		<author>
			<persName><surname>Mokdad</surname></persName>
		</author>
		<author>
			<persName><surname>Sanabria</surname></persName>
		</author>
		<author>
			<persName><surname>Shackelford</surname></persName>
		</author>
		<author>
			<persName><surname>Barac</surname></persName>
		</author>
		<author>
			<persName><surname>Boneya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Magdy Abd El</forename><surname>Horino</surname></persName>
		</author>
		<author>
			<persName><surname>Razek</surname></persName>
		</author>
		<author>
			<persName><surname>Mohammad</surname></persName>
		</author>
		<author>
			<persName><surname>Pereira</surname></persName>
		</author>
		<author>
			<persName><surname>Satpathy</surname></persName>
		</author>
		<author>
			<persName><surname>Sawhney</surname></persName>
		</author>
		<author>
			<persName><surname>Vlassov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Zaki</surname></persName>
		</author>
		<author>
			<persName><surname>Allen</surname></persName>
		</author>
		<author>
			<persName><surname>Barber</surname></persName>
		</author>
		<author>
			<persName><surname>Barregard</surname></persName>
		</author>
		<author>
			<persName><surname>Bhutta</surname></persName>
		</author>
		<author>
			<persName><surname>Brenner</surname></persName>
		</author>
		<author>
			<persName><surname>Dicker</surname></persName>
		</author>
		<author>
			<persName><surname>Forouzanfar</surname></persName>
		</author>
		<author>
			<persName><surname>Hay</surname></persName>
		</author>
		<author>
			<persName><surname>Hosgood</surname></persName>
		</author>
		<author>
			<persName><surname>Iii</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jonas</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><surname>Khubchandani</surname></persName>
		</author>
		<author>
			<persName><surname>Kutz</surname></persName>
		</author>
		<author>
			<persName><surname>Lan</surname></persName>
		</author>
		<author>
			<persName><surname>Larson</surname></persName>
		</author>
		<author>
			<persName><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><surname>Marczak</surname></persName>
		</author>
		<author>
			<persName><surname>Mokdad</surname></persName>
		</author>
		<author>
			<persName><surname>Pourmalek</surname></persName>
		</author>
		<author>
			<persName><surname>Salomon</surname></persName>
		</author>
		<author>
			<persName><surname>Sanabria</surname></persName>
		</author>
		<author>
			<persName><surname>Sartorius</surname></persName>
		</author>
		<author>
			<persName><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><surname>Stanaway</surname></persName>
		</author>
		<author>
			<persName><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><surname>Vollset</surname></persName>
		</author>
		<author>
			<persName><surname>Vos</surname></persName>
		</author>
		<author>
			<persName><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><surname>Westerman</surname></persName>
		</author>
		<author>
			<persName><surname>Zeeb</surname></persName>
		</author>
		<author>
			<persName><surname>Abd-Allah</surname></persName>
		</author>
		<author>
			<persName><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName><surname>Alabed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Alem</forename><surname>Aldhahri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ali</forename><surname>Alemayohu</surname></persName>
		</author>
		<author>
			<persName><surname>Al-Raddadi</surname></persName>
		</author>
		<author>
			<persName><surname>Amare</surname></persName>
		</author>
		<author>
			<persName><surname>Amoako</surname></persName>
		</author>
		<author>
			<persName><surname>Artaman</surname></persName>
		</author>
		<author>
			<persName><surname>Asayesh</surname></persName>
		</author>
		<author>
			<persName><surname>Atnafu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ba</forename><surname>Awasthi</surname></persName>
		</author>
		<author>
			<persName><surname>Saleem</surname></persName>
		</author>
		<author>
			<persName><surname>Barac</surname></persName>
		</author>
		<author>
			<persName><surname>Bedi</surname></persName>
		</author>
		<author>
			<persName><surname>Bensenor</surname></persName>
		</author>
		<author>
			<persName><surname>Berhane</surname></persName>
		</author>
		<author>
			<persName><surname>Bernabé</surname></persName>
		</author>
		<author>
			<persName><surname>Betsu</surname></persName>
		</author>
		<author>
			<persName><surname>Binagwaho</surname></persName>
		</author>
		<author>
			<persName><surname>Boneya</surname></persName>
		</author>
		<author>
			<persName><surname>Campos-Nonato</surname></persName>
		</author>
		<author>
			<persName><surname>Castañeda-Orjuela</surname></persName>
		</author>
		<author>
			<persName><surname>Catalá-López</surname></persName>
		</author>
		<author>
			<persName><surname>Chibueze</surname></persName>
		</author>
		<author>
			<persName><surname>Chitheer</surname></persName>
		</author>
		<author>
			<persName><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><surname>Cowie</surname></persName>
		</author>
		<author>
			<persName><surname>Damtew</surname></persName>
		</author>
		<author>
			<persName><surname>Neves</surname></persName>
		</author>
		<author>
			<persName><surname>Dey</surname></persName>
		</author>
		<author>
			<persName><surname>Dharmaratne</surname></persName>
		</author>
		<author>
			<persName><surname>Dhillon</surname></persName>
		</author>
		<author>
			<persName><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><surname>Driscoll</surname></persName>
		</author>
		<author>
			<persName><surname>Ekwueme</surname></persName>
		</author>
		<author>
			<persName><surname>Endries</surname></persName>
		</author>
		<author>
			<persName><surname>Farvid</surname></persName>
		</author>
		<author>
			<persName><surname>Farzadfar</surname></persName>
		</author>
		<author>
			<persName><surname>Fernandes</surname></persName>
		</author>
		<author>
			<persName><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><surname>Gebru</surname></persName>
		</author>
		<author>
			<persName><surname>Gopalani</surname></persName>
		</author>
		<author>
			<persName><surname>Hailu</surname></persName>
		</author>
		<author>
			<persName><surname>Horino</surname></persName>
		</author>
		<author>
			<persName><surname>Horita</surname></persName>
		</author>
		<author>
			<persName><surname>Husseini</surname></persName>
		</author>
		<author>
			<persName><surname>Huybrechts</surname></persName>
		</author>
		<author>
			<persName><surname>Inoue</surname></persName>
		</author>
		<author>
			<persName><surname>Islami</surname></persName>
		</author>
		<author>
			<persName><surname>Jakovljevic</surname></persName>
		</author>
		<author>
			<persName><surname>James</surname></persName>
		</author>
		<author>
			<persName><surname>Javanbakht</surname></persName>
		</author>
		<author>
			<persName><surname>Jee</surname></persName>
		</author>
		<author>
			<persName><surname>Kasaeian</surname></persName>
		</author>
		<author>
			<persName><surname>Khader</surname></persName>
		</author>
		<author>
			<persName><surname>Khang</surname></persName>
		</author>
		<author>
			<persName><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><surname>Leigh</surname></persName>
		</author>
		<author>
			<persName><surname>Linn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Magdy Abd El</forename><surname>Lunevicius</surname></persName>
		</author>
		<author>
			<persName><surname>Razek</surname></persName>
		</author>
		<author>
			<persName><surname>Malekzadeh</surname></persName>
		</author>
		<author>
			<persName><surname>Malta</surname></persName>
		</author>
		<author>
			<persName><surname>Marcenes</surname></persName>
		</author>
		<author>
			<persName><surname>Shifti</surname></persName>
		</author>
		<author>
			<persName><surname>Melaku</surname></persName>
		</author>
		<author>
			<persName><surname>Meles</surname></persName>
		</author>
		<author>
			<persName><surname>Mendoza</surname></persName>
		</author>
		<author>
			<persName><surname>Meretoja</surname></persName>
		</author>
		<author>
			<persName><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><surname>Mohammadi</surname></persName>
		</author>
		<author>
			<persName><surname>Mohammed</surname></persName>
		</author>
		<author>
			<persName><surname>Kedir</surname></persName>
		</author>
		<author>
			<persName><surname>Moradi-Lakeh</surname></persName>
		</author>
		<author>
			<persName><surname>Nagel</surname></persName>
		</author>
		<author>
			<persName><surname>Nand</surname></persName>
		</author>
		<author>
			<persName><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><surname>Nolte</surname></persName>
		</author>
		<author>
			<persName><surname>Ogbo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Oren</forename><surname>Oladimeji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><surname>Pereira</surname></persName>
		</author>
		<author>
			<persName><surname>Plass</surname></persName>
		</author>
		<author>
			<persName><surname>Qorbani</surname></persName>
		</author>
		<author>
			<persName><surname>Radfar</surname></persName>
		</author>
		<author>
			<persName><surname>Rafay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rana</forename><surname>Rahman</surname></persName>
		</author>
		<author>
			<persName><surname>Søreide</surname></persName>
		</author>
		<author>
			<persName><surname>Satpathy</surname></persName>
		</author>
		<author>
			<persName><surname>Sawhney</surname></persName>
		</author>
		<author>
			<persName><surname>Sepanlou</surname></persName>
		</author>
		<author>
			<persName><surname>Shaikh</surname></persName>
		</author>
		<author>
			<persName><surname>She</surname></persName>
		</author>
		<author>
			<persName><surname>Shiue</surname></persName>
		</author>
		<author>
			<persName><surname>Shrime</surname></persName>
		</author>
		<author>
			<persName><surname>So</surname></persName>
		</author>
		<author>
			<persName><surname>Soneji</surname></persName>
		</author>
		<author>
			<persName><surname>Stathopoulou</surname></persName>
		</author>
		<author>
			<persName><surname>Stroumpoulis</surname></persName>
		</author>
		<author>
			<persName><surname>Sufiyan</surname></persName>
		</author>
		<author>
			<persName><surname>Sykes</surname></persName>
		</author>
		<author>
			<persName><surname>Tabarés-Seisdedos</surname></persName>
		</author>
		<author>
			<persName><surname>Tadese</surname></persName>
		</author>
		<author>
			<persName><surname>Tedla</surname></persName>
		</author>
		<author>
			<persName><surname>Tessema</surname></persName>
		</author>
		<author>
			<persName><surname>Thakur</surname></persName>
		</author>
		<author>
			<persName><surname>Tran</surname></persName>
		</author>
		<author>
			<persName><surname>Ukwaja</surname></persName>
		</author>
		<author>
			<persName><surname>Uzochukwu</surname></persName>
		</author>
		<author>
			<persName><surname>Vlassov</surname></persName>
		</author>
		<author>
			<persName><surname>Weiderpass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yimam</forename><surname>Yebyo</surname></persName>
		</author>
		<author>
			<persName><surname>Hassen</surname></persName>
		</author>
		<author>
			<persName><surname>Yonemoto</surname></persName>
		</author>
		<author>
			<persName><surname>Younis</surname></persName>
		</author>
		<author>
			<persName><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><surname>Zaidi</surname></persName>
		</author>
		<author>
			<persName><surname>Zaki</surname></persName>
		</author>
		<author>
			<persName><surname>Zenebe</surname></persName>
		</author>
		<author>
			<persName><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Naghavi</surname></persName>
		</author>
		<author>
			<persName><surname>Allen</surname></persName>
		</author>
		<author>
			<persName><surname>Barber</surname></persName>
		</author>
		<author>
			<persName><surname>Dicker</surname></persName>
		</author>
		<author>
			<persName><surname>Fleming</surname></persName>
		</author>
		<author>
			<persName><surname>Forouzanfar</surname></persName>
		</author>
		<author>
			<persName><surname>Hunter-Merrill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jonas</forename><surname>Huynh</surname></persName>
		</author>
		<author>
			<persName><surname>Khubchandani</surname></persName>
		</author>
		<author>
			<persName><surname>Kutz</surname></persName>
		</author>
		<author>
			<persName><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><surname>Marquez</surname></persName>
		</author>
		<author>
			<persName><surname>Mokdad</surname></persName>
		</author>
		<author>
			<persName><surname>Salomon</surname></persName>
		</author>
		<author>
			<persName><surname>Stanaway</surname></persName>
		</author>
		<author>
			<persName><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Alem</forename><surname>Vos</surname></persName>
		</author>
		<author>
			<persName><surname>Amare</surname></persName>
		</author>
		<author>
			<persName><surname>Asayesh</surname></persName>
		</author>
		<author>
			<persName><surname>Boneya</surname></persName>
		</author>
		<author>
			<persName><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><surname>Endries</surname></persName>
		</author>
		<author>
			<persName><surname>Farzadfar</surname></persName>
		</author>
		<author>
			<persName><surname>Hailu</surname></persName>
		</author>
		<author>
			<persName><surname>James</surname></persName>
		</author>
		<author>
			<persName><surname>Kasaeian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Magdy Abd El</forename><surname>Khader</surname></persName>
		</author>
		<author>
			<persName><surname>Razek</surname></persName>
		</author>
		<author>
			<persName><surname>Mohammed</surname></persName>
		</author>
		<author>
			<persName><surname>Kedir</surname></persName>
		</author>
		<author>
			<persName><surname>Moradi-Lakeh</surname></persName>
		</author>
		<author>
			<persName><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><surname>Qorbani</surname></persName>
		</author>
		<author>
			<persName><surname>Satpathy</surname></persName>
		</author>
		<author>
			<persName><surname>Sawhney</surname></persName>
		</author>
		<author>
			<persName><surname>Shaikh</surname></persName>
		</author>
		<author>
			<persName><surname>Sykes</surname></persName>
		</author>
		<author>
			<persName><surname>Ukwaja</surname></persName>
		</author>
		<author>
			<persName><surname>Vlassov</surname></persName>
		</author>
		<author>
			<persName><surname>Yebyo</surname></persName>
		</author>
		<author>
			<persName><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><surname>Zaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Naghavi</surname></persName>
		</author>
		<author>
			<persName><surname>Abd-Allah</surname></persName>
		</author>
		<author>
			<persName><surname>Amoako</surname></persName>
		</author>
		<author>
			<persName><surname>Asayesh</surname></persName>
		</author>
		<author>
			<persName><surname>Awasthi</surname></persName>
		</author>
		<author>
			<persName><surname>Barac</surname></persName>
		</author>
		<author>
			<persName><surname>Bedi</surname></persName>
		</author>
		<author>
			<persName><surname>Bensenor</surname></persName>
		</author>
		<author>
			<persName><surname>Berhane</surname></persName>
		</author>
		<author>
			<persName><surname>Castañeda-Orjuela</surname></persName>
		</author>
		<author>
			<persName><surname>Catalá-López</surname></persName>
		</author>
		<author>
			<persName><surname>Das Neves</surname></persName>
		</author>
		<author>
			<persName><surname>Dhillon</surname></persName>
		</author>
		<author>
			<persName><surname>Fernandes</surname></persName>
		</author>
		<author>
			<persName><surname>Kasaeian</surname></persName>
		</author>
		<author>
			<persName><surname>Marcenes</surname></persName>
		</author>
		<author>
			<persName><surname>Meles</surname></persName>
		</author>
		<author>
			<persName><surname>Meretoja</surname></persName>
		</author>
		<author>
			<persName><surname>Mohammadi</surname></persName>
		</author>
		<author>
			<persName><surname>Mohammed</surname></persName>
		</author>
		<author>
			<persName><surname>Nand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Oren</forename><surname>Ogbo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Pereira</surname></persName>
		</author>
		<author>
			<persName><surname>Rahman</surname></persName>
		</author>
		<author>
			<persName><surname>Satpathy</surname></persName>
		</author>
		<author>
			<persName><surname>Sawhney</surname></persName>
		</author>
		<author>
			<persName><surname>Shaikh</surname></persName>
		</author>
		<author>
			<persName><surname>She</surname></persName>
		</author>
		<author>
			<persName><surname>Tedla</surname></persName>
		</author>
		<author>
			<persName><surname>Tran</surname></persName>
		</author>
		<author>
			<persName><surname>Ukwaja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Younis</forename><surname>Weiderpass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Allen</forename><surname>Supervision: Fitzmaurice</surname></persName>
		</author>
		<author>
			<persName><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><surname>Mokdad</surname></persName>
		</author>
		<author>
			<persName><surname>Shackelford</surname></persName>
		</author>
		<author>
			<persName><surname>Vos</surname></persName>
		</author>
		<author>
			<persName><surname>Westerman</surname></persName>
		</author>
		<author>
			<persName><surname>Barac</surname></persName>
		</author>
		<author>
			<persName><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><surname>Horita</surname></persName>
		</author>
		<author>
			<persName><surname>Jakovljevic</surname></persName>
		</author>
		<author>
			<persName><surname>Jee</surname></persName>
		</author>
		<author>
			<persName><surname>Nagel</surname></persName>
		</author>
		<author>
			<persName><surname>Tabarés-Seisdedos</surname></persName>
		</author>
		<author>
			<persName><surname>Weiderpass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Naghavi</forename><surname>Murray</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Obtained funding: Mokdad, Jee, Weiderpass, Murray. Administrative, technical, or material support</title>
				<meeting><address><addrLine>Allen, Hancock, Hay, Johnson, Liang, Marczak, Mokdad, Shackelford, Wagner</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2015">2015. 2016. 10053</date>
			<biblScope unit="volume">388</biblScope>
			<biblScope unit="page" from="1459" to="1544" />
		</imprint>
	</monogr>
	<note>Statistical analysis: Fitzmaurice. REFERENCES 1. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Aiming high: changing the trajectory for cancer</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Lowy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Collins</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMp1600894</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">374</biblScope>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page" from="1901" to="1904" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<monogr>
		<title level="m" type="main">A sickened body as cancer weapon. The New York Times</title>
		<author>
			<persName><forename type="first">D</forename><surname>Grady</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2016-07-30">July 30, 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Rethinking the war on cancer</title>
		<author>
			<persName><forename type="first">D</forename><surname>Hanahan</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(13)62226-6</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">383</biblScope>
			<biblScope unit="issue">9916</biblScope>
			<biblScope unit="page" from="62226" to="62226" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">The International Bank for Reconstruction and Development / The World Bank</title>
		<author>
			<persName><forename type="first">S</forename><surname>Horton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Gauvreau</surname></persName>
		</author>
		<ptr target="http://www.ncbi.nlm.nih.gov/books/NBK343620/.Accessed" />
	</analytic>
	<monogr>
		<title level="j">Cancer: Disease Control Priorities</title>
		<editor>Gelband H, Jha P, Sankaranarayanan R, Horton S</editor>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<date type="published" when="2015-07-31">2015. July 31. 2016</date>
		</imprint>
	</monogr>
	<note>Cancer in Low-and Middle-Income Countries: An Economic Overview</note>
</biblStruct>

<biblStruct xml:id="b66">
	<monogr>
		<title level="m" type="main">Addressing the Challenges of an Aging Population, Board on Health Care Services, Institute of Medicine. Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis</title>
		<ptr target="https://www.nap.edu/catalog/18359.Accessed" />
		<editor>Levit L, Balogh E, Nass S, Ganz PA</editor>
		<imprint>
			<date type="published" when="2013-08-05">2013. August 5, 2016</date>
			<publisher>National Academies Press</publisher>
			<pubPlace>Washington, DC</pubPlace>
		</imprint>
	</monogr>
	<note>Committee on Improving the Quality of Cancer Care</note>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Cancer survival: global surveillance will stimulate health policy and improve equity</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Coleman</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(13)62225-4</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">383</biblScope>
			<biblScope unit="issue">9916</biblScope>
			<biblScope unit="page" from="564" to="573" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Association of socioeconomic position with health behaviors and mortality</title>
		<author>
			<persName><forename type="first">S</forename><surname>Stringhini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sabia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Shipley</surname></persName>
		</author>
		<idno type="DOI">http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2010.297&amp;utm_campaign=articlePDF%26utm_medium=articlePDFlink%26utm_source=articlePDF%26utm_content=jamaoncol.2016.5688</idno>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">303</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1159" to="1166" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Socioeconomic status, structural and functional measures of social support, and mortality: The British Whitehall II Cohort Study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Stringhini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Berkman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dugravot</surname></persName>
		</author>
		<idno type="DOI">10.1093/aje/kwr461</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">175</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1275" to="1283" />
			<date type="published" when="1985">1985-2009. 2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Global cancer patterns: causes and prevention</title>
		<author>
			<persName><forename type="first">P</forename><surname>Vineis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Wild</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(13)62224-2</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">383</biblScope>
			<biblScope unit="issue">9916</biblScope>
			<biblScope unit="page" from="549" to="557" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<monogr>
		<title level="m" type="main">Sustainable Development Goals</title>
		<ptr target="https://sustainabledevelopment.un.org/" />
		<imprint/>
	</monogr>
	<note>United Nations</note>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries</title>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">388</biblScope>
			<biblScope unit="page" from="1545" to="1602" />
			<date type="published" when="1990">Accessed September 1, 2016. 12. 2015. 1990-2015. 2015. 2016. 10053</date>
		</imprint>
	</monogr>
	<note>: a systematic analysis for the Global Burden of Disease Study</note>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Global Burden of Disease Cancer Collaboration. The Global Burden of Cancer</title>
		<author>
			<persName><forename type="first">C</forename><surname>Fitzmaurice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Dicker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pain</surname></persName>
		</author>
		<idno type="DOI">http://jama.jamanetwork.com/article.aspx?doi=10.1001/jamaoncol.2015.0735&amp;utm_campaign=articlePDF%26utm_medium=articlePDFlink%26utm_source=articlePDF%26utm_content=jamaoncol.2016.5688</idno>
	</analytic>
	<monogr>
		<title level="j">JAMA Oncol</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="505" to="527" />
			<date type="published" when="2013">2013. 2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">GATHER Working Group. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Alkema</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Black</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pmed.1002056</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS Med</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">e1002056</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Measuring the global burden of disease</title>
		<author>
			<persName><forename type="first">Cjl</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Lopez</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMra1201534</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">369</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="448" to="457" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Lomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Leonardi-Bee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F ;</forename><surname>Bath-Hextall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Foreman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lozano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Lopez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Murray</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(14)61682-2</idno>
		<idno>doi:10.1016/S0140-6736(14)61682-2 19</idno>
	</analytic>
	<monogr>
		<title level="m">GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE)</title>
				<imprint>
			<date type="published" when="2012">2012. 2012. 2013. 2015. 2015. 2016. 10053</date>
			<biblScope unit="volume">166</biblScope>
			<biblScope unit="page" from="1603" to="1658" />
		</imprint>
	</monogr>
	<note>Lancet</note>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">NCDs: a challenge to sustainable human development</title>
		<author>
			<persName><forename type="first">H</forename><surname>Clark</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(13)60058-6</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">381</biblScope>
			<biblScope unit="issue">9866</biblScope>
			<biblScope unit="page" from="510" to="511" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">United Nations</title>
		<ptr target="http://www.un.org/en/ga/ncdmeeting2011/" />
	</analytic>
	<monogr>
		<title level="m">High-level meeting on prevention and control of non-communicable diseases</title>
				<imprint>
			<date type="published" when="2011-10-27">2011. Accessed October 27. 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<monogr>
		<title level="m" type="main">Global Action Plan for the prevention and control of NCDs</title>
		<ptr target="http://www.who.int/nmh/events/ncd_action_plan/en/" />
		<imprint>
			<date type="published" when="2013">2013-2020. Accessed October 27. 2016</date>
		</imprint>
	</monogr>
	<note>World Health Organization</note>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><surname>Collaborators</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">388</biblScope>
			<biblScope unit="page" from="1813" to="1850" />
			<date type="published" when="2015">2015. 2016. 10053</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">Cancer Care in Africa: an overview of resources</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Stefan</surname></persName>
		</author>
		<idno type="DOI">10.1200/JGO.2015.000406</idno>
		<idno>doi:10 .1200/JGO.2015.000406</idno>
	</analytic>
	<monogr>
		<title level="j">J Glob Oncol</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="30" to="36" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">The cervical cancer epidemic that screening has prevented in the UK</title>
		<author>
			<persName><forename type="first">J</forename><surname>Peto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gilham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Fletcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">E</forename><surname>Matthews</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(04)16674-9</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">364</biblScope>
			<biblScope unit="issue">9430</biblScope>
			<biblScope unit="page" from="249" to="256" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Saving the world&apos;s women from cervical cancer</title>
		<author>
			<persName><forename type="first">V</forename><surname>Tsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jerónimo</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMp1604113</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">374</biblScope>
			<biblScope unit="issue">26</biblScope>
			<biblScope unit="page" from="2509" to="2511" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">Trends of cervical cancer mortality in the member states of the European Union</title>
		<author>
			<persName><forename type="first">M</forename><surname>Arbyn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">O</forename><surname>Raifu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Weiderpass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Anttila</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ejca.2009.07.018</idno>
	</analytic>
	<monogr>
		<title level="j">Eur J Cancer</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="2640" to="2648" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<monogr>
		<ptr target="http://www.cervicalcanceraction.org/pubs/pubs.php.Accessed" />
		<title level="m">Action CC. Investing in cervical cancer prevention 2015-2020; meeting report London</title>
				<imprint>
			<date type="published" when="2015-08-04">November 3 &amp; 4, 2015. August 13. 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b86">
	<monogr>
		<title level="m" type="main">Gastric cancer: epidemiology and risk factors</title>
		<author>
			<persName><forename type="first">C</forename><surname>De Martel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Forman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Plummer</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title/>
		<idno type="DOI">10.1016/j.gtc.2013.01.003</idno>
	</analytic>
	<monogr>
		<title level="j">Gastroenterol Clin North Am</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="219" to="240" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies</title>
		<author>
			<persName><forename type="first">P</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Cancer</title>
		<imprint>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b89">
	<monogr>
		<title/>
		<idno type="DOI">10.1016/j.ejca.2009.04.019</idno>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="2867" to="2873" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition</title>
		<author>
			<persName><forename type="first">A</forename><surname>Steffen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-M</forename><surname>Huerta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Weiderpass</surname></persName>
		</author>
		<idno type="DOI">10.1002/ijc.29432</idno>
		<idno>doi:10 .1002/ijc.29432</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="646" to="657" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Ford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Forman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Hunt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Moayyedi</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.g3174</idno>
		<ptr target="http://www.iarc.fr/en/publications/pdfs-online/wrk/wrk8/index.php" />
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">348</biblScope>
			<biblScope unit="page" from="3174" to="3174" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>Helicobacter pylori eradication as a strategy for preventing gastric cancer</note>
</biblStruct>

<biblStruct xml:id="b92">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Accessed</forename></persName>
		</author>
		<imprint>
			<date type="published" when="2016-10-27">October 27. 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main">Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the National Cancer Screening Programme in Korea</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Jun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Suh</surname></persName>
		</author>
		<idno type="DOI">10.1038/bjc.2014.608</idno>
	</analytic>
	<monogr>
		<title level="j">Br J Cancer</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="608" to="612" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan</title>
		<author>
			<persName><forename type="first">K-J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Inoue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Otani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Iwasaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sasazuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S; Jphc Study</forename><surname>Tsugane</surname></persName>
		</author>
		<author>
			<persName><surname>Group</surname></persName>
		</author>
		<idno type="DOI">10.1002/ijc.21664</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="2315" to="2321" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">Asia Pacific Working Group on Gastric Cancer. Screening for gastric cancer in Asia: current evidence and practice</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Leung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kakugawa</surname></persName>
		</author>
		<idno type="DOI">10.1016/S1470-2045(08)70072-X</idno>
		<idno>doi:10 .1016/S1470-2045(08</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet Oncol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">70072</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">Lower risk of death from gastric cancer among participants of gastric cancer screening in Japan: a population-based cohort study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Miyamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kuriyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Nishino</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ypmed.2006.07.016</idno>
	</analytic>
	<monogr>
		<title level="j">Prev Med</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="12" to="19" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main">Japan Collaborative Cohort Study Group. Prospective study of screening for stomach cancer in Japan</title>
		<author>
			<persName><forename type="first">T</forename><surname>Mizoue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yoshimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Tokui</surname></persName>
		</author>
		<idno type="DOI">10.1002/ijc.11183</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="103" to="107" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">Global burden of cancers attributable to infections in 2012: a synthetic analysis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Plummer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>De Martel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vignat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ferlay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Franceschi</surname></persName>
		</author>
		<idno type="DOI">10.1016/S2214-109X(16)30143-7</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet Glob Health</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="e609" to="e616" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main">Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Forouzanfar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cjl</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Afshin</surname></persName>
		</author>
		<author>
			<persName><surname>Gbd</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">388</biblScope>
			<biblScope unit="page" from="1659" to="1724" />
			<date type="published" when="1990">2015. 1990-2015. 2015. 2016. 10053</date>
		</imprint>
	</monogr>
	<note>: a systematic analysis for the Global Burden of Disease Study</note>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">Primary prevention of colorectal cancer</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Giovannucci</surname></persName>
		</author>
		<idno type="DOI">10.1053/j.gastro.2010.01.057</idno>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2029" to="2043" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">Population-wide impact of long-term use of aspirin and the risk for cancer</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Nishihara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wu</surname></persName>
		</author>
		<idno type="DOI">http://jama.jamanetwork.com/article.aspx?doi=10.1001/jamaoncol.2015.6396&amp;utm_campaign=articlePDF%26utm_medium=articlePDFlink%26utm_source=articlePDF%26utm_content=jamaoncol.2016.5688</idno>
		<idno>doi:10 .1001/jamaoncol.2015.6396</idno>
	</analytic>
	<monogr>
		<title level="j">JAMA Oncol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="762" to="769" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main">Physical activity and cancer</title>
		<author>
			<persName><forename type="first">J</forename><surname>Clague</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bernstein</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11912-012-0265-5</idno>
		<idno>doi:10 .1007/s11912-012-0265-5</idno>
	</analytic>
	<monogr>
		<title level="j">Curr Oncol Rep</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="550" to="558" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">Potential health hazards of eating red meat</title>
		<author>
			<persName><forename type="first">A</forename><surname>Wolk</surname></persName>
		</author>
		<idno type="DOI">10.1111/joim.12543</idno>
		<idno>doi:10.1111 /joim.12543</idno>
	</analytic>
	<monogr>
		<title level="j">J Intern Med</title>
		<imprint>
			<date type="published" when="2016-09">2016. September</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main">Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Zauber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Winawer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>O'brien</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMoa1100370</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">366</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="687" to="696" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main">Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Piper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Perdue</surname></persName>
		</author>
		<idno type="DOI">http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.3332&amp;utm_campaign=articlePDF%26utm_medium=articlePDFlink%26utm_source=articlePDF%26utm_content=jamaoncol.2016.5688</idno>
		<idno>doi:10 .1001/jama.2016.3332</idno>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">315</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page" from="2576" to="2594" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main">High prevalence of advanced colorectal neoplasia in the Thai population: a prospective screening colonoscopy of 1,404 cases</title>
		<author>
			<persName><forename type="first">B</forename><surname>Siripongpreeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mahidol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Dusitanond</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12876-016-0526-0</idno>
	</analytic>
	<monogr>
		<title level="j">BMC Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">101</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main">Priorities for the primary prevention of breast cancer</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Colditz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bohlke</surname></persName>
		</author>
		<idno type="DOI">10.3322/caac.21225</idno>
	</analytic>
	<monogr>
		<title level="j">CA Cancer J Clin</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="186" to="194" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main">The International Bank for Reconstruction and Development / The World Bank</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">O</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lipscomb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Murillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Thomas</surname></persName>
		</author>
		<ptr target="http://www.ncbi.nlm.nih.gov/books/NBK343636/" />
	</analytic>
	<monogr>
		<title level="j">Cancer: Disease Control Priorities</title>
		<editor>Gelband H, Jha P, Sankaranarayanan R, Horton S</editor>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<date type="published" when="2015-09-14">2015. Accessed September 14. 2016</date>
		</imprint>
	</monogr>
	<note>Breast Cancer</note>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main">Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">O</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Cazap</surname></persName>
		</author>
		<author>
			<persName><forename type="first">El</forename><surname>Saghir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename></persName>
		</author>
		<idno type="DOI">10.1016/S1470-2045(11)70031-6</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet Oncol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="387" to="398" />
			<date type="published" when="2010">2010. 2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b110">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">C</forename><surname>Allemani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Weir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Carreira</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main">Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)</title>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">385</biblScope>
			<biblScope unit="issue">9972</biblScope>
			<biblScope unit="page" from="977" to="1010" />
			<date type="published" when="2015">2015</date>
		</imprint>
		<respStmt>
			<orgName>CONCORD Working Group</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main">The enigmatic epidemiology of nasopharyngeal carcinoma</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">T</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H-O</forename><surname>Adami</surname></persName>
		</author>
		<idno type="DOI">10.1158/1055-9965.EPI-06-0353</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1765" to="1777" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b113">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Gandini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Sera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Cattaruzza</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b114">
	<analytic>
		<title level="a" type="main">Meta-analysis of risk factors for cutaneous melanoma: III, family history, actinic damage and phenotypic factors</title>
		<idno type="DOI">10.1016/j.ejca.2005.03.034</idno>
	</analytic>
	<monogr>
		<title level="j">Eur J Cancer</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page" from="2040" to="2059" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b115">
	<analytic>
		<title level="a" type="main">Global incidence of oesophageal cancer by histological subtype in 2012</title>
		<author>
			<persName><forename type="first">M</forename><surname>Arnold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Soerjomataram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ferlay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Forman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="381" to="387" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b116">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">D</forename><surname>Loomis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Z</forename><surname>Guyton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Grosse</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b117">
	<analytic>
		<title level="a" type="main">Carcinogenicity of drinking coffee, mate, and very hot beverages</title>
		<idno type="DOI">10.1016/S1470-2045(16)30239-X</idno>
		<idno>doi:10.1016 /S1470-2045</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet Oncol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page">30239</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
		<respStmt>
			<orgName>International Agency for Research on Cancer Monograph Working Group</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b118">
	<analytic>
		<title level="a" type="main">Epidemiology and pathogenesis of esophageal cancer</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Holmes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Vaughan</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.semradonc.2006.09.003</idno>
	</analytic>
	<monogr>
		<title level="j">Semin Radiat Oncol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="2" to="9" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b119">
	<analytic>
		<title level="a" type="main">Epidemiology of esophageal adenocarcinoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Pera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Manterola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Vidal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Grande</surname></persName>
		</author>
		<idno type="DOI">10.1002/jso.20357</idno>
	</analytic>
	<monogr>
		<title level="j">J Surg Oncol</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="151" to="159" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b120">
	<analytic>
		<title level="a" type="main">A global assessment of civil registration and vital statistics systems: monitoring data quality and progress</title>
		<author>
			<persName><forename type="first">L</forename><surname>Mikkelsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Phillips</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Abouzahr</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(15)60171-4</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">386</biblScope>
			<biblScope unit="page" from="1395" to="1406" />
			<date type="published" when="2015">2015. 10001</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
